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Heterocycles are present in more than half of organic compounds. For organic chemists, 
they are valued as synthetic targets or scaffolds to construct valuable products. For the past two 
decades, the Howell group has made contributions towards the synthesis and applications of 4-
membered heterocyclic compounds, such as oxetanes and β-lactones. Most of the previously 
reported transformations that involve strained heterocyclic compounds rely on traditional methods 
in which rendering the reaction with good and predictable selectivity (regio-, chemo- and 
stereoselectivity) is challenging. 
The works described took advantage of the intrinsic reactivity of strained heterocycles and 
combined that with the highly selective transformations promoted by transition metal (TM) 
catalysts. Three successful methodologies were developed. Chapter 1 describes the discovery 
and scope of a novel Pt-catalyzed expansion of spirocyclopropyl oxetanes to synthetically useful 
3-methylenetetrahydrofurans. This unprecedented oxetane expansion was realized via 
cyclopropane activation under platinum catalysis. Mechanistic studies, through 13C-labelling and 
13C-DEPT NMR analyses, suggested that the oxetane expansion was promoted by a 
regioselective carbon-carbon bond activation of cyclopropane with platinum. 
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Chapter 2 describes two transition metal catalyzed transformations of α-methylene-β-
lactones. First is a Rh-catalyzed conjugate addition with aryl boronic acids to access various β-
lactones. β-Lactones are highly privileged synthetic products and intermediates. They have been 
shown to elicit serine hydrolase inhibition. They are also used as intermediates to obtain 
difunctionalized acyclic compounds, and this was the goal in the next method.  The second 
method developed involves a chemoselective opening of β-lactones to form β-hydroxy amides. 
Ring opening of β-lactones with several nucleophiles typically provide a mixture of two major 
products; opening via the (a) alkyl C–O bond, or (b) the acyl C–O bond. The selective ring-opening 
was realized via activation of acyl carbon-oxygen bond under palladium catalysis. Under the 
developed conditions, several β-lactones were selectively opened with various amine 
nucleophiles and gave β-hydroxy amides as sole product. This method was also translated to a 
Pd-catalyzed asymmetric kinetic resolution of racemic to enantioenriched β-lactones. 
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1.1 Introduction 
Oxetanes are valuable intermediates in organic synthesis due to their diverse 
reactivies. Strategies in utilizing oxetanes as synthetic intermediates include: (a) ring opening 
to afford 1,3-difunctionalized acyclic products, (b) ring expansion to access diverse 
heterocyclic products, and (c) functionalization at C2 or C3 to obtain novel oxetanes. These 
transformations are typically achieved using classical methods that often impose challenges 
in rendering them chemo- and regioselective. Recently, oxetane expansions with high 
selectivity have been developed by using transition metal catalysis. Successful 
transformations utilized activating groups such as allyl, aryl, or alkynyl. In this study, we 
developed a platinum catalyzed oxetane expansion using cyclopropane activation to obtain 
synthetically valuable 3-methylenetetrahydrofurans. 
The following introductory sections will include a background on oxetanes in 
biologically active compounds and as intermediates in organic synthesis. Recent methods on 
C2 oxetane functionalization and transition metal catalyzed oxetane expansions are 
emphasized. Lastly, activation of cyclopropane with platinum to form platinacyclobutanes and 
their reactivities are described. 
 
1.1.1 Oxetanes in Biologically Active Compounds 
Oxetanes are important motifs in synthetic and natural products1 and have recently 
received considerable attention as versatile elements in drug discovery.2 For example, 
paclitaxel, an FDA approved marketed drug (as Taxol) contains an oxetane ring which was 
postulated to contribute to the rigidity of the compound.3 Paclitaxel, together with the 
structurally related drug docetaxel (marketed as Taxotere), is presently used in cancer 
chemotherapy. 
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Other natural products that contain an oxetane ring have also shown biologically 
interesting activities. Oxetanocin A, first isolated from the soil-bacterium Bacillus megaterium 
NK84-0218, inhibits HIV reverse transcriptase by mimicking adenosine. For this reason, 
commercial and synthetic interest were considerable.4 Other oxetane containing compounds 
of biological importance include merrilactone A (rat neuron stimulant),5 oxetin (herbicidal and 
antibacterial),6 thromboxane A2 (promotes vasoconstriction),7 dictyoxetane,8 and others. 
Anthropogenic small molecules such as EDO9 and oxasulfuron10 also incorporate oxetane 
rings. The insecticide EDO is 25 times more potent than dichlorodiphenyltrichloroethane 
(DDT). In contrast to DDT, a persistent organic pollutant, EDO is biodegradable.9 
 
1.1.2 Oxetanes in Drug Discovery 
Oxetanes have remained a neglected unit in medicinal chemistry since the first 
preparation11 of the parent structure in 1878. In the past decade, however, a series of reports 
described the remarkable ability of oxetane units to influence physicochemical properties of 
drugs and drug candidates. Parameters such as solubility, lipophilicity, hydrogen bond affinity 
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Figure 1. Biologically active natural and synthetic products containing oxetane.
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and metabolic stability of both cyclic and acyclic frameworks were influenced when oxetane 
was used as a surrogate for other functionalities.2 
For example, oxetane was viewed as a gem-dimethyl equivalent wherein the two 
methyl groups are bridged by an oxygen atom (Figure 2a).12 It was reasoned that the polar 
oxygen in oxetane would compensate for the intrinsic lipophilicity of the gem-dimethyl group. 
Many drugs and drug candidates contain at least one gem-dimethyl group, thus highlighting 
its relevance in drug discovery. Sometimes, the purpose of having gem-dimethyl is to block 
the metabolically unstable benzylic positions in drug candidates.13 The replacement of 
benzylic hydrogens with methyl groups, however, can significantly increase the lipophilicity of 
the molecule. Consequently, the more polar oxetane is viewed as a beneficial surrogate. 
 
It has also been postulated that oxetanes can act as surrogates for carbonyl groups, 
such as aldehydes and ketones (Figure 2b).2 The electron lone pairs on the oxygen of oxetane 
and on the carbonyl groups display comparable spatial arrangements and polarizability. 
Likewise, the ability of oxetanes to act as hydrogen bond acceptors is almost equivalent to 
aldehydes and ketones. Replacement of a carbonyl group with an oxetane could be beneficial, 
since aldehydes and ketones are generally absent in drug discovery because of their inherent 
chemical and metabolic liability. 
MeMe
O
gem-dimethyl
(lipophilic)
oxetane
(liponeutral)
OO
carbonyl oxetane
1.2 A
o
2.1 A
o
N
O
R
N
O
N
O
R
R
carbonyl oxetane morpholine
(a) (b)
(c)
Figure 2. Oxetanes as surrogates for (a) gem-dimethyl, (b) carbonyl 
groups, and  (c) morpholines.
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Recently, spirocyclic oxetanes were also shown to serve as viable substitutes for 
morpholine (Figure 2c),2a a common moiety in pharmaceutical drugs. Morpholine is often used 
as a hydrophilic anchor in lipophilic compounds; however, it can also be the target of oxidative 
clearance mechanisms. 
A successful structural modification using oxetanes as modules in drugs was reported 
in oligonucleotide analogues.14 Oxetane derivatives of cytidine and thymidine have been 
examined for their use in antisense oligonucleotides (AONs). The resulting AON-RNA 
heterodimers displayed increased stability towards degradation by nucleases. Diederich and 
co-workers showcased the use of oxetanes to enhance the water solubility of a drug 
candidate.15 The oxetane appended cytosine showed inhibition of the protein IspE, a potential 
enzyme target for treatment of malaria. 
 
 
1.1.3 Reactivities of Oxetanes 
The strained nature of oxetanes and the availability of diverse methods for their 
preparation have provided opportunities for the discovery of novel transformations. In order to 
take advantage of the reactivities presented in oxetanes, one must consider the following 
distinct modes of reactivies: (a) ring opening to obtain 1,3-functionalized acyclic products, (b) 
oxetane-expansion to construct new heterocyclic systems, and (c) functionalization at C2 or 
C3 to obtain oxetane intact products (Scheme 1). Numerous advances have been made in 
NO
O
O O
N
NH2
O NO
O
O O
NH
O
O
(a)
N
N
EtO2C
O
NH2 N
H
S
O O
O
(b)
Figure 3. Oxetane-containing analogues of  (a) cytidine and thymidine used in 
novel antisense oligonucleotides and (b) cytosine as inhibitor of IspE.
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the ring opening16 of oxetanes to obtain 1,3-functionalized acyclic products or polymers. 
However, the utility of oxetanes in expansion reactions to contruct new heterocycles is still at 
its infancy.  In this section, strategies to exploit the potential of oxetanes as synthetic 
intermediates to construct biologically important heterocycles is discussed. Likewise, methods 
for the functionalization of oxetanes specifically at C2 will be reviewed. 
 
 
1.1.3.1. Metal catalyzed ring expansions of oxetanes 
Most of the recent oxetane ring expansions reported in the literature rely on transition 
metal catalysis and the presence of an activating group at C2 (Scheme 2). One of the earliest 
reports of an oxetane expansion reaction dates back to 1966 when Noyori and coworkers 
demonstrated the asymmetric insertion of methyl diazoacetate into 2-phenyloxetane to form 
3-phenyltetrahydrofuranyl-2-carboxylate under chiral Cu(II) catalysis (Scheme 3).17 
O
R
oxetane 
opening
oxetane 
expansion
C2 or C3 
functionalization
Nu OH
R
OR
n
O
R
O
R
FG
FG
or
Scheme 1. Reactivities of oxetanes: (a) oxetane opening to form 1,3-
functionalized acyclic products, (b) ring-expansion to form new 
heterocycles and (c) C-2 and C-3 functionalization of oxetanes.
(a) (b)
(c)
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 This remarkable copper catalyzed transformation was revisited by Katsuki18 and Fu,19 
using chiral bipyridine and bisazaferrocene Cu complexes, respectively, to furnish 2,3-
disubstituted tetrahydrofurans with moderate to good diastereoselectivities (Scheme 3). 
Mechanistic studies done by Katsuki suggested that these carbenoid insertions proceed 
through oxygen ylides (and perhaps zwitterionic intermediates) that undergo ring expansion, 
with the regioselectivity controlled by the presence of the stabilizing aromatic moiety at C2. 
Katsuki showcased the utility of the overall insertion in the total syntheses of trans-(+)-whisky 
lactone and (-)-avenaciolide,18f,18b where the C2 stabilization came from acetylenic moieties.  
O
O Pt
R R
Pd
O
N
X
R
X = O; NR'
G
G = aryl, alkenyl, alkynyl,
       spirocyclopropyl
O CO2R'
Scheme 2. Selected transition metal catalyzed expansion 
of C-2 activated oxetanes.
2
Ar
Cu
Ar
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 The C2 activation strategy was utilized by Alper and coworkers using a vinyl group as 
activator.20 Under Pd catalysis, several vinyl oxetanes reacted with heterocumulenes via a net 
cycloaddition to form 6-membered heterocyles (Scheme 4). It was proposed that the 
transformation involves the formation of a Pd-allyl intermediate. 
O
N2
CO2RAr
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or racemic
Noyori 1966
O
Ar
CO2R
+
chiral Cu cat.
Katsuki 1994
N N
TBSO
Me
Me OTBS
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Fu 2001
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O
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N
O N
O
Ph Me
Me Ph
O
Ph
CO2Me
85%
(trans:cis 2:1)
L1
O
Ph
CO2R
74%
(trans:cis 19:1)
e.s. = 99%
L3-R,R
Selected examples:
L1 L2 L3
O CO2R
29%
(trans:cis 3:1)
L3-R,R
OMe
O CO2R
74%
(trans:cis 1:6)
e.s. = 98%
L3-S,S
CF3
Scheme 3. Cu-catalyzed oxetane expansion with carbenoids to form tetrahydrofurans.
e.s. = enantiospecificity; obtained as %ee product / %ee starting material x 100.
O
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7-steps
O
O
O
H
H O
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Synthesis of avenaciolide:
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 From a successful copper catalyzed ring expansion of vinyl oxiranes, Njardason and 
and his group have further demonstrated the utility of vinyl oxetanes, showing they can also 
be opened to allylic intermediates using copper catalysts (Scheme 5).22 The transformations 
proceeded with high efficiency under Cu(OTf)2 catalysis. Brønsted acids, such as TfOH and 
p-TsOH, were also found to catalyze this process. The outcome led to the proposal that the 
reaction proceeds through an allylic intermediate, which undergoes cyclization with the 
oxygen atom in a 6-endo fashion. Furthermore, an enantioselective version was achieved by 
the desymmetrization of a dialkenyl oxetane using chiral catalysts. Although yields were lower 
compared to copper catalysis, chiral phosphoric acids/amides provided the dihydropyrans in 
up to 90% e.e. 
O cat. Pd2dba3
Phosphine ligandR
R = H or CH3
NAr C O
O
N
R
Y
Ar
NAr C N Ar
Pd (0)
O
Y
ArN
O
PdLn PdLn
or
Y = O or NAr
+
NAr C Y
Alper 1999
O
N
NPh
Ph
98%
O
N
NPh
Ph
83%
Me
O
N
O
Ph
83%
O
N
O
39%
Me
OMe
Scheme 4. Pd-catalyzed expansion of vinyl oxetanes with heterocumulenes.
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 Gagosz and coworkers have cleverly used dual C2 activation (aryl and alkylnyl) to 
promote oxidative Cu(I)-catalyzed ring expansion of oxetanes (Scheme 6).23 An interesting 
divergence in product selectivity was delivered by varying the nature of the pyridine oxide 
oxidant. Mechanistically, it was proposed that the formation of lactone or 
dihydrofuranaldehyde could originate from the same allenyloxypyridinium intermediate. It was 
found that the electron-deficient oxidant, 3-bromopyridine oxide, gave exclusive formation of 
dihydrofuranaldehyde, since 3-bromopyridine is a good leaving group during the 5-exo 
cyclization. In contrast, use of the more electron-rich oxidant, 4-methoxypyridine oxide, 
favored cyclization in a 6-endo fashion, providing only 6-membered lactones. 
chiral cat.
O
C4H9
C4H9
N
Cu
N
O O
TfO OTf
A; 17% ee, 84% yield
O
O
P
NHTs
O
Ar
Ar
O Cu(OTf)2 (1 mol%)
O
R
R
O
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CuOTf O
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Njardarson 2012
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O
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Ar = 9-anthracene
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OPh
95%
OPh
87%
OPh
92%
O
96%
O
83%
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Selected examples:
Scheme 5. Cu-catalyzed ring expansion of vinyl oxetanes.
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1.1.3.2 C-2 Functionalization of oxetanes via oxocarbenium ion 
  
 In the last two decades, the Howell group has engaged in the development of methods 
for the preparation and exploitation of oxetanes. In particular, we reported the first general 
approaches to 2-methyleneoxetanes24 and 1,5-dioxaspiro[3.2]hexanes.25 In exploring the 
reactivities of these unusual oxetanes, we found an analogous reactivity in the generation of 
oxetane oxocarbenium ions when treated with suitable Lewis acids or electrophiles (Scheme 
7). These oxocarbenium ions were intercepted with nucleophiles, and the reaction outcome 
has been diverted to two distinct pathways, ring opening or 1,2-addition.24-32 While there have 
been several functionalization strategies for oxetanes,2,33 specifically at the C-3 position, in 
this section our work on the generation of oxetane oxocarbenium ions and their reactivity with 
O
tBu Cu(NCCH3)4NTf2 
(4 mol%)
O[M]
C
Ar O
H
Pyr
Tf2N
O
C
Ar O
H
Pyr
Tf2N[M]
OPyr = 3-bromopyridine oxideOPyr = 4-methoxypyridine oxide
5-exo6-endo
OAr
CHO
O
O
Ar
Ar = p-tBuC6H4
5 examples
up to 88% yield
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up to 89% yield
74% yield
Gagosz  2012
Cu(NCCH3)4NTf2 
(4 mol%)
3-bromopyridine oxide4-methoxypyridine oxide
Ar = p-tBuC6H4
Scheme 6. Cu-catalyzed ring expansion of alkynyl and aryl oxetanes.
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Scheme 7. Oxetane oxocarbenium ion from 2-methyleneoxetane or 
dioxaspirohexane and reaction with nucleophiles to obtain C-2 
functionalized oxetanes.
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nucleophiles via 1,2-addition will be discussed. This constitutes an attractive method for 
functionalization of oxetanes at C-2. 
 
 
 Our first report in the generation of an oxetane oxocarbenium was in an intramolecular 
iodoetherification of a 2-methyleneoxetane to provide the first synthesis of a [2.2.0]-fused ketal 
system (Scheme 8).28 In the same year, the generation of oxetane oxocarbenium ions from 
dioxaspirohexanes was assumed from the outcomes of reactions with DIBAL-H or Me3Al.25 In 
these reactions, aluminum served as a Lewis acid, generating the oxocarbenium ion; 
subsequent reaction with hydride or a methyl group provided 2-hydroxymethyloxetanes 
(Scheme 9). We recognized that this protocol offered a way to functionalize oxetanes at the 
C-2 position, and the methodology was expanded to heteroatom nucleophiles, for example, 
azide and N-heteroaromatic bases.29,30 The functionalization of oxetanes at C-2 with N-
heteroaromatic bases appeared to be correlated with the pKa of the nucleophile, with more 
acidic nucleophiles (pKa <10) favoring 1,2-addition while more basic nucleophiles provided 
mainly ring-opened products (Table 1). 
O
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Scheme 8. Intramolecular C-2 functionalization of oxetane via oxocarbenium ion with 
O-nucleophile.
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Scheme 9. Intramolecular C-2 functionalization of oxetane via oxocarbenium ion with 
C  and H-nucleophiles.
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 The ability to generate and capture oxetane oxocarbenium ions from 2-
methyleneoxetanes and dioxaspirohexanes has been exploited in the syntheses of C-2 
functionalized oxetanes of biological importance. epi-Oxetin was synthesized from an L-serine 
derived dioxaspirohexane, which underwent an aluminum-assisted 1,2-addition with hydride 
to furnish a 2-hydroxymethyloxetane as the key intermediate (Scheme 10).31  
O
OR
+
O
R OH
Howell 2003
Table 1. Intramolecular C-2 functionalization of oxetane via 
oxocarbenium ion with N-nucleophiles.
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 Recently, the group developed a F+-mediated C-2 incorporation of nucleobases to 2-
methyleneoxetanes to access oxetanocin-type frameworks (Scheme 11).32 This method was 
used in the synthesis of the first psico-oxetanocin analog of the powerful antiviral natural 
product, oxetanocin A (see Figure 1). 
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Scheme 10. Utility of oxetane oxocarbenium ion in the synthesis of 
epi-oxetin.
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Scheme 11. Utility of oxetane oxocarbenium ion in the synthesis of psico-oxetanocins.
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1.1.4 The Chemistry of Platinacyclobutanes 
1.1.4.1. Formation of stable platinacyclobutanes 
 Activation of C−C bonds in the presence of transition metal complexes is a challenge 
in organic and organometallic chemistry. However, activation of C−C bonds in cyclopropanes 
with transition metals (e. g. Pt, Rh, Ni) to form metallacyclobutanes has been more frequently 
reported due to the release of ring strain associated with 3-membered rings. The first 
metallacyclobutane report dates back to 1955 when cyclopropane was reacted with 
hexaplatinic acid (H2PtCl6) to obtain an unknown Pt complex I.34 Treatment of complex I with 
pyridine gave a Pt complex with a proposed structure having cyclopropanes coordinated to Pt 
via an edge complexation mode (Figure 4a). The structure of the initial Pt complex I obtained 
by Tipper was identified independently by Chatt35 and Gilliard36 as a tetrameric complex 
involving platinacyclobutanes (Figure 4b). 
 
 HPtCl6
Pt
Cl
Pt
Cl
Py
ClPy
Cl
Pt complex proposed by Tipper
pyridine
Pt Cl
PtCl
Cl Pt
ClPt
Cl
Cl
Cl
(CH3CO)2O
Pt complex I
(unknown)
Pt complex I
(a) Tipper 1955
(b) Chatt 1961 ; Gillard 1966
Figure 4. (a) The first reaction to give platincyclobutane by Tipper and 
(b) a tetrameric structure of Pt complex I.
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 Several stable platinacyclobutanes were obtained using Ziese’s dimer [Pt(C2H4)Cl2]2, 
a more general Pt source (Scheme 12).37,38 It was believed that the formation of 
platinacyclobutanes occured by an initial edge-attack of cyclopropane to Pt(II). Subsequently, 
oxidative addition delivered Pt(IV) platinacyclobutanes. In the presence of a ligand such as 
pyridine, stable Pt(IV) platinacyclobutanes were obtained and characterized by NMR. In the 
absence of pyridine, dimerization of the initial platinacyclobutane complex led to a tetrameric 
Pt(IV) complex (Scheme 13). In the case of 1-substituted and 1,1-disubstituted 
cyclopropanes, the oxidative addition happened at the least sterically hindered C−C bond 
(Scheme 12). 
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1.1.4.2. Reactions involving platinacyclobutanes 
 The facile formation of platinacyclobutanes from cyclopropanes and Pt(II) constitutes 
an interesting C-C bond activation approach. However, due to the observed stability of the 
platinacyclobutanes obtained, their synthetic utility as intermediates or in a catalytic 
transformation was limited.39-42 Sonoda39 and co-workers first reported a Ziese’s dimer 
catalyzed C-C bond activation for the isomerization of silyloxycyclopropanes to form allyl silyl 
ethers (Scheme 14). The reaction was found to be completely regio- and stereoselective. 
Mechanistic studies suggested that β-hydride abstraction provided the olefin. This was 
confirmed by reacting deuterated silyloxycyclopropane with Ziese’s dimer which gave allyl silyl 
ether product with 100% deuterium content at the methylene carbon. A mechanism that was 
proposed involves initial formation of platinacyclobutane where Pt undergoes oxidative 
addition to the C−C bond next to oxygen. This then undergoes ring-opening to form a 
zwitterionic oxocarbenium ion. β-Hydride migration, followed by reductive elimination, 
provides the olefinic product.  
pyridinePt
Cl
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Cl Cl
Cl
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Cl
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Scheme 13. Proposed mechanism for the formation of platinacyclobutane complexes.
a platinacyclobutane
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 Jennings and Hoberg40 reported a Zeise’s dimer catalyzed isomerization of 
alkoxycyclopropanes to ketones (Scheme 15). This reaction was also found effective when 
hydroxycyclopropanes were used. To gain insight into the mechanism, a deuterated 
cyclopropane alcohol was treated with Ziese’s dimer in dry diethyl ether; this gave ketone 
product with deuteration at the methyl substituent. This led them to propose a mechanism that 
involves initial formation of a platinacyclobutane intermediate, followed by ring opening and 
subsequent reductive elimination. In a stoichiometric olefin trapping experiment, a ketone 
having a Pt-bound to olefin was isolated and characterized by X-ray crystallography. 
OSiR 2-5 mol%
[Pt(C2H4)Cl2]2
CDCl3, rtn
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n
n = 1, 2
R = TMS, TBS
73 to 96% yield
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DDTBSO HTBSO H
D
D
100% d2 content
1,2 hydride shift
Scheme 14. Pt(II)-catalyzed rearrangement of silyloxycyclopropanes.
Sonoda 1992
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 Madsen41 and coworkers reported a ring opening reaction involving 1,2-
cyclopropanated sugars with alcohols in the presence of catalytic Zeise’s dimer (Scheme 16). 
This reaction provided C-3 methylated sugars with high selectivity for the α-anomer. When 
this ring-opening reaction was conducted with deuterated alcohol as the nucleophile, product 
was obtained having deuteration on the methyl group at C-3. Based on previous mechanistic 
reports by Jennings, Madsen and coworkers proposed a mechanism that involves initial 
formation of a platinacyclobutane or platinated oxocarbenium ion intermediate. Subsequent 
nucleophilic attack by an alcohol, followed by reductive elimination would provide the 
observed C-2 methylated sugar. 
 
OR 5 mol%
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n Me
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Scheme 15. Pt(II)-catalyzed rearrangement of alkoxycyclopropanes.
Jennings 1996
OD 5 mol%
[Pt(C2H4)Cl2]2
Et2O
OD
PtCl2
O
PtCl2
D
O
CH2D
reductive 
eliminationO
Pt
Cl
D3CCN
olefin bound Pt complex
 20 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
CH2Cl2, rt
BnO
BnO
OBn
O
OBn
BnO
BnO OR3.7 mol%[Pt(C2H4)Cl2]2ROH+
O
OBn
BnO
BnO OMe
82%; α/β 21:1
O
OBn
BnO
BnO OBn
92%; α only
O
OBn
BnO
BnO O
95%; α/β 12:1
selected examples:
O
BnO
BnO
OBn
BnOD
[Pt(C2H4)Cl2]2
O
BnO
BnO
OBn
PtLn
O
BnO
BnO
OBn
PtLn
O
BnO
BnO
OBn
PtLn
OBn
Dreductive 
elimination
-PtLn
O
BnO
BnO
OBn
OBn
D
proposed mechanism:
Scheme 16. Pt(II)-catalyzed ring opening of cyclopropanated sugars with O-nucleophiles.
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1.2 Research Design and Mechanistic Hypothesis 
Our success on the C-2 functionalization of oxetanes via the generation of oxetane 
oxocarbenium ions from methyleneoxetanes 2 or dioxaspirohexanes 3 led us to explore other, 
starting materials (Scheme 17). We have previously shown that spirocyclopropyloxetanes 4 
can easily be generated from Simmon-Smith cyclopropanation of 2-methyleneoxetanes.43 We 
envisioned that stable spirocyclopropyloxetanes could generate oxetane oxocarbenium ions 
similar to those derived from methyleneoxetanes 2 and dioxaspirohexanes 3.  
                                                                                                                            
1.2.1 Mechanistic Hypothesis 
 
Based on previous reports by Madsen41 on the Pt(II)-catalyzed ring opening of 
cyclopropanated sugars with alcohols, we postulated that 2,2-disubstituted oxetanes 5 could 
be accessed as shown in Scheme 17. First, the cyclopropane in spirocyclopropyloxetane 4 
O
PtLn
OO
4
O Nu
NuHPtLn
Pt cat.R R R
R
-PtLn
A B
O
PtLn
R Nu
H
O
R
O
R
[OLA]
O
R
E
electrophile
Lewis acidOR
O
(E+)
(LA)
Nu O
OH/E
Nu
oxetane
oxocarbenium ions
CH2I2, Et2Zn
R 2
Scheme 17. Mechanistic hypothesis for the Pt(II)-catalyzed ring opening of spiro- 
cyclopropyloxetanes 4 with nucleophiles to obtain C-2 functionalized oxetanes. 
Mechanism involves: (a) oxidative addition of Pt(II) to the C−C bond
of cyclopropane adjacent to oxygen to form platinacyclobtaune A or oxetane 
oxocarbenium ion B, (b) nucleophilic 1,2 addition, followed by (c) reductive elimination.
DMDO
2
3
reductive 
elimination
2
(a) (b)
(c)
5
5
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could undergo oxidative addition to Pt(II) to form platinacyclobutane A where the platinum is 
inserted to the C−C bond adjacent to oxygen. This is analogous to oxetane oxocarbenium ion 
B. Second, nucleophilic attack of an external nucleophile would add to the oxocarbenium, 
leading to the formation of an oxetane-containing Pt complex. Finally, reductive elimination 
would provide novel C-2 functionalized oxetane with subsequent regeneration of Pt(II) 
catalyst. 
 
1.2.2 Initial studies 
 At the onset of this study, spirocyclopyloxetane 4a (or 4b) was used as a substrate 
model and reacted with Zeise’s dimer under the Madsen conditions.41 In the presence of 
methanol as nucleophile, mixtures of two products, 3-methylenetetrahydrofuran 6a (or 6b) 
and allyl ether 7a (or 7b) (Table 2) were obtained, unexpectedly.  When the reaction was 
conducted in the absence of methanol, 4a was converted to just 3-methylenetetrahydrofuran 
6a, while allyl ether 7a was the sole isolable product when the reaction was conducted in the 
presence of excess methanol.  Neither outcome could be rationalized by the initial formation 
of oxetane oxocarbenium ions (Scheme 17). Thus, these initial results represented a novel 
pathway for reactions between oxygen-substituted cyclopropanes and Zeise’s dimer. 
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3-Methylenetetrahydrofurans are highly sought intermediates in organic chemistry and 
are also found in several biologically important natural products.43 With the unanticipated Pt-
catalyzed expansion of spirocyclopropyloxetanes to synthetically useful 3-methylene-
tetrahydrofurans, we decided to optimize the reaction and explore the scope of this 
transformation. Likewise, since it was evident that oxidative addition of Pt was not occurring 
in the cyclopropane adjacent to the C-O bond, we conducted mechanistic studies. 13C-
Labeling coupled with 13C-DEPT NMR studies provided clear evidence of an alternative 
oxidative addition of Pt to cyclopropane. These results are described in the next section. 
 
 
 
 
 
O
R
Ph
 0.5 M CH2Cl2 
45 oC
O
R
Ph HO O
Ph R
+
6a/b 7a/b4a R = H
4b R = CH3
10 mol%
[Pt(C2H4)Cl2]2
MeOH
1 (4a) 2.0 1:1.5 - -
2 (4b) 2.0 1:2 - -
3 (4a) excess(~20 eq) 7a only 0 50%
4 (4a) 0 6a only 34% 0
Entry (subtrate) Yield 6 Yield 7aRatio 6:7MeOH (eq)
Table 2. Initial findings on the reaction of spirocyclopropyloxetanes with catalytic 
Zeise' dimer.
Reaction conditions: 0.5 to 1.0 mmol 4a/b; aRatios are based on 1H NMR of the crude 
reaction mixture. Yields are isolated yields.
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1.3 Results and Discussion 
1.3.1 Optimization of the reaction 
Several parameters to optimize the expansion of spirocyclopropyloxetanes to 3-
methylenetetrahydrofurans were initially examined by Sampada Chitale and Meena Thakur 
(Table 3).44 Evaluation of solvents for the reaction showed that non-coordinating solvents, 
such as methylene chloride, chloroform, and toluene, gave cleaner conversion of 
spirocyclopropyloxetane 4a to 3-methylenetetrahydrofuran 6a at concentrations from 0.2 to 
1.0 M. Solvents such as diethyl ether, tetrahydrofuran and ethyl acetate gave poor reaction 
outcomes.  
 
O
4a
solvent, temp. 
molar conc.
O
6a
Ph Ph
Pt catalyst 
(10 mol %)
aTime to complete consumption of the starting material or until a reaction time of 20 h. 
bConversions were monitored by 1H NMR (isolated yields in parentheses). 
cDfmp; Me(C2F5)2P. 
dDfepe; (C2F5)2PCH2CH2P(C2F5)2.
Table 3. Optimization of conditions for the Pt-catalyzed expansion of spirocyclopropyloxetanes 
to 3-methylenetetrahydrofurans.
entry solvent Pt catalyst temp conc (M) timea (h)
% conv.b 
(yield)
1
2
3
4
5
6
7
8
9
10
11
12
13
CD2Cl2
CD2Cl2
CD2Cl2
CD2Cl2
CD2Cl2
CDCl3
tol-D8
CD2Cl2
tol-D8
CD2Cl2
CD2Cl2
CD2Cl2
CD2Cl2
1
1
1
1
1
1
1
PtCl2
PtCl2
CODPtCl2
C2H2-Pt(PPh3)3
(dfmp)2PtMe2c
(dfepe)2PtEt2d
rt
rt
rt
45 oC
45 oC
55 oC
80 oC
45 oC
80 oC
45 oC
45 oC
45 oC
45 oC
0.2
0.5
1.0
0.5
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
20
20
20
1
1
0.75
0.5
20
20
20
20
20
20 0
0
0
0
0
0
100 (25%)
100 (30%)
100 (34%)
100
100
100
65
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When the reaction temperature was increased from room temperature to 45 oC, the 
reaction time needed for complete conversion decreased (entries 4-7). Subsequent reactions 
were conducted at 45 oC and with a concentration of 0.5 M in CH2Cl2. 
It was initially reasoned that the rearrangement was initiated by oxidative addition of 
Pt(II) into the cyclopropane;37,38  so a variety of Pt catalysts was examined (Table 3, entries 8-
13). Oxetane 4a did not react with the common Pt catalysts shown. This is consistent with 
literature precedent showing that the formation of platinacyclobutanes is achieved almost 
exclusively using Zeise’s dimer as the Pt source.37 
Electron-donating ligands have been previously reported to stabilize platinacycle 
complexes;37 so several nitrogen and phosphorus ligands were explored. In general, addition 
of phosphine ligands provided improved reactivity and increased isolated yields (Table 4). 
However, no reaction was observed when an electron withdrawing phosphine ligand was used 
(entry 3), even after 20 h of heating. In contrast, tricyclohexylphosphine and triethylphosphite 
decreased reaction times to 1 h or less and provided increased isolated yields (up to 70%). 
The reaction could also be performed at room temperature with no diminution in yield (entries 
10, 12 and 13). When this reaction was performed with decreased catalyst loading (5 instead 
of 10 mol%) at room temperature, clean conversion was still attainable giving 73% yield of 
product (entry 13). Although triethylphosphite provided the highest yield for 4h, 
tricyclohexylphosphine gave better results for a broader range of substrates. 
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1.3.2 Preparation of spirocyclopropyloxetane substrates 
A variety of spirocyclopropyloxetanes 4a-n was prepared to explore the scope of the 
ring expansion. The starting β-lactones were prepared from previously reported lactonization 
procedures (see Experimental Section for details). Methylenations of various β-lactones were 
conducted using our previously reported protocol by reacting them with dimethyltitanocene in 
toluene.24 The methyleneoxetanes were obtained in good yields (Scheme 18). The 
spirocyclopropyloxetanes were synthesized from the corresponding 2-methyleneoxetanes 2a-
n in moderate to high yields by a modified Simmon-Smith cyclopropanation (Scheme 19).43 
Spirocyclopropyloxetanes 2b, 2d–2g and 2m were previously prepared by Sampada 
Chitale44a and Meena Thakur. 44b 
none
PPh3 (20)
P(C6F5)3 (20)
P(t-Bu)3 (20)
P(n-octyl)3 (20)
bipyridine (10)
DCPE (10)
PCy3 (20)
PCy3 (20)
PCy3 (20)
P(OEt)3 (20)
P(OEt)3 (20)
P(OEt)3 (10)
Table 4. Survey of ligands for the Pt-catalyzed expansion of spirocyclopropyl-
oxetanes to 3-methylenetetrahydrofurans.
O
10 mol % 
[Pt(C2H4)Cl2]2   
20 mol % ligand
4c R = H
4h R = CH3
0.5 M, CD2Cl2, 
45 oC
O
R
BnO
R
BnO
6c R = H
6h R = CH3
aReaction time based on complete consumption of starting material as monitored by 1H 
NMR; bAfter 20 h no conversion was observed; cReaction run at room temperature; 
dCatalyst loading decreased to 5 mol %.
4h
4c
4c
4h
4h
4h
4h
4c
4h
4h
4h
4h
4h
1
2
 3b
4
5
6
7
8
9
 10c
11
 12c
13c,d
2.5 h
20 h
20 h
2 h
4.5 h
2.25 h
30 min
45 min
40 min
6 h
15 min
4 h
6 h
41%
34%
0%
60%
66%
61%
70%
64%
69%
70%
68%
72%
73%
entry        substrate             ligand (mol %)                timea                  isolated yield
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O  Cp2TiMe2
toluene, 80 oC, 2-4 h
O
O
R R
 2n (70%)
O
BnO
2j (57%)
O
O
2k (72%)
OO
 2i (74%)2h (75%)
O
2a (76%)
Ph
8a-n 2a-n
O
2e (48%)
O
2l (78%)
O
2f (25%)
BocHN
O
2g (60%)
TrHN
2m (77%)
O
2b (76%)
Ph
Ph
R'O
BnO
Ph
Ph
Ph O O
c-Hex
Ph
Ph
c-Hex
Scheme 18. 2-Methyleneoxetanes prepared from methylenation of β-lactones.
OR' = OBn; 2c (70%)
OR' = OTBDPS; 2d (49%)
O
BnO
  4j (60%)
O
O
4k (76%)
OO
  4i (78%)  4h (78%)
O
  4a (83%)
Ph
O
  4b (87%)
Ph
O
  4e (40%)
O
4f (51%)
BocHN
O
4g (45%)
TrHN
O
  4l (86%)   4m (98%)   4n (75%)
BnO
Ph
BnO
Ph
Ph
Ph
O O
c-Hex
Ph
Ph
c-Hex
O
R
2a-n
Et2O, 0 oC, 3 h
OCH2I2, Et2Zn R
4a-n
Scheme 19. Spirocyclopropyloxetanes prepared from cyclopropanation of 
2-methyleneoxetanes.
6 6
OR' = OBn; 4c (78%)
OR' = OTBDPS; 4d (68%)
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1.3.3 Scope of the Reaction 
Monosubstituted spirocyclopropyloxetanes rearranged to the corresponding 3-
methylenetetrahydrofurans 6c-e in good yields (Scheme 20). Similarly, trans-3-
methylenetetrahydrofurans 6h-j were obtained in up to 80% yield. Also of note, the reaction 
tolerated most aromatic groups, but for substrates with aryl groups directly attached to the 
oxetane ring, such as 4a, poor conversions and low yields were observed. With substrates 
containing protected amine substituents at C-6 (4f and 4g), no conversion was observed even 
with prolonged heating (20 h), presumably due to the interaction of the catalyst with the 
nitrogen groups. 
 
 
10 mol % 
[Pt(C2H4)Cl2]2
20 mol% PCy3, 0.5 M  CH2Cl2, 
45 oC, , 1-2 h
OR
O
R
4 6
O
BnO
H3C
O
O
O O
O
BnO
c-Hex
H3C
c-Hex
BnO
Ph
6c (65%)
6i (80%) 6j (75%)
6e (62%)
6a (34%)
O
BocHN
6f (n.r.)b
O
TrHN
6g (n.r.)b
O
TBDPSO
6d (64%)
   6h (69 %)       
 (70 %)c (73 %)d
Ph
aReaction conditions: 0.5 to 1.0 mmol scale, 10 mol % [Pt(C2H4)Cl2]2, 
20 mol % PCy3, 0.5 M in CH2Cl2. bNo reaction was observed even 
after 20 h. cReaction was conducted at room temperature. dReaction 
was conducted using 5 mol % Pt(C2H4)Cl2]2, 10 mol % P(OEt)3 at 
room temperature.
Scheme 20. Scope of the Pt(II)-catalyzed expansion of spirocyclo-
propanes to 3-methylenetetrahydrofurans.
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Unexpectedly, when 5,6-cis-disubstituted spirocyclopropyloxetane 4l was reacted 
under the standard conditions, ring opened allyl chloride 11 was isolated as the major product 
(Scheme 21). When 5,6-cis-disubstituted spirocyclopropyloxetane 4k was used, ring opened 
alcohol 12 was obtained in 42% yield. Analysis of the 1H NMR of the crude reaction mixture 
and the byproducts isolated from column chromatography showed the formation of additional, 
inseparable olefinic compounds, which could be the source of the hydrogen needed to form 
the ring opened, reduced alcohol 12.  
 
It is worth noting that consumption of both 5,6-cis-disubstituted spirocyclo-
propyloxetanes took longer than was required for the 5,6-trans-disubstituted compounds. The 
formation of the reduced product 12 necessitates a source of a hydride. This could come from 
tricyclohexylphosphine. When 4k was treated with Zeise’s dimer in the absence of 
tricyclohexylphosphine, the same products were observed, although the reaction times were 
O
H3C
Ph
Ph
CH3
CH3
OH O
H3C
Ph
4k 6k
(trace amount)c
9 (42%)
Ph CH3
11
(trace amount)
O
CH3
Ph
10 (~20%)
O
Ph
CH3
OH O
H3C
Ph
4l 8 (39%)
Ph
Ph
O
H3C
Ph
Ph
6l
(trace amount)b
1  (10 mol %)
CH2Cl2, 45 oC 
21 h
Cl
PCy3
1  (10 mol %)
CH2Cl2, 45 oC 
16 h
PCy3
Scheme 21. Reaction of cis-substituted spirocyclopropyloxetanes under 
Pt(II) catalyst.
aReaction conditions: 0.5 mmol scale, 10 mol % 1, 20 mol % PCy3, 0.5 M in 
CH2Cl2. bCis-3-methylenetetrahydrofuran 6l was isolated in a trace amount and 
characterized (see Experimental Section). cCis-3-methylenetetrahydrofuran 6k 
was isolated as a mixture with 11.
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even longer. The rearranged products, 3-methylenetetrahydrofurans 6l and 6k, were isolated, 
but in trace amounts. These alternative outcomes, and the longer reaction times will be 
discussed later. 
Tetrasubstituted-spirocyclopropyloxetanes 4m and 4n provided completely different 
results (Scheme 22). When 5,5-diphenylsubstituted spirocyclopropyloxetane 4m was treated 
with Zeise’s dimer, no 3-methylenetetrahydrofuran resulted; instead, tetrasubstituted alkene 
12 was isolated in 40% yield. On the other hand, 5,5-dialkyldisubstituted 
spirocyclopropyloxetane 4n provided α,β-unsaturated ketone 13 in 50% yield as the only 
isolable product. The different results with 4m and 4n and with the spirocyclopropyloxetane 
with cis-substituents on the oxetane ring again led us to question the pathway of these Pt 
promoted processes. 
 
 
1.3.4 Mechanistic Studies 
Oxidative additions of Pt(II) to cyclopropanes and to the C−O bond of β-lactones have 
been reported to produce stable platinacyclobutanes37 and platinalactone (Scheme 23)45a 
complexes, respectively. Moreover, the formation of platinaoxetanes as intermediates has 
O
O
4m
(not observed)b
12 (40%)
Ph
Ph
CH3
CH3Ph
Ph Ph
Ph
O
O
4n (not observed)b
13 (50%)
O
6m
6n
1  (10 mol %)
CH2Cl2, 45 oC 
20 h
PCy3
1  (10 mol %)
CH2Cl2, 45 oC 
20 h
PCy3
Scheme 22. Reaction of 5,5-disubstituted spirocyclopropaneoxetanes 
under Pt(II) catalyst.
aReaction conditions: 1.0 mmol scale, 10 mol % 3, 20 mol % PCy3, 0.5 M 
in CH2Cl2. bBased on the 1H NMR analysis of the crude mixture.
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been postulated in Pt-mediated activation of epoxides.45b Platinacyclobutanes are known to 
be stable and isolable, with many being well characterized, but there have been no reports of 
alkoxy-substituted platinacyclobutanes being isolated nor observed spectroscopically. This 
may be due to favorable formation of oxocarbenium ions resulting in isomerizations to ring 
opened products (see Section 1.1 Schemes 14-16).39,40 
 
Based on literature precedent related to Pt reactions with strained rings, we 
hypothesized two potential initial oxidative additions of Pt. These include the oxidative addition 
of Pt(II) into the cyclopropane ring (Figure 5, path a) to produce either intermediate I or II or 
oxidative addition into the C-O bond of the oxetane ring (path b) to give intermediate III or IV. 
 
The formation of 3-methylenetetrahydrofurans cannot be rationalized from oxetane 
oxocarbenium intermediate I. Similarly, intermediate IV would not lead to the formation of the 
observed products, and to date, there have been no reports of oxidative addition of Pt(II) into 
O
O
Pt
Me
Me
N
N
O O
stoichiometric
 Pt(bpy)Me2
Scheme 23. Stoichiometric oxidative addition of Pt(II) to C−O 
bond of β-propiolactone to form platinalactone complex.
stable platinum (IV) complex
Puddephatt 1988
path a
(through cyclopropane)
path b
(through oxetane)
O
O
PtLn
O
PtLn
platinacyclobutanes
PtLn
O
O
Ln
Pt
platinatetrahydrofurans
R
R'
R
R'
R
R'
R
R'
R
R'
or
I II III IV
or
Figure 5. Possible platinacycle intermediates obtained from spirocyclopropyl-
oxetanes via the cyclopropane ring (path a) or the oxetane ring (path b).
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simple oxetanes. To examine the possible insertion of Pt in simple oxetane rings, 3,3-
dimethyloxetane 14 was treated with Zeise’s dimer and tricyclohexyl phosphine under our 
standard conditions, but no reaction was observed, even after prolonged heating and the 
addition of Pt catalyst up to 20 mol %. However, the outcome with 14 may not represent the 
potential reactivity of the oxetane moiety in spirocyclopyloxetanes with Pt(II). 
 
In order to determine which path was operational, 13C-labeled spirocyclopropyloxetane 
13C-4h was synthesized by cyclopropanation of methyleneoxetane 10h using 13C-labeled 
diiodomethane (Scheme 25). The labeled compound 13C-4h was successfully obtained with 
a comparable yield of 71% as a pair of isotopic stereoisomers. 
 
13C-labeled 4h was treated with a stoichiometric quantity of Zeise’s dimer and 
tricyclohexylphosphine in CD2Cl2 at room temperature, and the resulting reaction was 
monitored by 13C NMR. Figure 6 provides a summary of the 13C-DEPT NMR analysis of the 
reaction as it progressed. Two intermediates with 13C-labeled carbon chemical shifts at 
15.04/7.94 ppm (region A) and at 49.52/113.70 ppm (regions B and B’) were observed. These 
intermediates were present over the course of the reaction (Figure 6b and 6c) and largely 
disappeared after complete conversion of 13C-4h (Figure 6d). Specifically, they were observed 
14
16
O
20 mol % 
[Pt(C2H4)Cl2]2   
40 mol % PCy3
24 h, rt or 45 oC
PtLn
O
+ ring opened products
15
X
Scheme 24. Attempted reaction of simple oxetane with Zeise's dimer to 
give platinatetrahydrofuran or ring opened products.
O
13C-4h (71%)
BnO OBnO
+
OBnO
1.1 equiv. 13CH2I2 
1.0 equiv. Et2Zn
2h
Et2O, 0 oC, 3 h
13
13
Scheme 25. Synthesis of C-13 labeled spirocyclopropyoxetane 13C-4h.
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Figure 6. 13C DEPT NMR monitoring of the reaction of 13C-4h (0.1 mmol) with a stoichiometric 
amount of Zeise's dimer and PCy3 and with 0.2M 13C-4h in CD2Cl2 at RT. (a) 13C DEPT NMR 
spectra of oxaspirohexanes 13C-4h; (b) 13C NMR spectrum after 1 h; (c) 13C DEPT after 2 h; (d) 
13C DEPT NMR after 4 h; (e) 13C DEPT of methylenetetrahydrofuran products 13C-6h, and (f) 13C 
DEPT of allyl chloride byproducts 13C-17.
for a span of 3 h when the reaction was monitored at room temperature or could persist for 
up to 15 h at 0 oC.  
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Figure 7. Regions in 13C DEPT NMR monitoring showing the 13C labeled carbon peaks 
observed as intermediates from the reaction of 13C-4h with Zeise's dimer: (A) 13C peaks for 
platinacyclobutane intermediate 13C-18 (as a pair of 13C-labeled isotopic stereoisomers), and (B) 
13C peaks for Pt-σ-allyl intermediate 13C-19 as a pair of 13C-labeled isotopic stereoisomers.
 
 
 
 
 
The observed 13C-labeled carbon peaks at 15.04 and 7.94 ppm (region A) correspond 
to the expected chemical shifts of carbon sigma bonded to Pt in platinacyclobutanes.37 These 
13C-labeled carbons show large Pt-13C coupling constants of 556.6 and 622.4 Hz, respectively, 
which fall in the range of usual 1JPt-13C values in platinacyclobutanes9 or Pt-C σ-bonds in 
general.46 This key intermediate was rationalized to be platinacyclobutane 13C-18 (as a pair 
of 13C-labeled isotopic stereoisomers). 
The additional 13C-labeled intermediate peaks observed in regions B and B’ were 
rationalized to be Pt-allyl complexes, which can be obtained from the ring puckering47 of the 
oxy-platinacyclobutane 13C-18. The large differences in 13C chemical shifts (49.5 and 113.70 
ppm) and the JP-13C values (19.1 and 2.5 Hz, respectively) suggest that the intermediate 
observed is an η1 Pt-allyl complex46,48 as a pair of isotopomers. Specifically, the Pt-η1-allyl 
intermediate observed in region B’ corresponds to 13C-19B’ as indicated by the small 3JPt-13C 
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(22.7 Hz), while the intermediate at region B corresponds to the other isotopomer, Pt-η1-allyl 
13C-19B. Given that the observed 1JPt-13C in region B (30.6 Hz) is relatively small compared to 
usual Pt-C σ-bonds46, the Pt-13C bond must be rather weak.48 The stability of η1 and η3 Pt-allyl 
complexes is highly dependent on the counterion.47 It would seem that the Pt allyl intermediate 
prefers a σ-coordination mode17 due to the propensity of intramolecular coordination of the 
negatively charged oxygen atom to the positively charged Pt to form a 6-membered Pt-η1-allyl 
complex. Sakaki and co-workers reported that a hydride coordinated Pt-η1-allyl complex is 8 
kcal/mol more stable than its corresponding η3-allyl complex.49 Likewise, Pregosin and 
coworkers have demonstrated that methoxy-modified MOP Pt allyl complexes prefer a σ-
coordination mode, albeit with a weak σ-bond.48 Although the Pt-allyl intermediates observed 
here appear to be of an η1 character, the occurrence of Pt-η3-allyl intermediates is not ruled 
out. In fact, unresolved peaks were also seen at around 64 and 73 ppm, which may 
correspond to Pt-η3-allyl intermediates46,48 as a pair of isotopomers. 
After purification, 13C labeled 3-methylenetetrahydrofurans 13C-6h (with 13C peaks at 
103.32 and 71.36 ppm, Figure 5e) were isolated in 55% yield as an isotopomeric mixture 
(Scheme 26).  In addition, isotopomeric byproducts, allyl chloride 13C-17  (with 13C peaks at 
115.69 and 48.06 ppm, Figure 6f) were also observed and isolated in 20% yield. The formation 
of the allyl chloride was not observed when a catalytic amount (5-10 mol%) of Zeise’s dimer 
was used.  
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The evidence delineated above is suggestive of the mechanistic interpretation shown 
in Scheme 27. First, regioselective oxidative addition of Pt(II) into the least substituted C-C 
bond in cyclopropane provides platinacyclobutane 20. Due to the reactivity of oxygen-
substituted platinacyclobutanes and perhaps also to the ring strain associated with 
oxetanes,50 ring-opening to Pt-allyl complexes results. Cyclization gives 3-
methylenetetrahydrofurans 6. This mechanism is consistent with the formation of allyl 
ethers/chlorides by intermolecular reactions of the Pt-allyl complexes with methanol or 
chloride ion when the reaction is conducted in the presence of methanol or a stoichiometric 
amount of Zeise’s dimer. The observed regioselective oxidative addition of Pt(II) into the 
cyclopropane is remarkable because this has not been the case for all examples of Pt-
catalyzed transformations of oxygen-substituted cyclopropanes, where C-C bond cleavage 
has always occurred adjacent to the oxygen.39-41 
Scheme 26. Reaction of 13C-labeled oxaspirohexane 13C-4h with a stoichiometric 
amount of Zeise's dimer
O
BnO
H3C
13C-6h (55%)
O
BnO
H3C
+
OH
BnO
CH3
Cl
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BnO
CH3
Cl+
13C-17 (20%)
O
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BnO
stoichiometric 
[Pt(C2H4)Cl2]2
PCy3                   
  0.2 M CD2Cl2
13C-4h
13
13
13
13
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 Attempts to isolate the platinacyclobutane complex by adding external ligands (e.g. 
pyridine, bipyridine) used previously in the crystallization of platinacyclobutanes37a were not 
successful. In most cases ring expansion to 3-methylenetetrahydrofuran was still the 
outcome. 
The facile isomerization of the platinacyclobutane intermediate is likely triggered by 
the favorable ring opening of the strained oxetane ring. We hypothesized that 
spirocyclopropyltetrahydrofuran 4p might provide a stable platinacyclobutane complex 
(Scheme 28). THF 4p was easily prepared in high yields from methylenenation of lactone 8p 
followed by cyclopropanation. However, when 4p was treated with catalytic amounts of 
Zeise’s dimer, complete conversion to form the ring expanded 3-methylentetrahydropyran 6p 
and several ring-opened products were obtained. This result suggests that the regioselective 
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Scheme 27. Proposed mechanism for the Pt(II)-catalyzed expansion of spirocyclopropyloxetanes 
to 3-methylenetetrahydrofurans. Key mechanistic feature involves the formation of 
platinacyclobutane and Pt-allyl complexes as intermediates.
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oxidative addition of Pt(II) to the cyclopropane is not altered by the increase in ring size of the 
oxygen-containing heterocycle. 
 
To gain insight on the unexpected outcome of spirocyclopropyloxetanes with cis-
substituents on the oxetane, 13C-labeling experiments were again conducted. 13C-Labeled cis- 
spirocyclopropyloxetane 13C-4l was obtained as a pair of isotopic stereoisomers from the 
cyclopropanation of cis-methyleneoxetane 10l (Scheme 29). The 13C-labeled cis- 
spirocyclopropyloxetane was treated with a stoichiometric amount of Zeise’s dimer under the 
same conditions as used for trans-isomer 13C-4h, and the reaction was monitored by 13C 
DEPT NMR. 
 
Somewhat unexpectedly, intermediate peaks analogous to those from 13C-4h were 
observed for a span of 3 h. Specifically, peaks at 8.65 and 13.00 ppm (region A, Figure 8) 
correspond to platinacyclobutanes 13C-21 with Pt satellites (1JPt-13C values of 622.6 and 556.3 
Hz, respectively). Likewise, similar to results with 13C-4h, isotopomer peaks were observed at 
O
OPh
O
Ph
O
Ph
8p 2p 4p
CH2I2, Et2Zn
-15 oC, Et2O, 3h
Cp2TiMe2
toluene, 80 oC, 2h
84% yield 96% yield
Scheme 28. Preparation and reaction of spirocyclopropyltetrahydrofuran 4p.
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Scheme 29. Synthesis of C-13 labeled spirocyclopropyloxetane 13C-4l.
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Figure 8. 13C DEPT NMR monitoring showing the regions of 13C labeled carbon peaks observed as 
intermediates from the reaction of 13C-4l with Zeise's dimer: (A) 13C peaks for platinacyclobutane 
intermediate 13C-21 (as a pair of 13C-labeled isotopic stereoisomers), and (B) 13C peaks for Pt-η1-allyl 
intermediate 13C-22 as isotopomeric mixture.
49.4 ppm (region B) with a 1JPt-13C value of 30.9 (JP-13C = 38.8 Hz) and at 113.6 ppm (region 
B’) with a 1JPt-13C value of 32.4. These shifts correspond to Pt-η1-allyl intermediates 13C-22B 
and 13C-22B’, respectively. As with the unresolved intermediate peaks observed in the 
reaction of trans- spirocyclopropyloxetanes 13C-4h, peaks at around 66 and 68 ppm, which 
could correspond to Pt-η3-allyl intermediates,46,48 were also observed. In contrast to the 
reaction outcome from 13C-4h, cis-spirocyclopropyloxetanes 13C-4l gave allyl chloride 13C-11 
and 3-methylenetetrahydrofuran 13C-6l as the major and minor products, respectively. As a 
reference, unlabeled cis-oxaspirohexane 4l was also treated with a stoichiometric amount of 
Ziese’s dimer. Allyl chloride 11 was obtained as the major product in 52% yield, and 3-
methylenetetrahydrofuran 6l was obtained in 16% yield (Scheme 30).  
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Results from the 13C labeling studies with cis isomer 13C-4l demonstrate that the initial 
intermediates involved in the reactions of cis-spirocyclopropyloxetanes with Zeise’s dimer are 
identical to those observed with the trans- spirocyclopropyloxetanes, even though the product 
distribution is different. Initial oxidative addition of cyclopropane to Pt to form 
platinacyclobutanes is followed by ring-opening to Pt-allyl intermediates (Scheme 31). 
However, rather than cyclization, the allyl intermediate reacts with a chloride ion to form allyl 
chloride 8. For 4k the Pt-allyl intermediate undergoes reductive elimination to give homoallyl 
alcohol 9 (Scheme 21). The contrasting outcome (reduction vs. substitution) between cis- 
spirocyclopropyloxetanes 4k and 4l requires that the allyl intermediates undergo different 
reactions. For the reaction of 4k the isolation of a significant amount of dienone 10 (which 
must arise from 4k, rather than a Pt-allyl intermediate) suggests a hydride source. Steric 
encumbrance could prevent 4l from providing a hydride. We propose that the low reactivity of 
the cis-isomers is due to steric effects that disfavor the conformation required for the formation 
of 3-methylenetetrahydrofurans, which leaves the door open for alternative pathways. 
Scheme 30. Reaction of cis-spirocyclopropyloxetane 4l with stoichiometric 
amount of Zeise's dimer.
O
Ph
Ph OH
Ph
Ph
Cl
O
Ph
Ph
+
6l (16%)
stoichiometric 
[Pt(C2H4)Cl2]2
PCy3, 0.2 M 
CH2Cl2
4l 8 (52%)
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For the case of 5,5-disubstituted spirocyclopropyloxetanes, we postulate a 
rearrangement where Pt mediated bond breaking of the C-O bond in the oxetane ring occurs 
before cleavage of the cyclopropane (Scheme 32). This is presumably due to the formation 
of a tertiary carbocation that ultimately leads to 12 or 13. The zwitterionic β-platinum(II) ketone 
intermediate 23 is analogous to the intermediates proposed39 and the platinum complex51 
isolated by Ryu and Sonoda during their mechanistic investigation of the Pt-catalyzed 
isomerization of silyloxycyclopropane to allyl silylethers (see Scheme 14). 
O [Pt(C2H4)Cl2]2 O
H
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R
PtLn
oxidative adition
R'
R'
R
platinacyclobutane
O
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R
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homoallylic alcohol (or allyl chloride)
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H/Cl
OR
R'
3-methylenetetrahydrofuran
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H- cyclization (disfavored due to
steric effects)(or Cl
-)
Scheme 31. Proposed mechanism for the Pt(II)-catalyzed expansion and opening 
of cis-spirocyclopropyloxetanes. Key mechanistic feature involves the formation of 
platinacyclobutane and Pt-allyl complexes as intermediates. Cyclization to of the 
allyl intermediates to 3-methylenetetrahydrofuran is disfavored pressumably due to 
sterric effects associated with the transition state leading to the cyclic THF product.
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 It could be argued that the regioselective formation of platinacyclobutane through the 
methylenes of the cyclopropane is governed by steric effects. Indeed, most reports of the 
reaction of Zeise’s dimer with 1,1-disubstituted cyclopropanes give products consistent with 
initial substitution into this less hindered C-C bond.37a However, earlier reports of the reaction 
of Zeise’s dimer with silyloxycyclopropanes had included 1,1-disubstituted compounds. For 
example, silyloxycyclopropanes were converted to ketones in the presence of Zeise’s dimer 
(Scheme 33).51 Formation of the ketone requires cleavage of the oxygen-substituted 
cyclopropane C-C bond. Thus, our initial expectation of platinacyclobutane formation through 
C-C bond adjacent to the oxetane was warranted. Nevertheless, it seemed worthwhile to 
examine the effect of placing additional substitution on the cyclopropane. 
 
H
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Scheme 32. Rationalization of the different outcome of 5,5-disubstituted 
spirocyclopropyloxetanes.
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O
Ryu and Sonoda 1991
Scheme 33. Reaction of a 1,1-disubstituted cyclopropane with 
stoichiometric amount of Zeise's dimer.
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A spirocyclopropyloxetane bearing a methyl substituent at the cyclopropyl moiety was 
prepared by the cyclopropanation of 10o using diodoethane (Scheme 34). This provided 4o 
in 78% yield (isolated as a single enantiomeric pair, but with the relative stereochemistries 
unknown). Other diasteromeric products were also obtained as an inseparable mixture in 
trace amounts. 1-Methyl substituted spirocyclopropyloxetane 4o was treated with Zeise’s 
dimer, and 3-methylenetetrahydrofuran 6o, isolated in 76% yield (4:1 cis/trans), resulted 
(Scheme 35). The observed complete regioselectivity and formation of cis isomer as the major 
product further supports the intermediacy of a Pt-allyl intermediate that undergoes a 5-exo 
cyclization mode via the more stable transoid Pt-allyl intermediate. Such outcomes were 
observed in cyclizations of related Pd-allyl systems with O-nucleophiles.52 These results 
demonstrate that an additional alkyl substituent on the cyclopropane did not alter the outcome 
of the reaction, confirming that the regioselectivity can not be entirely explained by steric 
effects. 
 
O
Ph
O
Ph
+ other diastereomers
CH3CHI2
Et2Zn
-15 oC, Et2O, 3h
4o (78% yield)2o
Scheme 34. Preparation of spirocyclopropyloxetane 4o having a methyl substituent on 
the cyclopropane.
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 René and coworkers recently described an analogous cyclopropane activation 
strategy for the ring expansion of spirocyclopropyl lactams to methylenecaprolactams under 
palladium catalysis (Scheme 36).53 In contrast to our mechanistic experiments, they have 
supported their work by computational studies. Calculations on possible mechanistic 
pathways suggest an initial oxidative addition of Pd(0) to the distal carbon-carbon bond of 
cyclopropane to form intermediate pallacyclobutane I (Scheme 37, path A). The formation of 
palladacyclobutane I is highly energetically favored over oxidative addition of Pd(0) to the C–
N bond of the lactam to form intermediate II. Rearrangement of I to Pd-allyl complex III 
followed by cyclization would provide the methylenecaprolactam product. However, when this 
reaction was conducted using Zeise’s dimer as the catalyst, no reaction was observed. 
O
Ph 10 mol% [Pt(C2H4)Cl2]2
20 mol % PCy3
CH2Cl2, 45 oC
2h
O
Ph
O
Ph+
6o (76% yield; cis/trans = 4:1)4o
O-Pt+
H
Ph O
-Pt+
H
Ph
transoid Pt allyl cisoid Pt allyl
or
(favored)
O
Ph
PtLn
Scheme 35. Reaction of spirocyclopropyloxetane 4o with catalytic Zeise's dimer and proposed 
mechanism on the observed regio- and diastereoselectivities.
Reaction conditions: 1.0 mmol scale, 10 mol % 3, 20 mol % PCy3, 0.5 M in CH2Cl2. 
Cis /trans ratio was based from 1H NMR analysis of the crude mixture.
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Scheme 36. Pd-catalyzed ring expansion of spirocyclopropyl lactams 
to methylenelactams.
N
O
Me
Pd0L
N
O
Me
LPd
++
N
O
Me
PdL
B
N
O
Me
LPd
++
N
Pd
O
Me
L
N
Pd
O
Me
L
A
N
Pd
O
Me
L
++
N
O
Me
IIIIII
0.0 kcal/mol
+32.8 kcal/mol +3.9 kcal/mol
-6.9 kcal/mol+8.0 kcal/mol-6.6 kcal/mol
+18.9 kcal/mol
-5.6 kcal/mol
Scheme 37. Proposed mechanism for Pd-catalyzed ring 
expansion of spirocyclopropyl lactams to methylenelactams 
based from computationally calculated mechanistic pathways.
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1.4 Conclusion 
A novel Pt(II)-catalyzed expansion of spirocyclopropyloxetanes to 3-
methylenetetrahydrofurans has been discovered. In this work, we highlight the first detection 
of alkoxy-substituted platinacyclobutane intermediates. In contrast to previous reactions with 
oxygen-substituted cyclopropanes, where oxidative addition to Pt occurred adjacent to the C-
O bond, regioselective platinacyclobutane formation through the distal methylene carbons of 
the cyclopropane ring resulted. The key platinacyclobutane and Pt-allyl intermediates were 
observed by 13C NMR studies using 13C-labeled spirocyclopropyloxetanes. In particular, these 
studies clarified that, although outcomes with cis-5,6-disubstituted oxaspirohexanes were 
different than those with trans-5,6-disubstituted (or 5- or 6-substituted) oxaspirohexanes, the 
intermediates were identical. A spirocyclopropyloxetane bearing a substituent on the 
cyclopropane ring was also efficiently converted to a 3-methylenetetrahydrofuran with 
complete regioselectivity.  
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1.5 Experimental 
1.5.1 General Information 
All moisture sensitive reactions were run in a flame-dried flask under nitrogen. All 
solvents were dried over CaH2 or 4 Å molecular sieves. Tetrahydrofuran (THF) was dried 
using J. C. Meyer Solvent Dispensing System (SDS) and dispensed under N2. Deuterated 
chloroform (CDCl3), and methylene chloride (CD2Cl2) were dried over 4 Å molecular sieves. 
Commercially available reagents were purchased from Aldrich, Acros, Alfa Aesar or TCI 
America and used without further purification. Zeise’s dimer was purchased from Strem 
chemicals.  
All 1H NMR experiments were recorded using a Bruker AVANCE 300, 400 or 500 MHz 
spectrometer. All 13C NMR experiments were recorded using a Bruker AVANCE 75, 100 or 
125 MHz spectrometer. Chemical shifts (δ) are given in ppm, and coupling constants (J) are 
given in Hz. The 7.26 resonance of residual CHCl3 for proton spectra and the 77.23 ppm 
resonance of CDCl3 for carbon spectra were used as internal references. High-resolution 
mass spectra (HRMS) were obtained using DART AccuTOF or JEOL JMS-AX505HA mass 
spectrometers. Reaction progress was monitored by thin layer chromatography (TLC) 
performed on glass plates coated with silica gel UV254. Visualization was achieved by 
ultraviolet light (254 nm), 0.5% KMnO4 in 0.1 M aqueous NaOH solution and/or 5% 
phosphomolybdic acid in ethanol. Column chromatography was performed using silica gel, 40 
microns flash silica. 
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1.5.2 Preparation of β-lactones 
 
Known β-lactones 8c, i, and n were prepared by following literature procedures. Spectral data 
are in accordance with the literature references. 
 
4-Benzyloxymethyloxetan-2-one (8c)54 was obtained as a colorless oil (1.10 g, 41%):  1H 
NMR (300 MHz, CDCl3) δ 7.34 (m, 5H), 4.60 (m, 3H), 3.74 (m, 2H), 3.40 (m, 2H); 13C NMR 
(75 Hz, CDCl3) δ 167.8, 137.5, 128.5, 127.9, 127.7, 73.6, 69.4, 69.3, 39.6. 
 
trans-3-Methyl-4-(2-phenylethyl)-oxetan-2-one (8i)55 was obtained as a pale yellow oil 
(1.12 g, 47%): 1H NMR (400 MHz, CDCl3) δ 7.34−7.17 (m, 5H), 4.16 (ddd, J = 7.5, 5.9, 4.0 
Hz, 1H), 3.20 (dq, J = 7.5, 4.0 Hz, 1H), 2.77 (m, 2H), 2.13 (m, 2H), 1.32 (d, J = 7.5 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δ 171.6, 139.9, 128.5, 128.2, 126.3, 78.6, 50.8, 35.6, 31.4, 12.5. 
 
3,3-Dimethyloxetan-2-one-4-spirocyclohexane (8n)56 was obtained as needle-like white 
crystals (2.12 g, 51%): 1H NMR (400 MHz, CDCl3) δ 1.95−1.91 (m, 2H), 1.68−1.60 (m, 7H), 
1.29 (br s, 7H); 13C NMR (100 MHz, CDCl3) δ 176.3, 85.3, 54.5, 32.5, 24.9, 22.8, 18.2. 
 
 
O
O
O
8c
O
H3C O
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  8n
O
O
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574-Cyclohexyloxetan-2-one (8e). A solution of Ag(SbF6)3 (9.10 g, 26.6 mmol) in dry CH2Cl2 
(60 mL) was added to a solution of AlCl3 (1.18 g, 8.88 mmol) and i-Pr2EtN (4.60 mL, 26.6 
mmol) in CH2Cl2 (60 mL) at −25 oC under N2 to form a heterogeneous mixture. i-Pr2EtN (7.70 
mL, 44.4 mmol), acetyl chloride (4.70 mL, 66.5 mmol) and a solution of 
cyclohexylcarboxaldehyde (5.00 g, 44.3 mmol) in CH2Cl2 (13 mL) were added, and the 
resulting mixture was stirred at −25 oC for 4 h. The reaction mixture was then filtered through 
a pad of Celite, and the Celite was washed with CH2Cl2 (3 x 5 mL). The filtrate was then 
concentrated to give a pale yellow oil. Purification by flash chromatography on silica gel 
(petroleum ether/EtOAc, 90:10) afforded 4-cyclohexyloxetan-2-one (8e) as a colorless oil (4.9 
g, 72%):10 1H NMR (300 MHz, CDCl3) δ 4.20 (m, 1H), 3.43 (dd, J = 16.3, 5.8 Hz, 1H), 3.11 
(dd, J = 16.3, 4.4 Hz, 1H), 1.97−1.52 (m, 6H), 1.39−0.90 (m, 5H). 
 
 
trans-4-Benzyloxymethyl-3-methyloxetan-2-one (8h). Anhydrous ZnCl2 (5.45 g, 39.9 
mmol) was freshly fused at ∼0.5 mmHg. After cooling to ambient temperature CH2Cl2 (140 
mL) was added, and the ZnCl2 was broken up into small pieces with a spatula. 2-
Benzyloxyacetaldehyde (25)58 (4.00 g, 26.6 mmol) dissolved in dry CH2Cl2 (20 mL) was then 
added, resulting in a cloudy solution. After 15 min of stirring, TBS-thiopyridylketene acetal 2611 
(8.25 g, 29.3 mmol) in dry CH2Cl2 (20 mL) was added and the reaction mixture was stirred for 
45 h at rt. After completion of the reaction, freshly made phosphate buffer (pH = 7, 25 mL) 
was added, and the resulting mixture was stirred vigorously for 15 min. It was then filtered 
O
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i-Pr2EtN                 
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through Celite, and the Celite was washed with CH2Cl2 (3 x 10 mL). The aqueous and organic 
layers were separated, and the aqueous layer was extracted with CH2Cl2 (3 x 15 mL). The 
combined organic extracts were dried (MgSO4), and CuBr2 (8.50 g, 38.1 mmol) was added. 
The reaction mixture was stirred for 1.5 h at rt. It was then filtered through a pad of Celite, and 
the Celite was washed with CH2Cl2 (3 x 10 mL). The filtrate was washed with saturated 
aqueous K2CO3 (15 mL), then brine (15 mL). The organic layer was dried (MgSO4) and 
concentrated to give a sticky oil. Purification by flash chromatography on silica gel (petroleum 
ether/EtOAc, 90:10) yielded trans-4-benzyloxymethyl-3-methyloxetan-2-one (9h) as a 
colorless oil (3.85 g, 70%):44a IR (neat) 3064, 3031, 2975, 1936, 2875, 1822, 1454, 1120, 839 
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.38−7.26 (m, 5H), 4.61 (d, J = 12.6 Hz, 1H), 4.58 (d, J = 
12.6 Hz, 1H), 4.31 (ddd, J = 4.0, 4.0, 4.0 Hz, 1H), 3.79 (dd, J = 11.8, 3.7 Hz, 1H), 3.72 (d, J = 
11.1, 4.7 Hz, 1H), 3.58 (dq, J = 7.7, 4.4 Hz, 1H), 1.39 (d, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 171.6, 137.6, 128.7, 128.1, 127.9, 77.5, 73.9, 69.3, 47.6, 12.4; HRMS (ESI) calcd 
for C12H15O3 (M
 + H)+ m/z 207.1021, found 207.1011. 
 
 
59(2R*,3R*)-2-Benzyloxy-3-cyclohexyl-3-hydroxy-1-S-tert-butylthiopropiolate (28). 2-
Benzyloxy-S-tert-butyl-1-thioacetate (27)60 (4.25 g, 17.8 mmol) was dissolved in dry CH2Cl2 
(60 mL) under nitrogen and cooled to −78 oC. A solution of TiCl4 (1 M in CH2Cl2, 17.8 mL, 17.8 
mmol) was added to the flask drop-wise over 10 min. After 5 min Et3N (5.00 mL, 35.7 mmol) 
was added. The solution was stirred at −78 oC for 30 min, and then a solution of 
cyclohexylcarboxylaldehyde (2.00 g, 17.8 mmol) in CH2Cl2 (18 mL) was added drop-wise. The 
reaction was stirred at −78 oC for 4 h. The reaction was quenched by the addition of saturated 
aqueous NaHCO3 (30 mL), and the resulting slurry was filtered through Celite. The Celite was 
O
BnO O
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washed with CH2Cl2 (3 x 5 mL). The organic and aqueous layers were then separated, and 
the aqueous layer was extracted with CH2Cl2 (3 x 25 mL). The combined organic extracts 
were dried (MgSO4) and concentrated under reduced pressure. Purification by flash 
chromatography on silica gel (petroleum ether/EtOAc, 85:15) afforded (2R*,3R*)-2-benzyloxy-
3-cyclohexyl-3-hydroxy-1-S-tert-butylthiopropiolate (28) as a colorless oil (3.18 g, 51%):44a IR 
(neat) 3031, 2912, 2853, 1826, 1728, 1452, 1115, 892 cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.38−7.30 (m, 5H), 4.81 (d, J = 11.4 Hz, 1H), 4.45 (d, J = 11.4 Hz, 1H), 3.85 (d, J = 6.4 Hz, 
1H), 3.63 (ddd, J = 4.8, 4.8, 4.8 Hz, 1H) 2.33 (d, J = 4.9 Hz, 1H), 1.70 (m, 2H), 1.63 (m, 4H), 
1.51 (s, 9H), 1.30−1.03 (m, 5H); 13C NMR (100 MHz, CDCl3): δ 203.4, 137.1, 128.6, 128.3, 
128.2, 85.5, 76.6, 73.5, 47.6, 39.2, 29.8, 26.7, 26.5, 26.4, 26.1; HRMS (ESI) calcd for 
C20H31O3S
 (M + H)+ m/z 351.1994, found 351.1998. 
 
trans-3-Benzyloxy-4-cyclohexyloxetan-2-one (8j). (2R*,3R*)-2-Benzyloxy-S-tert-butyl-3-
cyclohexyl-3-hydroxy-1-thiopropiolate (28) (2.00 g, 5.71 mmol) was dissolved in dry CH3CN 
(200 mL) under nitrogen at rt. Hg(OTFA)2 (2.74 g, 6.41 mmol) was added to this solution at 
once. The resulting reaction mixture was quickly immersed into a pre-heated oil-bath (50 oC). 
After 5 minutes the mixture was filtered through a pad of Celite which was washed with CH2Cl2 
(3 x 5 mL). The filtrate was then concentrated to give a pale brown oil. Purification by flash 
chromatography on silica gel (petroleum ether/EtOAc, 92:8) afforded trans-3-benzyloxy-4-
cyclohexyloxetan-2-one (8j) as a colorless oil (0.68 g, 46%):44a IR (neat) 3064, 3032, 2928, 
2854, 1833, 1451, 1146, 865, 698 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.40−7.32 (m, 5H), 4.81 
(d, J = 11.6 Hz, 1H) 4.66 (d, J = 11.5 Hz, 1H), 4.64 (d, J = 3.6 Hz, 1H), 4.22 (dd, J = 8.5, 3.6 
Hz, 1H), 1.87 (m, 1H) 1.79−1.50 (m, 5H), 1.28−1.13 (m, 3H), 1.08−0.96 (m, 2H); 13C NMR 
(100 MHz, CDCl3) δ 168.4, 136.4, 128.7, 128.4, 128.1, 83.8, 83.6, 72.5, 40.1, 28.4, 27.1, 25.9, 
25.3, 25.1; HRMS (ESI) calcd for C16H21O3 (M + H)+ m/z 261.1491, found 261.1465. 
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cis-3-Methyl-4-(2-phenylethyl)oxetan-2-one (8k). 3-Methylene-4-(2-phenylethyloxetan-2-
one (29a)61 (1.88 g, 10 mmol) and 10% Pd on carbon (0.30 mmol, 0.32 g) were mixed in dry 
THF (10 mL) under a N2 atmosphere. The reaction vessel was purged with H2 for 10 min. The 
reaction mixture was stirred at rt for 2 h under a balloon filled with H2. The crude mixture was 
filtered through a pad of Celite. The Celite was washed with CH2Cl2 (3 x 10 mL), and the 
filtrate was concentrated to give a pale yellow oil. 1H NMR analysis of the crude product 
showed a diastereomer ratio of 10:1 (cis:trans). Purification by flash chromatography on silica 
gel (petroleum ether/EtOAc, 92:8) afforded cis-4-(2-phenylethyl)-3-methyloxetan-2-one (8k) 
as a pale yellow oil (1.67 g, 88%):62 1H NMR (300 MHz, CDCl3) δ 7.38−7.24 (m, 5H), 4.57 
(ddd, J = 4.5, 4.5, 4.5 Hz, 1H), 3.74 (dq, J = 14.6, 7.4 Hz, 1H), 2.90 (ddd, J = 14.2, 5.3, 5.3 
Hz, 1H), 2.73 (m, 1H), 2.06 (m, 2H), 1.28 (d, J = 7.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
172.5, 140.4, 128.5, 128.4, 126.2, 74.6, 47.1, 31.8, 31.4, 8.0. 
 
 
cis-4-Benzhydryl-3-methyloxetan-2-one (8l). 4-Benzhydryl-3-methyleneoxetan-2-one 
(29b)61 (4.0 mmol, 1.0 g) and 10% Pd on carbon (0.12 mmol, 0.12 g) were mixed in dry THF 
(4 mL) under a N2 atmosphere. The reaction vessel was purged with H2 for 10 min. The 
reaction mixture was stirred at rt for 2 h under a balloon filled with H2. The crude mixture was 
filtered through a pad of Celite. The Celite was washed with CH2Cl2 (3 x 10 mL), and the 
O
O
29a
O
H3C O
8k
H2, Pd/C
THF
O
O
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O
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filtrate was concentrated to give a pale yellow oil. 1H NMR analysis of the crude product 
showed a diastereomer ratio of 20:1.7 (cis:trans). Purification by flash chromatography on 
silica gel (petroleum ether/EtOAc, 92:8) afforded cis-4-benzhydryl-3-methyloxetan-2-one (8l) 
as a pale yellow oil (0.91g, 88%): IR (neat) 3054, 3035, 2950, 1820, 1450, 1144 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.37−7.21 (m, 10H), 5.28 (dd, J = 11.2, 6.1, 1H), 4.28 (d, J = 11.2, 1H), 
3.86 (m, 1H), 1.12 (d, J = 8.0 Hz, 3H);  13C NMR (100 MHz, CDCl3) δ 172.2, 140.8, 139.6, 
129.2, 128.8, 128.4, 128.0 127.5, 127.3, 76.9, 51.5, 48.0, 9.1; HRMS (ESI) calcd for C17H17O2 
(M + H)+ m/z 253.1229, found 253.1233. 
 
 
3-Benzyltetrahydrofuran-2-one (8p). n-Buli (6.6 mL, 16.5 mmol, 2.5 M in hexane) was 
added to diisopropylamine (1.67 g, 16.5 mmol) in THF (20 mL) under N2 at –78 oC. The 
resulting solution was stirred for 20 min. γ-Butyrolactone (1.29 g, 15.0 mmol) was added neat 
over 20 min; then benzyl bromide (2.57 g, 15.0 mmol) in THF (10 mL) was added dropwise 
over 20 min. The resulting reaction mixture was stirred for 1.5 h at –78 oC. The reaction was 
quenched with saturated ammonium chloride and extracted with diethyl ether (50 mL x 3). 
The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo. The crude product was purified by flash chromatography on silica gel (petroleum 
ether/EtOAc, 85:15), providing 3-benzyltetrahydrofuran-2-one (8p) as a colorless oil (2.06 g, 
78%):63 δ 1H NMR (400 MHz, CDCl3) δ 7.20−7.16 (m, 2H), 7.12–7.07 (m, 3H), 4.05 (ddd, J = 
8.8, 8.8, 3.0 Hz, 1H), 3.97 (ddd, J = 9.4, 9.4, 6.7 Hz, 1H), 3.09 (dd, J = 13.5, 3.9 Hz, 1H), 2.70 
(ddd, J = 13.5, 9.2, 4.2 Hz, 1H), 2.61 (dd, J = 13.5, 9.3 Hz, 1H), 2.12−2.04 (m, 1H), 1.88−1.78 
(m, 1H); 13C NMR (100 MHz, CDCl3) δ 178.6, 138.4, 128.8, 128.5, 126.6, 66.4, 40.9, 35.9, 
27.8. 
O
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1.5.3 Preparation of 2-methyleneoxetanes 
General procedure for the preparation of 2-methyleneoxetanes 
 
A solution of dimethyltitanocene64 (0.5 M in toluene, 1.5-2 equiv) and β-lactone (1 equiv) was 
stirred in the dark at 80 °C under N2. The progress of the reaction was monitored over a period 
of 2-4 h by TLC until the disappearance of the starting material. The cooled reaction mixture 
was added to petroleum ether (10 volumes) and stirred overnight. The resulting mixture was 
filtered through a pad of Celite, washing with petroleum ether until the filtrate was colorless. 
The filtrate was concentrated to about one-third of the original volume of toluene, and the 
residue was purified by flash column chromatography on silica gel (deactivated by 4% Et3N in 
petroleum ether). 
 
4-Benzyloxymethyl-2-methyleneoxetane (2c). 4-Benzyloxymethyl-2-methyleneoxe-tane 
(10c) was prepared from 4-benzyloxymethyloxetan-2-one (8c) (0.50 g, 2.6 mmol) using 1.5 
equiv. of dimethyltitanocene. Purification by flash chromatography on silica gel (petroleum 
ether /EtOAc/Et3N, 99:0.5:0.5) afforded 4-benzyloxymethyl-2-methyleneoxetane (2c) as a 
pale yellow oil (0.35 g, 70%):44b IR (neat) 3100, 2926, 1691, 1452 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.35 (m, 3H), 7.28 (m, 2H), 4.91 (dddd, J = 19.1, 6.9, 5.1, 5.1 Hz, 1H), 4.63 (d, J = 
12.0 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.16 (ddd, J = 3.5, 2.4, 2.4 Hz, 1H), 3.78 (ddd, J = 
3.6, 1.8, 1.8 Hz, 1H), 3.71 (dd, J = 11.3, 5.0, 1H), 3.70 (dd, J = 11.3, 1.5 Hz, 1H), 3.20 (dddd, 
J = 14.8, 7.0, 1.2, 1.2 Hz, 1H), 3.03 (dddd, J = 14.8, 5.2, 2.0, 2.0 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 162.5, 138.1, 128.6, 128.0, 80.4, 77.6, 73.8, 71.9, 31.1; HRMS (ESI) calcd for 
C12H15O2 (M + H)+ m/z 191.1072, found 191.1058. 
O 1.5 - 2.0 equiv Cp2TiMe2
toluene, 80 oC
2-4 h
O
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4-Cyclohexyl-2-methyleneoxetane (2e). 4-Cyclohexyl-2-methyleneoxetane (2e) was 
prepared from 4-cyclohexyloxetan-2-one (8e) (1.0 g, 6.5 mmol) using 2.0 equiv. of 
dimethyltitanocene. Purification by flash chromatography on silica gel (petroleum ether /Et3N, 
99.5.0.5) afforded 4-cyclohexyl-2-methyleneoxetane (2e) as a pale yellow oil (0.48 g, 48%):18 
1H NMR (300 MHz, CDCl3) δ 4.39 (m, 1H), 4.07 (m, 1H), 3.69 (m, 1H), 3.12 (m, 1H), 2.83 (m, 
1H), 1.89 (m, 1H), 1.66 (m, 5H), 1.18 (m, 3H), 0.90 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 
162.9, 83.0, 79.5, 43.2, 32.4, 27.9, 26.5, 26.4, 25.7, 25.4. 
 
trans-4-Benzyloxymethyl-3-methyl-2-methyleneoxetane (2h). trans-4-Benzyloxy-methyl-
3-methyl-2-methyleneoxetane (2h) was prepared from trans-4-benzyloxy-methyl-3-
methyloxetan-2-one (8h) (0.50 g, 2.4 mmol) using 2.5 equiv. of dimethyltitanocene. 
Purification by flash chromatography on silica gel (petroleum ether /EtOAc/Et3N, 95.5:4:0.5) 
afforded trans-4-benzyloxymethyl-3-methyl-2-methylene-oxetane (2h) as a pale yellow oil 
(0.38 g, 75%): IR (neat) 3031, 2934, 2878, 1715, 1496, 1454, 1359, 1275, 1114, 740 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 7.37−7.28 (m, 5H), 4.62 (m, 2H), 4.57 (ddd, J = 4.7, 4.7, 4.7 Hz, 
1H), 4.13 (dd, J = 3.6, 2.3 Hz, 1H), 3.79 (dd, J = 3.6, 1.7 Hz, 1H), 3.75−3.65 (m, 2H), 3.30 (m, 
1H), 1.30 (d, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 168.4, 138.1, 128.5, 127.8, 112.1, 
85.5, 78.4, 73.7, 71.4, 38.6, 16.5; HRMS (ESI) calcd for C13H17O2 (M + H)+ m/z 205.1229, 
found: 205.1220. 
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trans-3-Methyl-2-methylene-4-(2-phenylethyl)oxetane (2i). trans-3-Methyl-2-methylene-4-
(2-phenylethyl)oxetane (2i) was prepared from trans-3-methyl-4-(2-phenylethyl)oxetan-2-one 
(8i) (0.56 g, 2.9 mmol) using 2.0 equiv. of dimethyltitanocene. Purification by flash 
chromatography on silica gel (petroleum ether /EtOAc/Et3N, 95.5:4:0.5) afforded trans-3-
methyl-2-methylene-4-(2-phenylethyl)oxetane (2i) as a pale yellow oil (0.41 g, 74%):24a 1H 
NMR (400 MHz, CDCl3) δ 7.31 (m, 2H), 7.22 (m, 3H), 4.39 (ddd, J = 7.7, 4.0, 4.0 Hz, 1H), 
4.09 (dd, J = 3.4, 2.4 Hz, 1H), 3.75 (dd, J = 3.6, 1.7 Hz, 1H), 3.05 (m, 1H), 2.76 (ddd, J = 14.0, 
9.5, 5.7 Hz, 1H), 2.65 (ddd, J = 14.1, 9.1, 7.1 Hz, 1H), 2.16 (m, 1H), 2.01 (m, 1H), 1.24 (d, J 
= 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 168.6, 141.2, 128.7, 128.6 126.3, 86.7, 78.1, 42.2, 
37.4, 30.9, 16.8. 
 
trans-3-Benzyloxy-4-cyclohexyl-2-methyleneoxetane (2j). trans-4-Benzyloxy-3-cyclo-
hexyl-2-methyleneoxetane (2j) was prepared from trans-3-benzyloxy-4-cyclohexyloxetan-2-
one (8j) (0.42 g, 1.6 mmol) using 1.5 equiv. of dimethyltitanocene. Purification by flash 
chromatography on silica gel (petroleum ether /Et2O/Et3N, 95.5:4:0.5) afforded trans-4-
benzyloxy-3-cyclohexyl-2-methyleneoxetane (2j) as a clear oil (0.23 g, 57%):44a IR (neat) 
2927, 2853, 1726, 1451, 1119, 739 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.35 (4H), 7.32−7.25 
(m, 1H), 4.61 (s, 2H), 4.57 (dd, J =1.7, 1.7 Hz, 1H), 4.42 (dd, J = 8.2, 3.8 Hz, 1H), 4.25 (dd, J 
= 3.3, 1.6 Hz, 1H), 4.01 (dd, J = 3.5, 1.0 Hz, 1H), 1.86 (m, 1H), 1.78−1.74 (m, 2H), 1.70−1.63 
(m, 2H), 1.60−1.53 (m, 1H), 1.25−1.12 (m, 3H), 1.03−0.92 (m, 2H); 13C NMR (100 MHz, 
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CDCl3) δ 164.2, 137.7, 128.7, 128.2, 128.0, 91.2, 81.7, 77.7, 71.1, 41.1, 28.1, 26.9, 26.4, 25.7, 
25.4; HRMS (ESI) calcd for C17H23O (M + H)+ m/z 259.1698, found 259.1674. 
 
cis-3-Methyl-2-methylene-4-(2-phenylethyl)oxetane (2k). cis-3-Methyl-2-methylene-4-(2-
phenylethyl)oxetane (2k) was prepared from cis-4-(2-phenylethyl)-3-methyloxetan-2-one (8k) 
(0.5 g, 2.7 mmol) using 2 equiv. of dimethyltitanocene. Purification by flash chromatography 
on silica gel (petroleum ether /Et2O/Et3N, 97.5:2:0.5) afforded cis-3-methyl-2-methylene-4-(2-
phenylethyl)oxetane (2k) as a pale yellow oil (0.36 g, 72%): IR (neat) 3026, 2924, 2854, 1706, 
1603, 1496, 1454, 1180, 1082, 1030 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.33−7.26 (m, 2H), 
7.22−7.18 (m, 3H), 4.80 (ddd, J = 9.6, 7.0, 3.9 Hz, 1H), 4.09 (dd, J = 3.4, 2.4 Hz, 1H), 3.73 
(dd, J = 3.4, 1.7 Hz, 1H), 3.55 (m, 1H), 2.81 (ddd, J = 14.1, 9.9, 5.1 Hz, 1H), 2.60 (m, 1H), 
2.16 (dddd, J = 19.1, 14.4, 9.5, 5.2 Hz, 1H), 1.88 (dddd, J = 20.8, 10.8, 6.9, 4.0 Hz, 1H), 1.18 
(d, J = 7.3 Hz, 3H); 13C NMR (75 Hz, CDCl3) δ 169.8, 141.5, 128.7, 126.3, 82.4, 78.0, 38.3, 
32.8, 31.5, 12.4; HRMS (ESI) calcd for C13H17O (M+) m/z 189.1279, found 189.1268. 
 
cis-4-Benzhydryl-3-methyl-2-methyleneoxetane (2l). cis-4-Benzhydryl-3-methyl-2-
methyleneoxetane (2l) was prepared from cis-4-benzhydryl-3-methyloxetan-2-one (8l) (0.15 
g, 0.60 mmol) using 2 equiv. of dimethyltitanocene. Purification by flash chromatography on 
silica gel (petroleum ether/Et2O/Et3N, 97.5:2:0.5) afforded cis-4-benzhydryl-3-methyl-2-
methyleneoxetane (2l) as a pale yellow oil (0.12 g, 78%). 1H NMR (500 MHz, CDCl3) δ 
O
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7.05−6.99 (m, 6H), 6.96−6.89 (m, 4H), 5.27 (dd, J = 11.2, 6.8 Hz, 1H), 4.14 (d, J = 11.2 Hz, 
1H), 3.86 (dd, J = 3.6, 2.2 Hz, 1H), 3.50 (dd, J = 3.6, 1.7 Hz, 1H), 3.37 (m, 1H), 0.78 (d, J = 
7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 168.8, 141.6, 140.7, 129.0, 128.8, 128.5, 128.2, 
127.0, 127.0, 83.9, 78.4, 51.9, 39.0, 13.4; HRMS (ESI) calcd for C18H18O (M + H)+ m/z 
251.1435, found 251.1422. 
 
3,3-Dimethyl-2-methylene-1-oxaspiro[3.5]nonane (2n). 3,3-Dimethyl-2-methylene-1-
oxaspiro[3.5]nonane (2n) was prepared from 3,3-dimethyloxetan-2-one-4-spirocyclohexane 
(8n) (1.5 g, 8.9 mmol) using 2 equiv. of dimethyltitanocene. Purification by flash 
chromatography on silica gel (petroleum ether/Et3N, 99.5:0.5) afforded 3,3-dimethyl-2-
methylene-1-oxaspiro[3.5]nonane (2n) as a pale yellow oil (1.1 g, 70%): IR (neat) 2925, 2859, 
1693, 1469, 1368, 1123 cm-1; 1H NMR (300 MHz, CDCl3) δ 3.93 (d, J = 3.3 Hz, 1H), 3.62 (d, 
J = 3.3 Hz, 1H), 1.97−1.92 (m, 2H), 1.64−1.52 (m, 8H), 1.22 (s, 6H); 13C NMR (75 MHz, CDCl3) 
δ 173.1, 90.1, 75.2, 46.4, 33.0, 25.3, 22.7, 22.1; HRMS (ESI) calcd for C11H19O (M + H)+ m/z 
167.1436, found 167.1424. 
 
3-Benzyl-2-methylenetetrahydrofuran (2p). 3-Benzyl-2-methylene-tetrahydrofuran (2p) 
was prepared from 3-benzyltetrahydrofuran-2-one (8p) (0.5 g, 2.8 mmol) using 1.5 equiv. of 
dimethyltitanocene. Purification by flash chromatography on silica gel (petroleum 
ether/EtOAc/Et3N, 96.5:3:0.5) afforded 3-benzyl-2-methylene-tetrahydrofuran (2p) as a pale 
yellow oil (0.41 g, 84%): 1H NMR (400 MHz, CDCl3) δ 7.36−7.24 (m, 5H), 4.34 (dd, J = 1.7, 
1.7 Hz, 1H), 4.10 (ddd, J = 8.2, 8.2, 4.2 Hz, 1H), 3.96 (ddd, J = 8.2, 8.2, 6.5 Hz, 1H), 3.89 (dd, 
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J = 1.6, 1.6 Hz, 1H), 3.07 (dd, J = 13.5, 5.2 Hz, 1H), 3.03−2.95 (m, 1H), 2.63 (dd, J = 13.4, 
9.6 Hz, 1H), 2.02−1.94 (m, 1H), 1.78−1.69 (m, 1H); 13C NMR (400 MHz, CDCl3) δ 166.1, 
140.0, 128.9, 128.4, 126.3, 78.9, 68.6, 42.6, 39.5, 31.1; HRMS (ESI) calcd for C12H15O (M + 
H)+ m/z 175.1123, found 175.1137. 
 
1.5.4 Preparation of 4-oxaspiro[2.3]hexanes (spirocyclopropyloxetanes) 
43General procedure for the preparation of 4-oxaspiro[2.3]hexanes 
 
A flame-dried three-neck reaction flask with a stir bar was charged with dry Et2O (3/4 total 
volume) under N2. After the solution was cooled to −15 oC neat Et2Zn (2.0 equiv) was added 
drop-wise. The cloudy solution was stirred until clear (approx. 5 min), and CH2I2 (4.0 equiv) 
was then added while maintaining the internal temperature below −15 oC. After the addition 
was complete, the reaction was allowed to warm to −5 oC (over 10 min). The solution was 
cooled to −15 oC again, and a solution of 2-methyleneoxetane (1 equiv, 1.0 to 1.5 M) in dry 
Et2O (1/4 total volume) was then added. The solution was stirred at −15 oC for 5 min and was 
then transferred to an ice-bath (0 oC). The reaction was stirred at 0 oC until complete 
consumption of 2-methyleneoxetane was observed by TLC (3-4 h). The reaction was 
quenched with saturated aqueous NH4Cl (5 mL) by drop-wise addition at 0 oC with stirring for 
5 min. The aqueous and organic layers were then separated, and the aqueous layer was 
extracted with Et2O (3 x 10 mL). The combined organic extracts were washed with brine, dried 
(MgSO4) and concentrated in vacuo. 
OOR R
2 equiv. Et2Zn
4 equiv. CH2I2
Et2O, -15 oC to 0 oC
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6-Phenyl-4-oxaspiro[2.3]hexane (4a). 6-Phenyl-4-oxaspiro[2.3]hexane (4a) was prepared 
from 2-methylene-3-phenyloxetane (2a)   (0.36 g, 2.5 mmol). Purification by flash chroma-
tography on silica gel (petroleum ether/EtOAc 98:2) afforded 6-phenyl-4-oxaspiro[2.3]hexane 
(4a) as a colorless oil (0.33, 83%):43 1H NMR (400 MHz, CDCl3) δ 7.25−7.43 (m, 5H), 5.02 
(dd, J = 8.3, 5.7 Hz, 1H), 4.66 (dd, J = 6.4, 5.7 Hz, 1H), 4.28 (dd, J = 8.3, 6.4 Hz, 1H), 0.97 
(ddd, J = 10.9, 7.6, 6.5 Hz, 1H), 0.76 (ddd, J = 10.2, 7.4, 6.8, Hz, 1H), 0.62 (ddd, J = 10.8, 
7.5, 6.5 Hz, 1H), 0.32 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 140.1, 128.9, 128.4, 127.6, 75.4, 
74.9, 46.5, 11.8, 9.3. 
5-Benzyloxymethyl-4-oxaspiro[2.3]hexane (4c). 5-Benzyloxymethyl-4-oxaspiro[2.3]-
hexane (4c) was prepared using 4-benzyloxymethyl-2-methyleneoxetane (2c) (0.14 g, 0.75 
mmol). Purification by flash chromatography on silica gel (petroleum ether/Et2O, 94:6) 
afforded 5-benzyloxymethyl-4-oxaspiro[2.3]hexane (4c) as a colorless oil (0.12 g, 78%):44b IR 
(neat) 2922, 1558, 1457, 1103 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.34 (m, 5H), 4.94 (m, 1H), 
4.68 (d, J = 12.1 Hz, 1H), 4.65 (d, J = 12.1 Hz, 1H), 3.80 (dd, J = 10.9, 5.8 Hz, 1H), 3.71 (dd, 
J = 10.9, 3.8 Hz, 1H), 2.88 (dd, J = 10.8, 7.9 Hz, 1H), 2.70 (dd, J = 10.8, 6.2 Hz, 1H), 0.84 (m, 
2H), 0.54 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 138.5, 128.6, 127.9, 127.8, 75.8, 73.7, 73.6, 
66.2, 31.3, 10.6, 10.5; HRMS (ESI) calcd for C13H16O (M + Na)+ m/z 227.1043, found 
227.1066. 
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5-Cyclohexyl-4-oxaspiro[2.3]hexane (4e). 5-Cyclohexyl-4-oxaspiro[2.3]hexane (4e) was 
prepared using 4-cyclohexyl-2-methyleneoxetane (2e) (0.27 g, 1.8 mmol). Purification by flash 
chromatography on silica gel (petroleum ether/Et2O, 99:1) afforded 5-cyclohexyl-4-
oxaspiro[2.3]hexane (4e) as a pale yellow oil (0.12 g, 40%): IR (neat) 1966, 1925, 1738, 1570, 
1076 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.42 (ddd, J = 7.2, 7.2, 7.2 Hz, 1H), 2.75 (dd, J = 
10.7, 7.6 Hz, 1H), 2.54 (dd, J = 11.2, 6.4 Hz, 1H), 1.90 (m, 1H), 1.78−1.74 (m, 2H), 1.70−1.61 
(m, 4H), 1.32−1.14 (m, 2H), 0.98 (m, 2H), 0.83−0.70 (m, 2H), 0.53 (ddd, J = 11.8, 5.9, 5.9 Hz, 
1H), 0.43 (ddd, J = 10.4, 5.4, 5.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 81.2, 65.2, 44.3, 32.6, 
27.9, 26.7, 26.6, 25.9, 25.7, 10.7, 10.6.; HRMS (ESI) calcd for C11H19O (M + H)+ m/z 167.1436, 
found 167.1417. 
trans-5-Benzyloxymethyl-6-methyl-4-oxaspiro[2.3]hexane (4h). trans-5-Benzyloxy-
methyl-6-methyl-4-oxaspiro[2.3]hexane (4h) was prepared using trans-4-benzyloxy-methyl-3-
methyl-2-methylene-oxetane (2h) (0.57 g, 2.8 mmol). Purification by flash chromatography on 
slica gel (petroleum ether/EtOAc 95:5) afforded trans-5-benzyloxymethyl-6-methyl-4-
oxaspiro[2.3]hexane (4h) as a colorless oil (0.49 g, 78%): IR (neat) 3065, 3031, 2961, 2926, 
2871, 1722, 1455, 1116 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.34−7.28 (m, 4H), 7.25−7.20 (m, 
1H), 4.61 (d, J = 12.4 Hz, 1H), 4.57 (d, J = 12.2 Hz, 1H), 4.46 (ddd, J = 5.7, 5.7, 3.9 Hz, 1H), 
3.72 (dd, J = 10.9, 5.7 Hz, 1H), 3.64 (dd, J = 10.9, 3.8 Hz, 1H), 2.90 (dq, J = 6.7, 6.7 Hz, 1H), 
1.10 (d, J = 6.9 Hz, 3H), 0.81 (m, 1H), 0.58 (m, 2H), 0.40 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 138.5, 128.4, 127.7, 127.7, 83.8, 73.5, 72.9, 71.3, 36.4, 15.6, 9.9, 6.5; HRMS (ESI) calcd 
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for C14H19O2 (M + H)+ m/z 219.1385, found 219.1388. 
 
trans-6-Methyl-5-(2-phenylethyl)-4-oxaspiro[2.3]hexane (4i). trans-6-Methyl-5-(2-
phenylethyl)-4-oxaspiro[2.3]hexane (4i) was prepared using trans-3-methyl-2-methylene-4-
(2-phenylethyl)oxetane (2i) (0.34 g, 1.8 mmol). Flash chromatography on silica gel (petroleum 
ether/Et2O, 97:3) afforded trans-6-methyl-5-(2-phenylethyl)-4-oxaspiro[2.3]hexane (4i) as a 
colorless oil (0.28 g, 78%): IR (neat) 3027, 2927, 1604, 1454, 1194, 699 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.32−7.17 (m, 5H), 4.35 (ddd, J = 7.2, 5.8, 5.8 Hz, 1H), 2.80−2.72 (m, 2H), 
2.69−2.61 (m, 1H), 2.23−2.13 (m, 1H), 2.11−2.01 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 0.84 (ddd, 
J = 11.8, 7.5, 6.5 Hz, 1H), 0.66−0.56 (m, 2H), 0.44 (ddd, J = 10.6, 7.7, 6.5 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ 141.8, 128.6, 126.0, 84.9, 70.4, 39.8, 38.6, 30.9, 15.7, 10.0, 6.5; HRMS 
(ESI) calcd for C14H19O (M + H)+ m/z 203.1436, found 203.1419. 
 
trans-6-Benzyloxy-5-cyclohexyl-4-oxaspiro[2.3]hexane (4j). trans-6-Benzyloxy-5-cyclo-
hexyl-4-oxaspiro[2.3]hexane (4j) using trans-3-benzyloxy-4-cyclohexyl-2-methyl-eneoxetane 
(2j) (0.19 g, 0.75 mmol). Purification by flash chromatography on silica gel (petroleum 
ether/Et2O, 99:1) afforded trans-6-benzyloxy-5-cyclohexyl-4-oxaspiro-[2.3]hexane (4j) as pale 
yellow oil (0.12 g, 60%): IR (neat) 3067, 3034, 2865, 1729, 1451, 1274, 1112, 1026 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.36−7.27 (m, 5H), 4.51 (d, J = 11.8 Hz, 1H), 4.39 (d, J = 2.9 Hz, 
1H), 4.36 (dd, J = 3.8, 3.8 Hz, 1H), 4.33 (d, J = 4.6 Hz, 1H), 1.87 (m, 1H), 1.80−1.67 (m, 4H), 
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1.65−1.58 (m, 1H), 1.31−1.13 (m, 3H), 1.03 (dd, J = 11.8, 3.6 Hz, 1H), 0.97 (dd, J = 11.8, 3.4 
Hz, 1H), 0.87 (m, 2H), 0.74 (m, 1H), 0.50-0.43 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 138.1, 
128.6, 128.0, 127.8, 89.9, 79.8, 71.5, 70.6, 42.0, 28.3, 27.2, 26.5, 25.9, 25.7, 9.8, 6.9; HRMS 
(ESI) calcd for C18H25O2 (M + H)+ m/z 273.1855, found 273.1784. 
 
 
 
cis-6-Methyl-5-(2-phenylethyl)-4-oxaspiro[2.3]hexane (4k). cis-6-Methyl-5-(2-phenyl-
ethyl)-4-oxaspiro[2.3]hexane (4k) was prepared using cis-3-methyl-2-methylene-4-(2-
phenylethyl)oxetane (2k) (0.50 g, 2.6 mmol). Purification by flash chromatography on silica 
gel (petroleum ether/Et2O, 97:3) afforded cis-6-methyl-5-(2-phenylethyl)-4-oxaspiro-
[2.3]hexane (4k) as a colorless oil (0.41 g, 76%): IR (neat) 3078, 3063, 2933, 2238, 1641, 
1497, 1173, 798 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.35−7.21 (m, 5H), 4.83 (ddd, J = 9.7, 8.3, 
4.5 Hz, 1H), 3.17 (dq, J = 7.1, 7.1 Hz, 1H), 2.78 (ddd, J = 13.9, 10.0, 5.1 Hz, 1H), 2.58 (ddd, 
J = 13.9, 9.7, 6.6 Hz, 1H), 2.18 (dddd, J = 14.2, 9.9, 9.9, 5.4 Hz, 1H), 1.89 (dddd, J = 10.6, 
10.6, 6.6, 4.2 Hz, 1H) 1.04 (d, J = 7.0 Hz, 3H), 0.89−0.83 (m, 1H), 0.63−0.58 (m, 1H), 
0.56−0.51 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 141.9, 128.6, 128.5, 126.0, 80.1, 71.2, 36.1, 
33.7, 31.4, 11.1, 9.7, 6.7; HRMS (ESI) calcd for C14H19O (M + H)+ m/z 203.1436, found 
203.1418. 
cis-5-Benzhydryl-6-methyl-4-oxaspiro[2.3]hexane (4l). cis-5-Benzhydryl-6-methyl-4-oxa-
spiro[2.3]hexane (4l) was prepared using cis-4-benzhydryl-3-methyl-2-methylene-oxetane 
(2l) (0.12 g, 0.48 mmol). Purification by flash chromatography on silica gel (petroleum 
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ether/Et2O, 96:4) afforded cis-5-benzhydryl-6-methyl-4-oxaspiro[2.3]hexane (4l) as a 
colorless oil (0.11 g, 86%): IR (neat) 3082, 2925, 1495, 1451, 970, 695 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.33−7.13 (m, 10H), 5.63 (dd, J = 11.0, 7.4 Hz, 1H), 4.47 (d, J = 11.0 Hz, 1H), 
3.20 (dq, J = 7.2, 7.2 Hz, 1H), 0.96 (d, J = 7.2 Hz, 3H), 0.92-0.87 (m, 1H), 0.67−0.62 (m, 1H) 
0.60−0.50 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 142.1, 141.5, 128.9, 128.7, 128.5, 128.3, 
126.8, 126.7, 81.8, 70.9, 52.7, 37.0, 12.0, 10.0, 6.4; HRMS (ESI) calcd for C19H21O (M + H)+ 
m/z, 265.1592, found 265.1599. 
9,9-Dimethyl-3-oxadispiro[2.2.5.0]undecane (4n). 9,9-Dimethyl-3-oxadispiro[2.2.5.0]unde-
cane (4n) was prepared using 3,3-dimethyl-2-methylene-1-oxaspiro[3.5]nonane (2n) (0.70 g, 
4.2 mmol). Flash chromatography on silica gel (petroleum ether/Et2O, 99.5:0.5) afforded 9,9-
dimethyl-3-oxadispiro[2.2.5.0]undecane (4n) as a colorless oil (0.56 g, 75%): 1H NMR (400 
MHz, CDCl3) δ 2.00 (m, 2H), 1.59−1.50 (br m, 8H), 1.05 (s, 6H), 0.58 (m, 2H), 0.44 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 86.9, 72.9, 41.3, 33.8, 25.6, 22.7, 20.7, 7.0; HRMS (ESI) calcd 
for C12H21O (M + H)+ m/z 181.1592, found 181.1587. 
 
7-Benzyl-4-oxaspiro[2.4]heptane (4p). 7-Benzyl-4-oxaspiro[2.4]heptane (4p) was prepared 
using 3-benzyl-2-methylenetetrahydrofuran (2p) (420 mg, 2.4 mmol). Purification by flash 
chromatography on silica gel (petroleum ether/Et2O, 98:2) afforded 7-benzyl-4-
oxaspiro[2.4]heptane (4p) as a colorless oil (434 g, 96%): 1H NMR (400 MHz, CDCl3) δ 
7.33−7.19 (m, 5H), 3.96 (ddd, J = 8.2, 8.2, 5.3 Hz, 1H), 3.84 (ddd, J = 8.0, 8.0, 8.0 Hz, 1H), 
2.69 (dd, J = 13.5, 5.0 Hz, 1H), 2.52 (dd, J = 13.4, 10.3 Hz, 1H), 2.42−2.35 (m, 1H), 2.16−2.08 
(m, 1H), 1.85−1.77 (m, 1H), 0.87−0.76 (m, 2H), 0.70−0.65 (m, 1H), 0.48−0.43 (m, 1H); 13C 
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NMR (400 MHz, CDCl3) δ 140.7, 128.9, 128.5, 126.1, 67.2, 66.3, 43.3, 38.3, 32.2, 10.0, 7.0; 
HRMS (ESI) calcd for C13H17O (M + H)+ m/z, 189.1279, obs. 189.1298. 
 
1.5.5 Pt(II)-catalyzed expansion of 4-oxaspiro[2.3]hexanes 
General procedure for the Pt(II)-catalyzed expansion of 4-oxaspiro[2.3]hexanes 
 
Zeise’s dimer (0.1 equiv) and PCy3 (0.2 equiv) were mixed in dry CH2Cl2 (1/4 of total volume) 
in a nitrogen purged flask/NMR reaction tube at rt. 4-Oxaspiro[2.3]hexane (1 equiv, 0.5 M) 
dissolved in dry CH2Cl2 (3/4 of total volume) was added and the reaction mixture was heated 
at 45 oC. The reaction was monitored by NMR/TLC for disappearance of the 4-
oxaspiro[2.3]hexane. The reaction mixture was concentrated in vacuo, and the resulting oil 
was purified by flash column chromatography on neutral alumina or silica gel. 
3-Methylene-4-phenyltetrahydrofuran (6a). The general procedure was followed using 6-
phenyl-4-oxaspiro[2.3]hexane (4a) (0.10 g, 0.63 mmol). The reaction was stirred for 3.5 h. 
Purification by column chromatography on neutral alumina (petroleum ether/EtOAc, 96:4) 
afforded 3-methylene-4-phenyltetrahydrofuran (6a) as a colorless oil (34 mg, 34%). 1H NMR 
(400 MHz, CDCl3) δ 7.32 (m, 2H), 7.24 (m, 3H), 5.05 (m, 1H), 4.77 (dd, J = 4.6, 2.2 Hz, 1H), 
4.51 (m, 2H), 4.29 (dd, J = 6.2, 6.2 Hz, 1H), 3.85 (m, 1H), 3.81 (d, J = 7.8 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ 152.6, 141.3, 128.8, 128.5, 127.0, 106.2, 76.2, 72.3, 50.8. HRMS (ESI) 
calcd for C11H11O (M - H)+ m/z 159.0810, found 159.0795. 
 
10 mol % 
[Pt(C2H4)Cl2]2
PCy3, 0.5 M  
45 oC, CH2Cl2 
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3-Methoxymethyl-2-phenylbut-3-en-1-ol (7a). The general procedure was followed using 6-
phenyl-4-oxaspiro[2.3]hexane (4a) (60 mg, 0.37 mmol) in the presence of MeOH (20 equiv). 
The reaction was stirred for 2 h. Purification by column chromatography on neutral alumina 
(petroleum ether/EtOAc, 95:5) afforded 3-methoxymethyl-2-phenylbut-3-en-1-ol (7a) as a 
yellow oil (44 mg, 50%): IR (neat) 3060, 2924, 2853, 1715, 1453, 1111 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.34-7.22 (m, 5H), 5.30 (s, 1H), 5.15 (s, 1H), 4.02 (dd, J = 18.1, 10.7 Hz, 1H), 
3.91 (dd, J = 17.6, 6.8 Hz, 1H), 3.77 (d, J = 12.8 Hz, 1H), 3.75 (d, J = 12.6 Hz, 1H), 3.61 (dd, 
J = 7.0, 7.0 Hz, 1H), 3.27 (s, 3H), 2.01 (br s, 1H); 13C NMR (100 MHz, CDCl3)  δ 145.7, 140.2, 
128.8, 128.4, 127.2, 114.2, 75.2, 65.2, 58.2, 51.3; HRMS (FAB) calcd for C12H17O2 (M + H)+ 
m/z 193.1229, found 193.1236. 
 
 
 
2-Benzyloxymethyl-4-methylenetetrahydrofuran (6c). The general procedure was 
followed using 5-benzyloxymethyl-4-oxaspiro[2.3]hexane (4c) (39 mg, 0.19 mmol). The 
reaction mixture was stirred for 40 min. Purification by column chromatography on neutral 
alumina (petroleum ether/EtOAc 96:4) afforded 2-benzyloxymethyl-4-methylenetetrahydro-
furan (6c) as a colorless oil (25 mg, 65%):65 IR (neat) 2919, 2857, 1497, 1101, 698 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.30 (m, 5H), 4.96 (ddd, J = 4.4, 2.2, 2.2 Hz, 1H), 4.90 (ddd, J = 
4.3, 2.1, 2.1 Hz, 1H), 4.59 (d, J = 12.1 Hz, 1H), 4.54 (d, J = 12.1 Hz, 1H), 4.39 (m, 1H), 4.26 
(m, 1H), 4.19 (m, 1H), 3.15 (m, 2H), 2.58 (m, 1H), 2.37 (m, 1H); 13C NMR (100 MHz, CDCl3) 
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δ 147.5, 138.2, 128.4, 127.7, 127.6, 104.4, 78.5, 73.4, 72.0, 71.2, 35.2; HRMS (ESI) calcd for 
C13H15O2 (M - H)+ m/z 203.1072, found 203.1046. 
2-Cyclohexyl-4-methylenetetrahydrofuran (6e). The general procedure was followed using 
5-cyclohexyl-4-oxaspiro[2.3]hexane (4e) (35 mg, 0.21 mmol). The reaction was stirred for 1.5 
h. Purification by column chromatography on neutral alumina (petroleum ether/Et2O, 99:1) 
afforded 2-cyclohexyl-4-methylenetetrahydrofuran (6e) as a colorless oil (21 mg, 62%):66 1H 
NMR (400 MHz, CDCl3) δ 4.95 (dd, J = 2.2, 2.2 Hz, 1H), 4.87 (dd, J = 2.2, 2.2 Hz, 1H), 4.36 
(m, 1H), 4.21 (m, 1H), 3.60 (m, 1H), 2.56 (m, 1H), 2.25 (m, 1H), 1.96 (m, 2H), 1.80−1.59 (m, 
4H), 1.44−1.14 (m, 3H), 0.99 (m, 2H). Spectral data are in accordance with literature reference 
65. 
 
trans-2-Benzyloxymethyl-3-methyl-4-methylenetetrahydrofuran (6h). The general 
procedure was followed using trans-5-(benzyloxymethyl)-6-methyl-4-oxaspiro[2.3]-hexane 
(4h) (50 mg, 0.23 mmol). The reaction mixture was stirred for 45 min. Purification by column 
chromatography on neutral alumina (petroleum ether/EtOAc, 96:4) afforded trans-2-
benzyloxymethyl-3-methyl-4-methylenetetrahydrofuran (6h) as a colorless oil (34.5 mg, 69%): 
IR (neat) 3064, 2964, 2931, 2872, 1766, 1723, 1453, 1379, 1091, 913 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.35−7.25 (m, 5H), 4.92 (m, 1H), 4.88 (ddd, J = 2.5, 2.5, 2.5 Hz, 1H), 4.60 (s, 
2H), 4.52−4.48 (m, 1H), 4.35−4.30 (m, 1H), 3.67−3.54 (m, 3H), 2.46 (m, 1H), 1.09 (d, J = 6.7 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 153.3, 138.4, 128.6, 127.9, 127.8, 103.3, 85.4, 73.7, 
71.3, 40.1, 15.1; HRMS (ESI) calcd for C14H17O2 (M + H)+ m/z 217.1229, found 217.1198. 
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trans-3-Methyl-4-methylene-2-(2-phenylethyl)tetrahydrofuran (6i). The general 
procedure was followed using trans-4-methyl-5-(2-phenylethyl)-4-oxaspiro[2.3]hexane (4i) 
(50 mg, 0.25 mmol). The reaction mixture was stirred for 45 min. Purification by column 
chromatography on neutral alumina (petroleum ether/Et2O, 98:2) afforded trans-3-methyl-4-
methylene-2-(2-phenylethyl)tetrahydrofuran (6i) as a colorless oil (40 mg, 80%): IR (neat) 
3027, 2917, 2853, 1765, 1496, 1455, 1377, 1030, 909 cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.23−7.10 (m, 5H), 4.84 (m, 1H), 4.79 (m, 1H), 4.42 (m, 1H), 4.23 (m, 1H), 3.32 (ddd, J = 8.8, 
8.8, 3.1 Hz, 1H), 2.82 (ddd, J = 13.9, 10.8, 5.1 Hz, 1H), 2.62 (ddd, J = 13.8, 10.3, 6.4 Hz, 1H), 
2.2 (m, 1H), 1.88 (m, 1H), 1.77 (m, 1H), 1.0 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
154.0, 142.5, 128.6, 128.6, 126.0, 102.9, 85.8, 70.9, 43.7, 36.0, 32.7, 14.9; HRMS (ESI): calcd 
for C14H19O (M - H)+ m/z 201.1279, found: 201.1278. 
 
trans-3-Benzyloxy-2-cyclohexyl-4-methylenetetrahydrofuran (6j). The general procedure 
was followed using trans-6-benzyloxy-5-cyclohexyl-4-oxaspiro[2.3]hexane (4j) (60 mg, 0.22 
mmol). The reaction mixture was stirred for 2 h. Purification by column chromatography on 
neutral alumina (petroleum ether/Et2O, 95:5) afforded trans-3-benzyloxy-2-cyclohexyl-4-
methylenetetrahydrofuran (6j) as a colorless oil (45 mg, 75%): IR (neat) 2925, 2853, 1731, 
1573, 1451, 1260, 1065 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.35−7.34 (m, 4H), 7.30−7.27 (m, 
1H), 5.24 (m, 1H), 5.19 (m, 1H), 4.66 (d, J = 11.7 Hz, 1H), 4.51 (d, J = 11.7 Hz, 1H), 4.46−4.43 
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(m, 1H), 4.32−4.27 (m, 1H), 4.09 (m, 1H), 3.76 (dd, J = 7.4, 3.0 Hz, 1H), 1.82 (m, 1H), 
1.74−1.72 (m, 2H), 1.65−1.61 (m, 2H), 1.39−1.32 (m, 1H), 1.25−1.13 (m, 3H), 1.10−0.97 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ 147.8, 138.4, 128.6, 128.0, 127.8, 109.8, 88.6, 81.9, 70.2, 
70.0, 40.6, 29.6, 28.8, 26.6, 26.3, 26.1; HRMS (ESI): calcd for C18H25O2 (M
 + H)+ m/z 
273.1855, found 273.1837. 
 
Reaction of cis-6-methyl-5-(2-phenylethyl)-4-oxaspiro[2.3]hexane (4k). 
The general procedure was followed using cis-6-methyl-5-(2-phenylethyl)-4-
oxaspiro[2.3]hexane (4k)  (110 mg, 0.54 mmol). The reaction mixture was stirred for 16 h. The 
reaction was monitored by NMR/TLC for disappearance of cis-6-methyl-5-2-phenylethyl-4-
oxaspiro[2.3]hexane. Purification by column chromatography on neutral alumina (petroleum 
ether/EtOAc 99.5:0.5 to 95:5) afforded (*3R,*4R)-2,3-dimethyl-6-phenylhex-1-ene-4-ol (12) 
and (E)-4-methyl-6-phenylhepta-1,4-diene-3-one (13) as the major and minor products, 
respectively. cis-3-Methyl-4-methylene-2-(2-phenylethyl)tetrahydrofuran (6k) was also 
observed and obtained in a trace amount with an unknown impurity. 
 
(3R*,4R*)-2,3-Dimethyl-6-phenylhex-1-ene-4-ol (9) was obtained as the major product in 
the above reaction as a clear oil (46 mg, 42%): 1H NMR (400 MHz, CDCl3) δ 7.30−7.26 (m, 
2H), 7.22−7.16 (m, 3H), 4.85 (s, 1H), 4.78 (s, 1H), 3.59 (m, 1H), 2.85 (ddd, J = 14.0, 9.3, 6.0 
Hz, 1H), 2.66 (ddd, J = 16.4, 9.0, 7.0 Hz, 1H), 2.20 (dq, J = 6.8, 6.8 Hz, 1H), 1.76 (m, 2H), 
1.69 (s, 3H), 1.06 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 148.2, 142.4, 128.6, 128.6, 
126.0, 111.7, 72.0, 46.6, 36.7, 32.8, 21.4, 13.6; HRMS (ESI) calcd for C14H21O (M + H)+ m/z 
205.1592, found 205.1583. 
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(E)-4-Methyl-7-phenylhepta-1,4-diene-3-one (10) was obtained as the minor product from 
the above reaction as colorless oil (21 mg, 20%): 1H NMR (400 MHz, CDCl3) δ 7.31−7.28 (m, 
2H), 7.22−7.18 (m, 3H), 6.87 (dd, J = 17.0, 10.6 Hz, 1H), 6.65 (m, 1H), 6.19 (dd, J = 17.0, 1.8 
Hz, 1H), 5.68 (dd, J = 10.6, 1.8 Hz, 1H), 2.79 (dd, J = 7.4, 7.4 Hz, 1H), 2.59 (ddd, J = 7.4, 7.4, 
7.4 Hz, 1H), 1.80 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 192.7, 142.7, 141.2, 138.3, 132.1, 
128.7, 128.5, 128.1, 126.4, 34.9, 31.1, 11.8; HRMS (ESI): calcd for C14H17O (M
 + H+) m/z 
201.1279, found 201.1249.	
 
cis-3-Methyl-4-methylene-2-(2-phenylethyl)tetrahydrofuran (6k) was also observed and 
obtained as a colorless oil in a trace amount with an unknown impurity: 1H NMR (400 MHz, 
CDCl3) δ 7.22−7.16 (m, 5H), 4.89 (m, 1H), 4.84 (m, 1H), 4.41 (d, J = 13.3 Hz, 1H), 4.30 (d, J 
= 14.0 Hz, 1H), 3.95 (ddd, J = 8.9, 6.0, 4.6 Hz, 1H), 2.85 (m, 2H), 2.69 (m, 2H), 1.01 (d, J = 
7.1 Hz, 3H). 
 
Reaction of cis-5-benzhydryl-6-methyl-4-oxaspiro[2.3]hexane (4l). 
The general procedure was followed using cis-5-benzhydryl-6-methyl-4-oxaspiro[2.3]hexane 
(4l) (27 mg, 0.10 mmol). The reaction mixture was stirred for 21 h. The reaction was monitored 
by NMR/TLC for disappearance of cis-5-benzhydryl-6-methyl-4-oxaspiro[2.3]hexane. 
Purification by column chromatography on neutral alumina (petroleum ether/EtOAc 99:1 to 
95:5) afforded (2S*,3R*)-4-chloromethyl-3-methyl-1,1-diphenylpent-4-ene-2-ol (8) as the 
major product and cis-5-benzhydryl-4-methyl-3-methylenetetrahydrofuran (6l) as the minor 
6k
O
H3C
CH3
O
10
 71 
product. 
 
(2S*,3R*)-4-Chloromethyl-3-methyl-1,1-diphenylpent-4-ene-2-ol (8) was obtained as a 
clear oil (13 mg, 39%): 1H NMR (400 MHz, CDCl3) δ 7.42−7.19 (m, 10H), 5.30 (s, 1H), 5.12 
(s, 1H), 4.53 (ddd, J = 9.4, 3.1, 3.1 Hz, 1H), 4.14 (d, J = 3.1 Hz, 1H), 4.04 (d, J = 11.8 Hz, 1H), 
4.04 (d, J = 9.5 Hz, 1H), 2.51 (m, 3H), 1.56 (d, J = 3.1 Hz, 1H), 1.13 (d, J = 7.0 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 148.4, 142.1, 141.9, 129.1, 128.8, 128.4, 127.1 127.0, 116.2, 74.5, 
56.1, 47.9, 38.8, 12.0; HRMS (ESI) calcd for C19H25NClO (M
 + NH4)+ m/z 318.1625, found 
318.1632. 
 
cis-2-Benzhydryl-3-methyl-4-methylenetetrahydrofuran (6l) was obtained from the 
reaction of cis-5-benzhydryl-6-methyl-4-oxaspiro[2.3]hexane (4l) in a trace amount as 
colorless oil: 1H NMR (400 MHz, CDCl3) δ 7.81–7.14 (m, 10H), 4.91 (m, 1H), 4.84 (m, 1H), 
4.68 (dd, J = 10.9, 4.7 Hz, 1H), 4.48 (m, 1H), 4.23 (m, 1H), 4.03 (d, J = 10.9 Hz, 1H), 2.66 (m, 
1H), 0.98 (d, J = 7.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 154.7, 143.4, 142.3, 128.9, 128.7, 
128.3, 128.1, 126.8, 126.6, 103.7, 84.3, 70.7, 52.6, 41.5, 15.5; HRMS (ESI) calcd for C19H21O 
(M + H)+ m/z 263.1436, found 263.1439. 
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4-Benzyl-3-methylenetetrahydropyran (6p). The general procedure was followed using 4-
7-benzyl-4-oxaspiro[2.4]heptane (4p) (50 mg, 0.26 mmol). The reaction mixture was stirred 
for 24 h. Purification by column chromatography on neutral alumina (petroleum ether/Et2O, 
98:2) afforded 4-benzyl-3-methylenetetrahydropyran (6p) as a colorless oil (10 mg, 20%): 1H 
NMR (400 MHz, CDCl3) δ 7.31−7.16 (m, 5H), 4.92 (s, 1H), 4.85 (s, 1H), 4.20 (d, J = 11.9 Hz, 
1H), 3.93 (d, J = 11.9 Hz, 1H), 3.94-3.90 (m, 2H), 3.54-3.49 (m, 1H), 3.10 (dd, J = 12.8, 4.4 
Hz, 1H), 2.58-2.52 (m, 1H), 1.65-1.61 (m, 1H), 1.44-1.37 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 147.7, 140.3, 129.3, 128.5, 126.2, 108.6, 73.2, 67.6, 41.7, 38.5, 33.5; HRMS (ESI): calcd 
for C13H15O (M - H)+ m/z 187.1123, found: 187.1132. 
2-(1-Cyclohexenyl)-2-methylpentan-3-one (13). The general procedure for the reaction of 
4-oxaspirohexane with Zeise’s dimer was followed using 9,9-dimethyl-3-
oxadispiro[2.2.5.0]undecane (4n) (20 mg, 0.11 mmol). Purification by column chromatography 
on neutral alumina (petroleum ether/EtOAc, 99:1) afforded 2-(1-cyclohexenyl)-2-
methylpentan-3-one (13) as clear oil (10 mg, 50%):44a 1H NMR (400 MHz, CDCl3) δ 5.62 (m, 
1H), 2.35 (q, J = 7.3 Hz, 2H), 2.05 (m, 2H), 1.75 (m, 2H), 1.54 (m, 4H), 1.15 (s, 6H), 0.99 (t, J 
= 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 215.6, 140.4, 122.1, 53.6, 29.7, 26.1, 25.7, 23.3, 
23.3, 22.4, 8.7; HRMS (ESI) calcd for (M + H)+ C12H21O m/z 181.1592, found 181.1562. 
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1.5.6 Preparation of 13C-labeled 4-oxaspiro[2.3]hexanes 
 
A flame-dried three-neck reaction flask with a stir bar was charged with dry Et2O (3/4 total 
volume) under N2. After the solution was cooled to −15 oC neat Et2Zn (1.0 equiv) was added 
drop-wise. The cloudy solution was stirred until clear (approx. 5 min), and 13CH2I2 (1.1 equiv) 
was then added while maintaining the internal temperature below −15 oC. After the addition 
was complete, the reaction was allowed to warm to −5 oC (over 10 min). The solution was 
cooled to −15 oC again, and a solution of 2-methyleneoxetane (1 equiv) in dry Et2O (1/4 total 
volume) was then added. The final solution is 1.0 M of methyleneoxetane in Et2O. The solution 
was stirred at −15 oC for 5 min and was then transferred to an ice-bath (0 oC). The reaction 
was stirred at 0 oC until complete consumption of 2-methyleneoxetane was observed by TLC 
(3-4 h). The reaction was quenched with saturated aqueous NH4Cl (5 mL) by drop-wise 
addition at 0 oC with stirring for 5 min. The aqueous and organic layers were then separated, 
and the aqueous layer was extracted with Et2O (3 x 10 mL). The combined organic extracts 
were washed with brine, dried (MgSO4) and concentrated in vacuo. 
 
13C-Labeled trans-5-benzyloxymethyl-6-methyl-4-oxaspiro[2.3]hexane (13C-4h). The 
general procedure for the preparation of 13C-labeled 4-oxaspiro[2.3]hexanes was followed 
using trans-4-benzyloxymethyl-3-methyl-2-methyleneoxetane (2h) (0.1 g, 0.5 mmol. 
Purification by column chromatography on silica gel (petroleum ether/EtOAc 95:5) afforded 
13C-labeled trans-5-benzyloxymethyl-6-methyl-4-oxaspiro[2.3]hexane (13C-4h) as a mixture of 
O
13C-4h
O
13
O
13C-4
O
1.1 equiv. 13CH2I2 
1.0 equiv. Et2Zn
2
1 M Et2O, 0 oC, 3h
R R
13
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isotopomers (colorless oil) (0.08 g, 71%): 1H NMR (400 MHz, CDCl3) δ 7.42−7.25 (m, 5H), 
4.65 (d, J = 12.2 Hz, 1H), 4.62 (d, J = 12.2 Hz, 1H), 4.50 (ddd, J = 5.7, 5.7, 3.8 Hz, 1H), 3.76 
(dd, J = 11.0, 5.8 Hz, 1H), 3.76 (dd, J = 11.0, 3.8 Hz, 1H), 2.94 (m, 1H), 1.14 (d, J = 6.9 Hz, 
3H), 1.10−0.14 (m1, 4H ); 13C NMR (100 MHz, CDCl3) δ 138.5, 128.6, 127.8, 127.8, 83.9, 73.7, 
73.0, 71.5 (71.3 for the other isotopomer), 36.5, 15.7, 10.0 (13C-labeled), 6.6 (13C-labeled); 
HRMS (ESI) calcd for C1313CH17O2 (M
 + H)+ m/z 220.1385, found 220.1375. 
 
 
 
 
13C-Labeled cis-5-benzhydryl-6-methyl-4-oxaspiro[2.3]hexane (13C-4l). The general 
procedure for the preparation of 13C labeled 4-oxaspiro[2.3]hexanes was followed using cis-
4-benzhydryl-3-methyl-2-methyleneoxetane (2l) (120 mg, 0.48 mmol). Purification by column 
chromatography on silica gel (petroleum ether/EtOAc 95:5) afforded 13C labeled cis-5-
benzhydryl-6-methyl-4-oxaspiro[2.3]hexane (13C-4l) as a mixture of isotopomers (colorless 
oil) (69 mg, 55%): IR (neat) 3082, 2925, 1495, 1451, 970, 695 cm-1;  1H NMR (400 MHz, 
CDCl3) δ 7.32−7.11 (m, 10 H), 5.62 (dd, J = 11.1, 7.3 Hz, 1H), 4.46 (d, J = 11.1 Hz, 1H), 3.20 
(m, 1H), 0.95 (d, J = 7.2 Hz, 3H), 1.26−0.53 (m2, 4H); 13C NMR (125 MHz, CDCl3) δ 142.1, 
141.5, 128.9, 128.7, 128.6, 128.3, 126.8, 126.7, 81.8, 71.0 (70.8 for the other isotopomer), 
52.7, 37.0, 10.0 (13C-labeled carbon), 6.4 (13C-labeled carbon); HRMS (ESI) calcd for 
C1813CH21O (M
 + H)+ m/z 266.1592, found 266.1605. 
 
 
																																																						
1 Complex multiplets were observed as a result of 1J13C-H and 2J13C-H coupling. 
2 Complex multiplets were observed as a result of 1J13C-H and 2J13C-H coupling.	
O
H3C
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1.5.7 13C NMR monitoring for the reaction of 13C-labeled oxaspirohexane with Zeise’s 
dimer. 
Zeise’s dimer (0.5 equiv) and PCy3 (1.0 equiv) were mixed in dry CD2Cl2 (0.3 mL) in a N2 
purged NMR reaction tube. 4-Oxaspiro[2.3]hexane (0.1 mmol) dissolved in dry CD2Cl2 (0.2 
mL) was added at −30 oC. The solution was then allowed to warm to room temperature. The 
reaction was monitored by 13C NMR until complete conversion of starting material to products.  
 
13C-Labeled trans-5-benzyloxymethyl-6-methyl-4-oxaspiro[2.3]hexane (13C-4h) 
Figure 9a. 13C NMR Spectrum (CD2Cl2, rt, 100 MHz) of the reaction after 1 h: 
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Figure 9b. 13C-DEPT NMR Spectrum (CD2Cl2, rt, 100 MHz) of the reaction after 2 h: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9c. 13C-DEPT NMR Spectrum (CD2Cl2, rt, 100 MHz) of the reaction after 4 h: 
The labeled peaks correspond to the 13C-labeled carbons in compounds 13C-6h and 13C-7, as 
major and minor products, respectively, and were both isolated. 
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13C-labeled trans-5-benzyloxymethyl-4-methyl-3-methylenetetrahydrofuran (13C-6h). 
The general procedure was followed using 13C-labeled trans-5-benzyloxymethyl-6-methyl-4-
oxaspiro[2.3]hexane (13C-4h) (22 mg, 0.1 mmol). The reaction mixture was concentrated in 
vacuo. Purification by column chromatography using petroleum ether/Et2O (95:5) afforded an 
isotopomeric mixture of 13C-labeled trans-5-benzyloxymethyl-4-methyl-3-
methylenetetrahydrofuran (13C-6h) as a colorless oil (12 mg, 55%): 1H NMR (400 MHz, CDCl3) 
for isotopomer A: δ 7.35−7.25 (m, 5H), 4.96 (dm3, 1J13C-H = 156.9 Hz, 1H), 4.91 (dm3, 1J13C-H = 
157.7 Hz, 1H), 4.63 (s, 2H), 4.53−4.49 (m, 1H), 4.39−4.31 (m, 1H), 3.70−3.57 (m, 3H), 2.49 
(m, 1H), 1.12 (d, J = 6.7 Hz, 3H); for isotopomer B: δ 7.35−7.25 (m, 5H), 4.96 (m, 1H), 4.91 
(m, 1H), 4.63 (s, 2H), 4.53−4.49 (dm3, 1J13C-H = 146.4 Hz, 1H), 4.35−4.30 (dm3, 1J13C-H = 143.0 
Hz, 1H), 3.70−3.57 (m, 3H), 2.49 (m, 1H), 1.12 (d, J = 6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 153.3, 138.4, 128.6, 127.9, 127.8, 103.3 (13C-labeled carbon in isotopomer A), 85.4, 73.7, 
71.3, (13C-labeled carbon in isotopomer B), 70.8, 40.0, 15.1 (match with compound 6h); 
HRMS (ESI) calcd for C1313CH19O2 (M + H)+ m/z 220.1385, found 220.1379; (M + NH4)+, calc. 
237.1651, found 237.1629, (M – OH)+, 202.1279, found 202.1298 and (M – H)+, 218.1229, 
found 218.1224. 
 
 
 
13C-labeled (2R*, 3S*)-1-benzyloxy-4-chloromethyl-3-methyl-pent-4-ene-2-ol (13C-17) 
was obtained as the minor product (colorless oil, 5 mg, 20%): 1H NMR (400 MHz, CDCl3) for 
isotopomer A: δ 7.38−7.30 (m, 5H), 5.31 (d, 1J13C-H = 157.8 Hz, 1H), 5.11 (d, 1J13C-H = 156.8 Hz, 
1H), 4.59 (d, J = 11.2 Hz), 4.54 (d, J = 11.9 Hz), 4.14 {dd, J = 5.9 Hz (3J13C-H), 5.9 Hz, 2H}, 3.79 
(m, 1H), 3.59 (dd, J = 9.6, 3.1 Hz, 1H), 3.43 (dd, J = 9.6, 7.2 Hz, 1H), 2.54 (m, 1H), 2.35 (d, J 
																																																						
3 dm = doublet of multiplet; where the large coupling constant (1J13C-H) is shown. 
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= 3.7 Hz, 1H), 1.09 (d, J = 7.1 Hz, 3H); for isotopomer B: δ 7.38−7.30 (m, 5H), 5.31 (d, 3J13C-H 
= 8.0 Hz, 1H), 5.11 (d, 3J13C-H = 13.6 Hz, 1H), 4.59 (d, J = 11.2 Hz), 4.54 (d, J = 11.9 Hz), 4.14 
{dd, J = 151.0 Hz (1J13C-H), 7.0 Hz, 2H}, 3.79 (m, 1H), 3.59 (dd, J = 9.6, 3.1 Hz, 1H), 3.43 (dd, 
J = 9.6, 7.2 Hz, 1H), 2.54 (m, 1H), 2.35 (d, J = 3.7 Hz, 1H), 1.09 (d, J = 7.1 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 147.4, 138.1, 128.7, 128.1, 128.0, 115.9 (13C-labeled carbon in 
isotopomer A), 77.4, 73.7, 72.6, 53.6, 48.3 (13C-labeled carbon in isotopomer B), 16.9; HRMS 
(ESI) calcd for C1313CH20ClO2 (M + H)+ m/z 256.1152, found 256.1168. 
 
13C-Labeled cis-5-benzhydryl-6-methyl-4-oxaspiro[2.3]hexane (13C-4l) 
Figure 10a. 13C DEPT NMR (CD2Cl2, room temp., 100 MHz) of the reaction after 1 h: 
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Figure 10b. 13C DEPT NMR (CD2Cl2, room temp., 100 MHz) of the reaction after 4 h: 
The labeled peaks correspond to the 13C-labeled carbons in compounds 13C-11 and 13C-6l as 
major and minor products (no purification was done). As reference, compound 4l was treated 
in the same conditions and compounds 8 and 6l were isolated in 52% and 16% yields, 
respectively. 
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Chapter 2 
Transition Metal Catalyzed Transformations of α-Methylene-β-lactones 
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2.1 Introduction 
β-Lactones are an important class of heterocyclic compounds found in several 
synthetic and natural products of biological relevance.1-4 For instance, orlistat,1 an FDA-
approved drug for the treatment of obesity, contains a β-lactone which was found to be 
associated with its activity as a pancreatic lipase inhibitor (Figure 11). Orlistat 
(tetrahydrolipstatin) is a synthetic product derived from the modification of its natural product 
analog, lipstatin. Other β-lactone-containing natural products of biological importance include 
salinosporamide A,2 a potent anticancer agent, and obafluorin,3 a natural product with 
moderate antibacterial activity. 
 
Aside from the prevalence of β-lactones in natural products, they are considered 
privileged intermediates in organic synthesis as they offer a broad range of reactivities.5 The 
Howell group has recently utilized a particular class of β-lactones, α-methylene-β-lactones, in 
a ruthenium catalyzed cross-metathesis reaction6,7 that provided access to a library of 
disubstituted β-lactones (Scheme 38). Some of these lactones were recently evaluated in 
activity-based protein profiling (ABPP) studies as small molecule inhibitors of fatty acid 
synthase (FAS) and phosphatidylserine (PS) lipase.7 Other previous reports on the reaction 
of α-methylene-β-lactones (Scheme 38) include: (a) Michael addition with cyclic secondary 
amines,8 thiolates8 and enolates9 (b) enzymatic transesterification with alcohols,10 and (c) 
thermal decarboxylation to allenes.11 
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Figure 11. Selected biologically active natural and synthetic β-lactones.
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The belief that α-methylene-β-lactones are advantaged intermediates in the 
construction of valuable products led this work to explore their reactivities under transition 
metal catalysis. This chapter consists of two successful transition metal catalyzed 
transformations of α-methylene-β-lactones. First is a rhodium catalyzed conjugate addition 
with aryl boronic acids to access trans- and cis-β-lactones. Second, a chemoselective 
amidation with amines via a palladium catalyzed acyl C−O bond activation is described. 
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Scheme 38. Previous reports on the reactions of α-methylene-β-lactones.
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2.2 Rhodium Catalyzed Conjugate Addition of Aryl Boronic Acids to α-Methylene-β-
lactones 
 
2.2.1 Background and Significance 
2.2.1.1 Approaches to disubstituted β-lactones 
The recent finding that orlistat (see Figure 11), a disubstituted trans-β-lactone, is a 
potent inhibitor of FAS (fatty acid synthase) led to the development of practical routes to 
various disubstituted β-lactones.1 The well-documented up-regulation of FAS in cancer cells 
makes this enzyme an interesting therapeutic target for cancer treatment.12,13 The Howell 
group and others have reported methods to easily construct various disubstituted β-lactones 
as small molecule inhibitors of FAS or other serine/threonine proteases. 
The Romo group14 reported a route to disubstituted β-lactones based on a two-step 
process involving Calter’s15 organocatalytic, asymmetric ketene dimerization of acid chlorides 
followed by a facial-selective hydrogenation leading to cis-substituted-β-lactones. (Scheme 
39). Several acyl chlorides underwent quinidine catalyzed ketene dimerization and gave 
isolable β-alkylidene-β-lactones in good enantioselectivities. Hydrogenation of the ketene 
dimers under Pd catalysis provided cis-β-lactones with excellent diastereoselectivities. 
Subsequent base mediated α-epimerization allowed access to trans-β-lactones, albeit with 
low diastereoselectivities (Scheme 40). This two step process provided a practical approach 
to simple, pseudosymmetric dialkyl β-lactones. Products obtained from this protocol were 
evaluated for FAS inhibition. β-Lactone 32a (both cis and trans, Schemes 39 and 40) 
displayed significant FAS inhibitory activities, only 10-fold lower than that of orlistat. The 
promising FAS inhibitory activity displayed by simple, disubstituted β-lactones opens 
opportunities specifically in developing other methods than can provide access to a more 
diverse range of β-lactones. 
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In exploring the reactivities of strained heterocycles with exocyclic unsaturation, the 
Howell group found that α-methylene-β-lactones 29 participated in cross-metathesis (CM) 
reactions with Type I alkenes,16 with couplings proceeding in high yields and with excellent Z-
stereoselectivities.6 This method was recently utilized to access a wide range of previously 
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Scheme 39. β-Lactone synthesis by ketene dimerization/hydrogenation sequence.
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unexplored β-lactones for their evaluation as electrophilic probes or inhibitors of FAS and 
other related enzymes, particularly in the serine/threonine hydrolase class.7,17 
 
 
The methodology described above is an attractive approach to a focused library of β-
lactones for several reasons. First, the α-alkylidene-β-lactones can be used as probes. In a 
recent report from the Howell and Cravatt groups,17 α-alkylidene-β-lactone 33b was identified 
as a potent inhibitor of ABHD16A, a poorly characterized enzyme found to regulate 
immunomodulatory lysophosphatidylserines (lyso-PS). Moreover, the identification of lactone 
33b as an inhibitor facilitated the functional characterization of the ABHD16A. Secondly, the 
α-alkylidene-β-lactones can be converted selectively to trans- or cis- β-lactones via 
diastereoselective reductions. cis-β-Lactones were accessed by hydrogenation reactions. The 
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Scheme 41. β-Lactone synthesis by cross-metathesis/reduction sequence.
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trans-isomers were obtained via a cobalt catalyzed 1,4-reduction in good yields, albeit, with 
moderate diastereoselectivities.7 
The β-lactones obtained were screened as probes in a competitive ABPP assay 
against several serine hydrolase targets in the mouse brain membrane proteome. Among the 
β-lactones, trans-32d displayed one of the broadest reactivity profiles against detected serine 
hydrolase targets. Specifically, trans-32d potently inhibited FAS, ABHD16A, and six other 
enzyme targets. The promising activities exhibited by β-lactones, in particular, disubstituted 
β-lactones, as inhibitors of serine hydrolases exposes the need to prepare diverse analogs of 
these compounds. While the utility of α-methylene-β-lactones in CM/reduction sequence 
provides access to diverse disubstituted β-lactones, we hoped that these intermediates could 
also be used in conjugate addition reactions.18,19 However, conjugate addition reactions 
typically require strong nucleophiles that might potentially cause the β-lactones to undergo 
ring opening reactions. Nonetheless, promising conjugate addition reactions have been 
developed, including rhodium-catalyzed conjugate additions of aryl boronic acids. Examples 
of these type of reactions and potential application to α-methylene-β-lactones are summarized 
in the next section. 
 
2.2.1.2 Rhodium catalyzed conjugate addition of aryl boronic acids 
 Catalytic conjugate addition reactions of organometallic reagents to enones has 
emerged as a fundamental methodology in the construction of C-C bonds.18,19 This type of 
reaction has been known since 1900 when Kharash20 reacted isophorone with methyl 
Grignard reagent in the presence of catalytic amount of copper chloride (Scheme 42). Other 
metal complexes, such as those of Ni and Pd, were reported to effect similar transformations. 
21,22 However, with these catalysts, air and moisture sensitive organometallic coupling partners 
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(Grignard or organolithium reagents, enolates) are required, leading to difficulty in handling 
and manipulation of reactions, as well as problems with broad functional group tolerance. 
 
 Miyaura and co-workers18 reported the first conjugate addition reaction to an enone 
(methyl vinyl ketone) with phenyl boronic acid under rhodium catalysis (Scheme 42). In 
contrast to previous transition metal catalyzed conjugate additions, the reaction was done in 
the presence of water as co-solvent. In the last two decades, rhodium catalyzed conjugate 
addition has witnessed advancements. In particular, new rhodium complexes and 
organoboron reagents have been developed.19,23 Likewise, various substrates, including α,β-
unsaturated esters, amides, lactones, lactams, nitriles, and aldehydes, have been utilized.19 
O O
+ CH3MgBr
cat. CuCl
Et2O
Kharasch 1900
Scheme 42. The first copper and rhodium catalyzed conjugate addition reactions 
reported.
Miyaura 1997
O
B(OH)2
O
Ph
cat.[Rh(acac)(CO)2
dppb
MeOH/H2O (6:1)
50 oC, 16 h
+ Ph2P
PPh2
dppb
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 Hayashi and co-workers24-26 pursued the rhodium catalyzed conjugate addition of aryl 
boronic acids to endocyclic α,β-unsaturated lactones and lactams.  Selected examples of 
products obtained through this process are shown in Scheme 43. Most examples provided 
products in excellent yields, and in the presence of appropriate chiral ligands, high 
enantioselectivities were achieved. In the case of γ-butyrolactone, the low yield obtained was 
thought to be associated with potential instability of the 5-membered lactone under the 
conditions (use of KOH, reaction temperature up to 100 oC). Dihydropyridinones were also 
utilized in Rh-catalyzed conjugate additions to access 4-arylpiperidinones.27 The 4-
arylpiperidinone shown in Scheme 44 is a known intermediate in the synthesis of (−)-
paroxetine,28 a drug used for the treatment of Parkinson’s disease. 
X
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n
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O
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Scheme 43. Selected examples of Rh-catalyzed conjugate addition of 
aryl boronic acids with α,β-unsaturated lactones and lactams.
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 The conjugate addition reactions to exocyclic α,β-unsaturated lactones and lactams 
under rhodium catalysis with organoboron reagents is rare. Frost and co-workers29 reported 
1,4-additions with α-methylenepyrrolizidinones that provided products in good yields with 
modest selectivity towards the trans-adduct (Scheme 45). Very recently, Viaud-Massuard and 
co-workers30 disclosed the conjugate addition of aryl boronic acids with α-benzylidene-7-
azaoxindoles. 
 
Frost30 also pursued a Rh-catalyzed conjugate addition to benzylidene dilactones 
derived from Meldrum’s acid (Scheme 46). One challenge associated with this type of 
N O
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Scheme 44. Rh-catalyzed conjugate addition to dihydropyridinone for the synthesis of 
(−)-paroxetine.
63% yield
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Scheme 45. Rhodium catalyzed conjugate addition of exocyclic lactams with 
aryl boronic acids.
Frost 2006
N
O
H
cat. [Rh(cod)2Cl]2PhB(OH)2+
dioxane/H2O (10:1)
110 oC, 24 h
N
O
H
Ph N
O
H
Ph+
70% yield (dr 3:1)
Viaud-Massuard 2015
N N
O
cat. [Rh(C2H2)2Cl]2
(R,R)-Phbod
KOH (0.5 equiv)
dioxane/H2O (10:1)
60 oC, 3 h
85% yield (dr 1:1)
N N
O
PhB(OH)2+
(3 equiv) Ph
Ph
(R,R)-Phbod
Ph
MeO MeO
E/Z = 80:20
 96 
substrate is its instability with nucleophiles, including water, requiring the need for anhydrous 
conditions.31 Aryl boronic acids and potassium trifluoroborate salts were found ineffective, 
presumably due to their low solubility in organic solvents. However, novel TMS-protected aryl 
dioxaborinanes yielded desired products in moderate yields. 
 
These successful reports of Rh-catalyzed conjugate addition reactions to exocyclic 
α,β-unsaturated lactones and lactams provide openings, in particular, to four-membered 
heterocyles. To our knowledge, there has been no report of Rh-catalyzed conjugate addition 
reactions to exocyclic α,β-unsaturated β-lactones or β-lactams. We envisioned that α-
methylene-β-lactones could undergo Rh-catalyzed conjugate addition with aryl boronic acids. 
However, potential challenges were anticipated. First, β-lactones could undergo ring opening 
reactions under basic conditions, elevated temperatures and in aqueous solutions. Second, 
as described in Scheme 45, the diastereoselectivity of this type of reaction could be difficult 
to control. In the next sections, we describe the development of a rhodium catalyzed conjugate 
addition reactions of α-methylene-β-lactones with aryl boronic acids. The optimization and 
scope of the reactions were investigated. 
 
 
 
Frost 2012
cat. [Rh(cod)2Cl]2Ph−[B]+
KOH (1 equiv)
dioxane, rt, 24 h
O
OO
O
MeO
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O
O OTMSPhBF3K
O
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O
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% conv (% yield): 25% <5% 65% (64%)
(2 equiv)
Scheme 46. Rhodium catalyzed conjugate addition of benzylidene Meldrum's 
acid with organoboron reagents.
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2.2.2 Mechanistic Hypothesis and Initial Studies  
Inspired by the biological activities displayed in disubstituted β-lactones and the 
advancement in Rh-catalyzed conjugate additions, it was hypothesized that α-methylene-β-
lactones 29 would undergo conjugate addition with organoboron reagents (Scheme 47). To 
test this hypothesis, α-methylene-β-lactone 29a was reacted with phenyl boronic acid in the 
presence of Wilkinson’s catalyst.33 This initial reaction provided a mixture of the desired 
conjugate addition product, β-lactone 32a, together with the Heck-type product α-alkylidene-
β-lactone 33a (Scheme 47). The Rh-catalyzed conjugate addition to give β-lactone 32a 
constitutes a one-step process for disubstituted β-lactones from α-methylene-β-lactones, in 
contrast to the cross-metathesis/reduction sequence our group previously reported. However, 
the results from the initial studies required optimization in order to: (a)  selectively obtain 
conjugate addition product, (b) prevent decomposition, and (c) improve the 
diastereoselectivity of the reaction. 
 
Herein we report a strategically distinct, one-step approach to access disubstituted β-
lactones from α-methylene-β-lactones. Optimization of reaction conditions to improve 
selectively towards conjugate addition, as well as an exploration of the scope and limitations 
(CA) 32aa (HC) 33a
O
O
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O
O
Ph
O
OPh
+PhB(OH)2+
2 mol%RhCl(PPh3)3
2 eq. K2CO3, 80 oC
tol/H2O (3:1), 24h
100% conv.
Ph Ph
Ph
1:1 mixture (65% total yield)
Scheme 47. Hypothesis and initial studies on the Rh-catalyzed conjugate addition for direct access to 
disubstituted β-lactones.
aThe obtained trans:cis ratio was 2:1.
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of the reaction, are presented in the following sections. 
2.2.3 Results and Discussions 
2.3.4.1 Optimization of reaction conditions 
At the onset of this study, we realized two challenges. First, α-methylene-β-lactones 
and their corresponding products are highly susceptible to nucleophilic attack (e.g. with water 
or base additives) either via conjugate addition or ring-opening reactions. Second, based on 
the initial reaction conducted by reacting α-methylene-β-lactone 29a with phenyl boronic acid 
using Wilkinson’s catalyst as the rhodium source,33 an equal mixture of conjugate addition 
and Heck-type product was obtained. The formation of Heck-type products in Rh-catalyzed 
reactions was previously observed when α,β-unsaturated esters and amides were used.33 
This competitive pathway was proposed to occur via β-hydride elimination (versus 
protonolysis) from the α-metallated intermediate. However, with α,β-unsaturated esters and 
amides the conjugate addition products can be selectively obtained by using appropriate 
conditions. 
Several parameters evaluated included rhodium catalyst, temperature, solvent 
system, and base additives. Table 5 summarizes the results of the preliminary screening. 
Using Wilkinson’s catalyst as the rhodium source, a complete conversion was observed. 
However, a 1:1 mixture of conjugate addition and Heck-type coupling product was obtained 
together with unidentified decomposition products. When a lower temperature (60 oC) was 
employed, no significant conversion was observed after 24 h.  
Gratifyingly, improved results were obtained when the rhodium dimer, [Rh(cod)Cl]2 
was utilized under the conditions independently developed by Hayashi and Miyaura.19,23 In 
contrast to the use of Wilkinson’s catalyst, the reaction was rendered more efficient, having 
faster reaction time and cleaner conversion. However, the ratio of CA/HC (conjugate 
addition/Heck-coupling) was found to be 2:1. Several additives or bases were screened 
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(entries 3–8), and it was found that in the presence of KOH in a stoichiometric or greater 
amount (1–2 equivalents), exclusive conversion to conjugate addition product was obtained 
after 1 h. It is worth noting that the β-lactones (starting material or product) did not undergo 
ring opening reactions under the basic conditions. The conjugate addition product 32a was 
isolated in 92% yield with a trans:cis ratio of 2:1. Moreover, the reaction could also be 
achieved using 1 mol% Rh catalyst providing similar results. 
 
Further optimization studies were conducted to improve the diastereoselectivity of this 
method using various conditions (entries 7–11); however, no significant improvement was 
observed. The formation of both diastereomers could presumably arise from the protonolysis 
(CA) 32a (HC) 33a
O
O
29a
O
O
Ph
O
O
Ph
+PhB(OH)2+
2 mol% [Rh] cat.
conditions
Table 5. Initial studies on the Rh-catalyzed conjugate addition of phenyl boronic acid to 29a.
(1.5 equiv)
Ph Ph Ph
Entry bConversion, timeConditionsRh catalyst cCA:HC
1 RhCl(PPh3)3 2 eq. K2CO3, 80 oC
2 eq. K2CO3, 60 oCRhCl(PPh3)32
3 [Rh(cod)Cl]2
*Solvent: entries 1 to 3, toluene/H2O (3:1); entries 4 to 11, dioxane/H2O (10:1)
2 eq. K2CO3, 60 oC
2 eq. KOH, 60 oC
1 eq. KOH, 60 oC
0.5 eq. KOH, 60 oC
0.1 eq. KOH, 60 oC
1 eq. KOH, r.t.
1 eq. KOH, 60 oCRhCl(PPh3)3
[Rh(cod)Cl]2
[Rh(cod)Cl]2
[Rh(cod)Cl]2
[Rh(cod)Cl]2
[Rh(cod)Cl]2
[Rh(nbd)Cl]2 1 eq. KOH, 60 oC
2 eq. KF, 60 oC[Rh(cod)Cl]2
100%, 24h 1:1 (with decomposition)d
<5%, 24h
100%, 1h 2:1
-
30%, 24h 1:1
100%, 1h >20:1 (60% yield)d
>20:1 (92% yield)d100%, 1h
100%, 1h
100%, 48h 2:1
3.5:1
75% 5:1
4
5
6
7
8
9
10
11
100%, 24h
100%, 1h >20:1 (90% yield)d
2:1
aReaction conditions: 0.5 mmol 29a, 0.75 mmol PhB(OH)2, 2 mol% Rh catalyst. Yields were isolated yields. 
bPercent conversion based from 1H NMR analysis of the crude mixture.
cCA:HC, ratio of conjugate addition and Heck coupling products based from 1H NMR analysis of the crude mixture. 
dThe obtained trans:cis ratio was 2:1.
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step, similar to the Co-catalyzed reduction of α-alkylidene-β-lactones we have previously 
reported.7 Nonetheless, the optimized conditions above represent a simple, one-step access 
to the desired disubstituted β-lactones from α-methylene-β-lactones.  
 
2.3.4.2 Preparation of α-methylene-β-lactones 
 A variety of α-methylene-β-lactone substrates was readily prepared from lactonization 
of α-methylene-β-hydroxy acids 37.34,35 β-Hydroxy acids were accessed from a one-pot, 2-
step reaction sequence involving Morita-Baylis-Hillman (MBH) reaction of aldehydes and 
methyl acrylate, followed by hydrolysis.34,36 
 
 The MBH adducts were obtained quantitatively in 2 days by using catalytic 
amounts of 3-quinuclidinol as the organocatalyst. DABCO could also be used and provided 
similar results, but typically required much longer reaction times (1–2 weeks).34 Hydrolysis of 
the MBH adducts gave β-hydroxy acids in good yields over 2-steps (Table 6a). β-Hydroxy acid 
37f was obtained in low yields. This was due to the formation of an aldol condensation product 
during the MBH step with quinuclidinol after 3 h. Other organocatalysts, including DABCO, 
DBU and triphenylphosphine, were examined; however, inferior results were obtained. A nosyl 
chloride mediated lactonization34 provided desired α-methylene-β-lactones 29 in moderate to 
good yields (Table 6b). 
 
R
OH
OH
O
37
R
O
OMe
O
H
34
O
O
R
29
+
lactonization Baylis-Hillman
hydrolysis
Scheme 48. Retrosynthesis of  α-methylene-β-lactones 29.
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R
OH
OH
O
N
OH
R
O
OMe
O
+
H
34 35 37
1.
2. 2 M KOH
    MeOH/H2O
C10H21
OH
OH
O
OH
OH
O
OH
OH
O
Ph
Ph
OH
OH
O
Ph
C3H7
OH
OH
O
OH
OH
O
37a 37c
37b 37d
37e
37f
(59%)
(83%)
(n.a.)b
(75%)
(50%)
(23%)c
aValues in parentheses are isolated yields in 2-steps. bProduct 37c was not purified and was carried through the next 
step. cLow isolated yield was associated with the MBH step where aldol condensation product was also obtained.
Table 6a. MBH/hydrolysis sequence to obtain β-hydroxy acids 37.
O
O
c-hex
O
O
Ph
Ph
O
O
O
O
C11H23
O
O
Ph
O
O
29a
29b
29c
29e
29d
29f
(65%)
(73%)
(77%)b
(65%)
(78%)
(30%)
aValues in parentheses are isolated yields in 2-steps. 
bYield of 29c was over 3-steps.
Table 6b.  o-Nosyl chloride mediated lactonization of β-hydroxy acids 
37 to α-methylene-β-lactones 29.
R
OH
OH
O
37
Na2CO3, CH2Cl2
O
O
R
o-Nosyl chloride
29
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2.3.4.4 Scope and limitation of the reaction 
 After accessing α-methylene-β-lactones with various β-chains, and with the optimal 
conditions in hand, the scope of the rhodium catalyzed conjugate addition reaction was 
explored (Scheme 49). α-Methylene-β-lactones with various β-chains reacted with phenyl 
boronic acid and gave their corresponding disubstituted β-lactone products in good to 
excellent yields. Almost complete selectivities (>20:1) towards conjugate addition products 
were observed in all cases. In these examples, diastereoselectivies ranged from a 2:1 to 3:1 
(trans:cis) ratio. It is worth noting that β-lactones 32a14a and trans-33d7 were previously 
reported to have promising inhibitory activities against serine hydrolases. 
 
 Investigation of the scope of the conjugate addition reaction was also extended to 
various aryl boronic acids. The results are summarized in Scheme 49. Several coupling 
partners, including electron rich and electron deficient aryl boronic acids, were tolerated, 
providing products in good yields. To further exemplify the scope of the reaction, heteroaryl 
O
O
Ph
32e (dr 2.2:1)b
O
O
PhPh
Ph
O
O
C10H21
Ph
O
O
PhPh
(92%; dr 2:1)
O
O
Ph
32b; (dr 3:1)b
trans-32d; 60%
cis-32d; 25%
trans-32c; 60%
cis-32c; 30%
O
O
1 mol% [Rh(cod)Cl]2
+ Ph B(OH)2
R
1 equiv KOH
dioxane/H2O (10:1)
60 oC, 1h
aTypical reaction conditions: 0.5 mmol 29, 0.75 mmol PhB(OH)2, 1 mol% [Rh(cod)Cl]2, 1 
equiv KOH in 2.5 mL dioxane/H2O (10:1) at 60 oC for 1h.  In all cases, the CA:HC selectivity 
is >20:1. Yields are isolated yields; dr are diastereomeric ratios based from 1H NMR 
analysis. Structure drawn represents the major diastereomer obtained.
bProducts were not isolated, dr values were obatined based from 1H NMR analysis of the 
crude mixture.
32a
O
O
PhR
3229
Scheme 49. Scope of the reaction of phenyl boronic acid with α-methylene-β-
lactones.
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boronic acids as coupling partners were explored. N-Methyl indole and benzodioxan were 
successfully incorporated into the β-lactones. These examples are notable since both 
heterocycles are often found in biologically active products. Likewise, their incorporation into 
the β-lactone motif through the CM/reduction sequence could be challenging due to the lack 
of availability of necessary olefin coupling partners. 
 
α-Methylene−β-lactones did not convert into products when coupling was attempted 
with some organoboron compounds, including alkyl boronic acid, N,N-dimethylaminophenyl 
boronic acid, and several heteroaryl boronic acids. However, the organoboron reagents were 
consumed, and in several cases protodeborylated products were observed based on 1H NMR 
analysis of the reaction mixture. These exceptions could be explained by the propensity of the 
organoborons to undergo protodeborylation reactions, outcompeting conjugate addition, 
especially under aqueous conditions. 
O
O
C10H21
N
Me
O
O
Ph
N
Me
O
O
O
O
Ph
O
O
C10H21
F
trans-32l; 65%
(90%; dr 3:1)
O
O
O
N
O
O
Ph
Me
Ph
32g (87%; dr 2:1)
32h (70%; dr 2.15:1)
O
O
C10H21
32j (84%; dr 2:1)
32i (92%; dr 4:1) trans-32k; 60%
(92%; dr 2.2:1)
trans-32m; 67%
(75%; dr 3:1)
O
O
1 mol% [Rh(cod)Cl]2
+ Ar B(OH)2
R
1 equiv KOH
dioxane/H2O (10:1)
60 oC, 1h
O
O
ArR
3229
Scheme 50. Scope of the reaction of α-methylene-β-lactones with various aryl boronic acids.
aTypical reaction conditions: 0.5 mmol 29, 0.75 mmol PhB(OH)2, 1 mol% [Rh(cod)Cl]2, 1 equiv KOH in 2.5 mL dioxane/H2O (10:1) 
at 60 oC for 1h. In all cases, unless specified, the CA:HC selectivity is >20:1. Yields are isolated yields. Values in parenthesis are 
mixed isolated yields of both isomers; dr is diastereomeric ratio. Structure drawn represents the major diastereomer obtained.
bProducts were not isolated, dr values were obatined based from 1H NMR analysis of the crude mixture.
cThe CA:HC selectivity was 11:1.
O
O
Ph
OMe
32f (dr 2.5:1)b
O
O
Ph
OH
32n (dr 1.2:1)b,c
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The rhodium catalyzed conjugate addition reaction was extended to the five-
membered α-methylene-γ-butyrolactone. Arylated γ-lactone products 39a and 39b were 
obtained using the same protocol in excellent yields up to 93% (Scheme 52). 
 
The protocol described above demonstrated high selectivity towards conjugate 
addition over Heck-type coupling reactions. It also worth mentioning that an exclusive 
chemoselectivity towards conjugate addition was observed over reaction at other several 
potential electrophilic sites present in α-methylene−β-lactones.7,8-10 
α-Methylene-β-lactones are viewed as masked MBH adducts. Darses and Genet37,38 
reported that, when acyclic MBH adducts were treated with aryl boronic acids using similar 
rhodium catalysts, in sharp contrast to the results obtained above, trisubstituted alkenes were 
obtained (Scheme 52). This outcome was observed even when the reaction conditions were 
N
B(OH)2
B(OH)2Me2N
N
O
B(OH)2
Boc
B(OH)2
N
B(OH)2B(OH)2
O
O
1 mol% [Rh(cod)Cl]2
+ 1 equiv KOH
dioxane/H2O (10:1)
60 oC, 1h29a
B(OH)2
NMe2
Ph
HMe2N
observed by
1H NMR analysis
Scheme 51. Selected aryl boronic acids explored that did not undergo 
conjugate addition with 29a.
O
O
Ph
O
O
N
Me39a; 93% 39b; 89%
O
O 1 mol% [Rh(cod)Cl]2
+ Ar B(OH)2 1 equiv KOH
dioxane/H2O (10:1)
60 oC, 1h
O
O
Ph
39
Scheme 52. Rh-catalyzed conjugate addition of aryl boronic acids to 
α-methylene-γ-butyrolactone.
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varied to different rhodium catalysts, solvents and types of organoboron reagent.38 When the 
acetate of a MBH adduct was utilized, lower reactivity was observed. However, the same 
product was obtained (Scheme 53). The observed reaction was believed to proceed via a 
mechanism involving conjugate addition with a subsequent β-hydroxy (or β-acetoxy) 
elimination steps.37  
 
2.3.4.4 Proposed mechanism 
 Based on previous mechanistic information on rhodium catalyzed conjugate additions 
of aryl boronic acids to α,β−unsaturated systems,19,23 together with several observations from 
control reactions conducted, the mechanism shown in Figure 13 is proposed. First, the active 
rhodium catalyst I is generated from transmetallation with KOH. Rh-complex I undergoes 
transmetallation with aryl boronic acid to form aryl-Rh complex II. Coordination to the olefin of 
the α-methylene-β-lactone with subsequent aryl migration will provide metallated lactone III. 
This metallated species could undergo hydrolysis to provide the β-lactone product with 
subsequent regeneration of the active Rh-complex I. The formation of the Heck-type Z-
R OMe
OH O
0.5 mol%
[Rh(cod)Cl]2
MeOH, 50–55 oC
0.5 h
R OMe
O
+ ArB(OH)2
Ar
Me OMe
O
Ph
OMe
O
Ph
OMe
O
C8H17
90%, E/Z 99:1 32%, E/Z 90:10 20%, E/Z 97:3
Me OMe
OAc O
0.5 mol%
[Rh(cod)Cl]2
MeOH, 50–55 oC
2 h
Me OMe
O
+ PhB(OH)2
Ph
35%, E/Z 89:11
Scheme 53. Unexpected reaction pathway observed from MBH adducts 
and acetates under Rh-catalyed reaction with aryl boronic acids.
Darsens and Genet  2004
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alkylidene β-lactone product can be explained via a syn β-hydride elimination from metallated 
lactone III. 
 
 This proposed mechanism is consistent with several observations and previously 
reported mechanistic investigations. Some of these observations include: (a) the rhodium 
catalyst and KOH were necessary for the reaction; (b) the observation and isolation of 
protodeborylated products from the organoboron reagents suggest the formation of complex 
II, (c) and lastly, the formation of the conjugate addition and Heck-type coupling products can 
only both occur from the intermediacy of a metallated species like III.33 At present, there is no 
evidence available to explain the observed selectivity towards conjugate addition over Heck-
type coupling products. 
 The rhodium catalyzed conjugate addition of aryl boronic acids into α-methylene-β-
lactones provided a one-step access to diverse disubstituted β-lactones. Reaction 
O
O
R
Ar–B(OH)2
Ln[Rh]–OH
I
Ln[Rh]–Ar
II
[Rh(cod)Cl]2
KOH
B(OH)3
O
O
R
Ln[Rh]
Ar
H2O
O
O
R
Ar
III
-Ln[Rh]-H
O
O
R
Ar
transmetallation
protonolysis
coordination;
aryl migration
syn β-hydride 
elimination
Figure 13. Proposed mechanism for the Rh-catalyzed conjugate 
addition reaction.
 107 
optimization allowed the selective formation of the conjugate addition adduct over the Heck-
type coupling product. Moreover, the reaction tolerated various types of aryl boronic acids. 
However, rendering the protocol to achieve better diastereoselectivities is still challenging. 
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2.3 Palladium Catalyzed Acyl C-O Activation of α-Methylene-β-lactones 
2.3.1 Background and Significance 
β-Lactones are increasingly utilized intermediates or scaffolds in organic synthesis 
(Figure 14).5 This is mainly due to the many distinct reactions associated with the inherent 
ring strain exhibited by this heterocyle. One particularly interesting type of reaction associated 
with β-lactones is their ability to under ring-opening with various nucleophiles. Previously 
reported ring-opening reactions of β-lactones happen with good nucleophiles (e.g. alkyl 
amines, enolates, alkoxides and thiolate anions).5 However, traditional ring-opening reactions 
of β-lactones with these types of nucleophiles typically suffer from poor regioselectivities, and 
the outcomes are hard to predict. In most cases, mixtures of two ring-opened products are 
obtained arising from either alkyl C-O bond cleavage or acyl C-O bond cleavage. 
 
 One classic example that demonstrates the two competing ring opening pathways for 
β-lactones was described by Vederas and co-workers39,40 in the reaction of serine-β-lactone 
with trimethylsilylamine (Scheme 54). The product distribution between alkyl C-O cleavage 
and acyl C-O cleavage showed a high solvent dependency; however, low to only moderate 
O
OR
R'
acyl C-O
cleavage
alkyl C-O 
cleavage
Nucleophilic 
ring opening
Alkylation
Decarboxylation
Rearrangement/
ring expansion
Methylenation
R'
OH
R
O
Nuc
R'
Nuc
R
CO2H
R'
R
O
OR
R'
Alkyl
O
R
R'
O
O
R
n
Figure 14. Selected reactions of β-lactones as precursors to functionalized intermediates.
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selectivities were attained. Problems with regioselectivity in this type of reaction have been 
well-reviewed in the literature, and to date, there has been no practical solution that has met 
this challenge.5 
 
 Our interest in the utility of strained heterocycles, particularly β-lactones, led us to 
explore their potential regioselective ring-opening with nucleophiles. Recently, we have 
reported successful transformations of strained heterocycles under transition metal 
catalysis.6,41,42 We envisioned that a selective cleavage of β-lactones, either at the alkyl or 
acyl C-O bond, should be achievable through transition metal catalysis. 
 To date, there are only a few reports on the opening of β-lactones using transition 
metals. Puddephatt43 reported an alkyl C-O bond fission of oxetane-2-one with a 
stoichiometric amount of a Pt complex to form a platina-γ-lactone complex (Scheme 55). 
 
 Noels44 reported that vinyl-substituted β-lactones can be ring-opened to butadiene 
acids under palladium catalysis (Scheme 56). It was found that, when the reaction was 
conducted in the presence of trimethoxyphosphine, higher yields were obtained up to 90% 
(Scheme 56). An analogous reaction was reported by Hattori and co-workers (Scheme 
O
OBzCHN
Me3SiNMe2
solvent HO NMe2 Me2N OH
NHCBz
O O
NHCbz
+
80:20
65:35
20:80THF
CHCl3
DCM
product ratio
Vederas 1985
Scheme 54. Ring-opening reaction of β-lactone with amines.
O
O
Pt
Me
Me
N
N
O O
stoichiometric 
Pt(bpy)Me2
stable platinum (IV) complex
Puddephatt 1988
 1 example
Scheme 55. Stoichiometric oxidative addition of Pt(II) to alkyl 
C−O bond of β-propiolactone to form platinalactone complex.
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56).45,46 In this case, the vinyl β-lactones were generated in situ from the reaction of a ketene 
with an enal. In both reactions it was proposed that palladalactone intermediate is involved.45 
β-Hydride elimination (or cyclization) will lead to the formation of butadiene acid (or the 6-
membered lactone). 
 
 These examples of Pd-catalyzed activation of β-lactones were limited to alkyl C-O 
bond cleavage, in particular, allylic C-O bonds of a narrow group of β-lactones. To our 
knowledge, there have been no reports of TM-catalyzed activation of acyl C-O bonds in β-
lactones. Consequently, we looked into TM-catalyzed acyl C-O bond activations of simple 
esters. 
 The TM-catalyzed activation of the alkyl C-O bond in esters is well document (Figure 
15, path a). These type of reactions are typically observed in allylic systems (e.g. Tsuji-Trost 
allylation) or in aryl esters (as electrophiles in cross coupling reactions).47 On the other hand, 
reports on TM-catalyzed activation of acyl C-O bond in esters are rare (Figure 15, path b). 
O
O
R
cat. Pd(OAc)2 O
R
OH
R = H; 50% yield
w/ P(OMe)3; R = H or Me; 80-90% yield
O
HR
R'
+
O
cat. Pd
R
R'
O O
O
O
R
R'
Scheme 56. Pd-catalyzed ring-opening of vinyl β-lactones via an 
allyl C-O bond cleavage.
Noels 1976
Hattori 2000
O
O
R
[Pd]
R
O[Pd] Oallyl C-O 
activation
β-hydride 
elimination O
R
OH
proposed mechanism:
R, R' = H or Me or Ph
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One of the earliest reports on TM-catalyzed acyl C-O activation was developed by 
Yamamoto (Scheme 57).48 This was demonstrated by the reaction of aryl trifluoroacetates 
with aryl boronic acids under palladium catalysis. It was proposed that the acyl C-O bond 
undergoes oxidative addition to Pd(0) to form a Pd(II) complex (Scheme 57). This complex 
then undergoes cross coupling reactions with aryl boronic acids to provide trifluromethyl aryl 
ketones. 
 
 
 Murai and co-workers49 reported a Ru-catalyzed acyl C-O bond activation of pyridine 
substituted esters (Scheme 58). In this reaction, the metallated ester intermediate undergoes 
decarbonylation to obtain arene products. Chatani and co-workers50,51 extended Murai’s work 
to a Pd-catalyzed cross-coupling reaction of similar substrates with aryl boronic acids to obtain 
unsymmetrical ketones. This reaction was limited to pyridine containing esters, in which the 
pyridine acts as a directing group to facilitate Pd-activation of the acyl C-O bond. To date, all 
examples of TM-catalyzed acyl C-O bond activation happen in the presence of directing 
groups or in activated esters.52 
ArAcO
AcO
R O
O
R' [M]
acyl C-O
activation
alkyl C-O
activation
path a
path b
R O
O
R'
R
O
O
R'
cat. [M]
cat. [M]
Ar[M]
[M]
[M] = Pd, Ni, Ir
[M] = Ru, Pd
M
M
Alkyl C-O activation happens if R' = Ar, allyl:
Acyl C-O activation is rare.
Figure 15. Inspiration from TM-catalyzed activation of esters: alkyl versus 
acyl C-O bond activation.
F3C O
O
Ar + Ar'B(OH)2
5 mol% Pd(OAc)2
F3C
O
Ar'
Yamamoto 2001
15 mol% PnBu3
up to 84% yield
Scheme 57. Pd-catalyzed acyl C-O bond activation of aryl 
trifluoromethyl esters under Pd catalysis.
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2.3.2 Mechanistic Hypothesis 
Our interest in α-methylene-β-lactones as substrates in developing TM-catalyzed 
transformations led to us to evaluate their propensity to undergo selective ring-opening 
reactions. In particular, Ding and co-workers53 recently reported the utility of MBH acetates in 
Pd-catalyzed allylic amination (Scheme 59A).54,55 Analogous to Pd-catalyzed allylations, this 
reaction involves initial formation of a Pd-allyl intermediate formed from activation of an allyl 
C-O bond by palladium. Conversely, Bao56 recently developed a Pd-catalyzed amidation of 
pentafluoroesters with various amines (Scheme 59B). This reaction was believed to involve 
an acyl C-O bond cleavage under palladium catalysis. However, instead of using substrates 
with pyridine directing groups, activated esters, such as those that possess good leaving 
groups (e.g. pentafluorophenyl) were utilized. 
O
O
N
10 mol% 
Ru3(CO)12
3 equiv HCOONH4
dioxane
160 oC, 20 h
H
+ HOR
R = 2,5-Me2 (100%)
R = 4-OMe (90%)
R = 4-NMe2 (95%)
R
Murai 2001
O
O
N
M
O
N
O[M] = Pd or Ru
O
Nu
Nu
Scheme 58. Ru- and Pd-catalyzed acyl C-O bond activation of methylpyridine 
esters.
R O
O
3 mol% Pd(OAc)2
9 mol% PPh3
dioxane
50 oC, 10 h
Chatani 2004
N
R = alkyl or aryl
R
O
+ PhB(OH)2
R = naphthyl (92%)
R = n-pentyl (75%)
R = cyclohexyl (71%)
Ph
Proposed acyl C-O bond activation
N
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Based on these recent reports, we hypothesized that α-methylene-β-lactones could 
undergo a Pd-catalyzed selective ring-opening reaction with amines (Scheme 60). First, α-
methylene-β-lactones might undergo oxidative addition to Pd(0) selectively, either via allylic 
C-O bond cleavage (path a) or olefin directed acyl C-O bond cleavage (path b). The resulting 
palladacyles (A57 or B) could undergo ring-opening with amines to form either β-amino acids 
or β-hydroxy amides. 
 
 
 
 
 
Ar
O
CO2R
cat. [Pd]
ArNH2 Ar
NH
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NHAr
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(A) Ding 2014
(B) Bao 2014
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O
Scheme 59. Pd-catalyzed (A) allylic amination of acetates of MBH adducts 
and (B) aminolysis of aryl esters.
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Scheme 60. Mechanistic hypothesis for Pd-catalyzed activation of α-methylene-β-lactones.
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2.3.3 Results and Discussions 
The initial exploration was conducted using α-methylene-β-lactone 29a and reacting it 
with benzyl amine under palladium catalysis (Table 7, entry 1). No β-amino acid product was 
observed. Rather, α-methylene-β-hydroxy amide 40a was isolated as the major product in 
80% yield, and diaminated adduct 41 was observed as a minor product. The formation of 41 
was believed to come from Michael addition of 40a with excess benzyl amine. 
 
Various optimizations were conducted, and it was found that the desired β-hydroxy 
amide was obtained as the sole product in 92% yield when benzyl amine was used at 1.1 
equivalents (Table 7, entry 2). Under these conditions typical conversions after 24h was 
~95%. When the reaction was conducted at 45 oC, complete conversion was obtained with 
1 2 equiv of BnNH2, 0.5 M 4:1 80%
2 none >20:1 92%
3 0 mol% Pd(OAc)2 - <5% convc
4 0 mol% PPh3 - <10% convc
5 45 oC, 12 h (instead of rt, 24 h) >20:1 98%
6 2 mol% [Pd(allyl)Cl]2; 6 mol% PPh3 >20:1 90d
7 2 mol% Pd2(dba)3; 6 mol% PPh3 >20:1 95d
8 5 mol% Pd2(dba)3; 0 mol% PPh3 - n. r.e
9 5 mol% Pd(PPh3)4; 0 mol% PPh3 10:1 -
Entry Ratio 3:4c Yield 3Variation from standard conditionb
O
O
Ph
BnNH2
5 mol% Pd(OAc)2
15 mol% PPh3
0.2 M CH2Cl2
rt, 24 h
Ph NHBn
OOH
+ Ph NHBn
OOH
BnHN
+
Table 7. Initial studies on the Pd-catalyzed reaction of α-methylene-β-lactone 29a 
with benzylamine.
(1.1 equiv)
aStandard conditions: 0.1 to 0.2 mmol 29a, 1.1 equiv benzylamine, 5 mol%Pd(OAc)2, 15 mol% PPh3, in 0.2 M 
CH2Cl2 at room temp for 24 h. Yiels are isolated yields. bParameters varied from the standard conditions. 
cRatio and conversions were estimated by 1H NMR analysis of the crude reaction mixture. dH NMR yields 
using 1,3,5-trimethoxybenzene as internal standard. eNo reaction, Pd black formation observed.
29a 40a 41
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quantitative yield (entry 5). Other palladium sources were also examined, and in most cases, 
similar results were obtained. 
The nature of the active palladium catalyst is important. For example, when no 
phosphine ligand was used (Table 7, entries 4 and 8 or Figure 16, red line), no significant 
conversion (0 to <10%) was observed. This suggests that the active catalyst is a low valent 
palladium species, most likely Pd(0), as evidenced by the observed reactivity when a Pd(0) 
precursor Pd(PPh3)4 was used (entry 9). For the case of Pd2(dba)3 (entry 8), no reaction was 
observed mainly due to the decomposition of the Pd complex that formed (Pd black was 
deposited on the walls of the reaction tube). However, when Pd2(dba)3 was combined with the 
biphosphine ligand, BINAP, complete conversion was observed (Figure 16, purple line). It also 
worth mentioning that no reaction was observed when no palladium catalyst was used (Figure 
16, light blue and blue lines). 
 
The observed selective ring-opening reaction of α-methylene-β-lactone to form an 
amide is remarkable in comparison to the results obtained by Ding when MBH acetates were 
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Figure 16. Reaction profile of lactone 29a with benzyl amine under various conditions. 
Reaction conditions: 0.1 mmol 29a, 0.11 mmol benzyl amine, in CD2Cl2 at rt. Percent conversions 
were obtained by 1H NMR analysis of the reaction mixture using 1,3,5-trimethoxybenzene as internal 
standard;  L4 = BINAP.
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used (Scheme 58A). Likewise, typically, α-methylene-β-lactones react with nucleophiles, 
including secondary alkyl amines, via 1,4-addition (see Scheme 48). 
 
Various alkyl amines (primary and secondary) gave β-hydroxy amides in excellent 
yields, all with complete chemoselectivity towards amidation products (Scheme 60). Likewise, 
less nucleophilic aryl amines were found effective for the selective ring-opening of α-
methylene-β-lactones to form aryl amides. Both electron rich and deficient aryl amines 
coupled with α-methylene-β-lactones. The heterocycle, indoline, also coupled to form the 
indoline amide 40l. In these reactions, 2 to 4 equivalents of aryl amines, reaction temperature 
of 45 oC and 0.5 M solutions (conc. of 29 in DCM) were necessary to obtain high conversions. 
Highly electron deficient aryl amines, such 2-nitroaniline and 4-nitroaniline, were found 
unreactive even after prolonged heating. 
A highly enantioenriched β-lactone was accessed via enzymatic kinetic resolution of 
the racemic lactone 29a (Scheme 61A). The kinetic resolution was done based from a 
Scheme 61. Scope of the Pd-catalyzed amination of methylene-β-lactones   
with various types of amines.
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modified procedure originally developed by Adam and co-workers.10 Reacting rac-29a with 
benzyl alcohol in the presence of lipase CAL-B (Candida antarctica; Novozyme 435) resulted 
in ~50% conversion after 24 h. α-Methylene-β-lactone (+)-29a was isolated in 42% yield. The 
absolute configuration of (+)-29a was determined by converting to (+)-8k through 
hydrogenation. The resulting product (+)-8k has an opposite configuration to know (–)-(3R)-
(4S)-8k.58 With this, the obtained (+)-29a was designated as the (R) isomer. HPLC analysis 
on a chiral column gave 99% ee for (R)-29a. Pd-catalyzed amidation of α-methylene-β-lactone 
(R)-29a gave chiral β-hydroxy amide (R)-40a in high yields without erosion of stereochemical 
integrity (Scheme 61B). 
 
To further expand the scope of the reaction, an α-allkylidene-β-lactone was prepared 
using our previously reported protocol of Ru-catalyzed cross metathesis of α-methylene-β-
lactones with olefins.6 α-Allkylidene-β-lactone 29g was treated with benzyl amine under 
palladium catalysis. α-Alkylidene-β-hydroxy amide 40m was obtained in high yield and with 
O
Ph
O
+
OH
NHR'
O
Ph
(+)-(R)-40a (92% yield)
99% ee; [α]D +24.8
5 mol% Pd(OAc)2
15 mol% PPh3
O
Ph
O
BnOH
lipase CAL-B
+ MTBE, rt
O
Ph
O
(+)-(R)-29a (42% yield)
99% ee, [α]D +60.3
OH O
OBnPh
(S)-42
+
Scheme 62. (A) Lipase catalyzed kinetic resolution to obtain enantioenriched α-methylene-β-
lactone (+)-29a; (B) stereospecific Pd-catalyzed aminolysis of α-methylene-β-lactone (+)-29a; 
and (C) determination of the absolute configuration of (+)-29a.
(A)
(B)
(4 equiv)
(+)-(R)-29a
99% ee
BnNH2
rac-29a
O
Ph
O
(+)-(R)-29a
99% ee
H2, Pd/C
THF, rt
O
Ph
O
(+)-(3S)-(4R)-8k
[α]D +46.9
*(-)-(3R)-(4S)-8k is a known 
compound with an [α]D (–)47.2
(C)
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complete retention of olefin geometry. This type of product is difficult to access or unattainable 
via MBH reaction or CM of MBH adducts. 
 
Analogous to previous reports on TM-catalyzed acyl C-O bond activation of esters,50,51 
a mechanism involving an olefin-mediated oxidative addition of Pd(0) to the acyl C-O bond of 
lactone to form a palladacycle intermediate is proposed (Scheme 59, path b). Coupling with 
amines56 would provide the β-hydroxy amide products. 
To extend the generality of this present method, simple β-lactones were treated under 
the same conditions. It is not surprising that α-phenyl-β-lactone 8a underwent facile ring-
opening with benzyl amine at rt. Similar to α-methylene-β-lactones, the aryl group facilitated 
the palladium towards acyl C–O bond activation. β-Lactone 8i also furnished the 
corresponding amide product with complete selectivity, albeit in lower conversions. 
Nonetheless, when the reaction is done in a longer period of time, high yields can be obtained. 
O
O
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Scheme 63. Pd-catalyzed amination of alkylidene-β-lactones.
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To date, enantioenriched α-methylene-β-lactones were only accessed via kinetic 
resolution with enzymes.10 Our interest in α-methylene-β-lactones as priviledged 
intermediates in organic synthesis led us to propose that the Pd-catalyzed amidation 
described above can be rendered stereoselective through kinetic resolution. Several chiral 
phosphine ligands typically used in Pd-catalyzed asymmetric allylic amination reactions were 
screened (Table 8). Racemic α-methylene-β-lactone 29a underwent amidation reaction in all 
examples. Reactions were monitored by 1H NMR analysis and were quenched after obtaining 
~50-55% conversion. Ligands, such as homochiral BINAP and SEGPHOS did not provide any 
enantiomeric excess for either the amide or the unreacted 29a. When Trost ligands (L3 and 
L4) were utilized, enantiomeric excess of up to 38% was observed for the unreacted 29a. To 
our delight, the spiroketal phosphine ligands developed by Ding and co-workers53a provided 
enantiomeric excess up to 68% for L5. The use of aniline, anisidine or benzyl alcohol (instead 
of benzyl amine) at room temperature gave no conversion. Reactions conducted at higher 
dilution (0.1 M in CDCl3, instead of 0.2 M) or 0.5 equivalents of benzylamine gave very slow 
reaction, typically <10 conversion after 48 h. 
 
O
O
O
O
Ph
OH
Ph
NHBn
O5 mol% Pd(OAc)2
15 mol% PPh3
CH2Cl2, rt, 24 h
+ BnNH2
OH
NHBn
O
5 mol% Pd(OAc)2
15 mol% PPh3
CH2Cl2, rt
BnNH2+ Ph
Scheme 64. Pd-catalyzed amidation of β-lactones.
8a
8i
43 (96%)
44 
24 h; ~70% conv.
48 h; 82% yield
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 The developed Pd-catalyzed asymmetric kinetic resolution was tested for several α-
methylene-β-lactones (Scheme 65). Lactones 29b, 29d and 29e were enantioenriched with 
modest enantiomeric excess up to 74%. Although this method suffers from loss in yield (50% 
maximum), it has the potential to be used as a late-stage enantiomeric enrichment of α-
methylene-β-lactones. 
 
 
 
O
O
rac-29a β-hydroxyamide
BnNH2+
2 mol% Pd(OAc)2
Ph
Ligand Yield
5 mol% chiral Ligand
OH
Ph NHBn
O
O
O
(R)-(+)-29a
Ph
+
% ee
L1
L3
L4
L5
L6
40%
38%
42%
43%
46%
0
5 (R)
38 (R)
68 (R)
40 (R)
L5, Ar = phenyl
O O
PAr2 Ar2P
(R,R,R)-SKP ligand
L6, Ar = xylyl
PPh2
PPh2
PPh2
PPh2
O
O
O
O
(R)-BINAP L1 (R)-SEGPHOS L2
NH NH
O O
PPh2 Ph2P
(R,R)-DACH-Phe-Trost L3
NH NH
O O
PPh2 Ph2P
(R,R)-DACH-Naph-Trost L4
L2 trace
(>90% conv, 12h)
0
(+)-β-lactone
Reaction conditions: 1 equiv BnNH2, 0.2 M CDCl3, rt, 16 - 20 h, >50-55% conversion
Table 8. Ligand screening for the asymmetric kinetic resolution of α-methylene-β-lactone.
(+)-29e (38% yield)
72% ee, [α]D +40.1
Scheme 65. Pd-catalyzed asymmetric kinetic resolution of racemic α-methylene-
β-lactones.
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2.4 Conclusions 
α-Methylene-β-lactones are a privileged class of lactones because of their ability to 
undergo a diverse range of useful reactions. Our previous work on Ru-catalyzed cross 
metathesis/reduction sequence to access disubstituted β-lactones with promising biological 
activities served as our benchmark to develop other transition metal catalyzed transformations 
of this important class of lactone. Two successful transformations were described above. The 
Rh-catalyzed conjugate addition with aryl boronic acids provided a one-step, highly efficient 
method to disubstituted β-lactones. The second transformation demonstated a highly 
selective ring-opening of β-lactones through amidation that involved acyl C-O bond activation 
by palladium. 
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2.5 Experimental 
2.5.1 General Information 
All moisture sensitive reactions were run in a flame-dried flask under N2. 
Tetrahydrofuran (THF) was dried using J. C. Meyer Solvent Dispensing System (SDS) and 
dispensed under N2. All other solvents were dried over CaH2 or 4 Å molecular sieves. 
Deuterated chloroform (CDCl3), and methylene chloride (CD2Cl2) were dried over 4 Å 
molecular sieves. Commercially available reagents were purchased from Aldrich, Acros, Alfa 
Aesar or TCI America and used without further purification. 
All 1H NMR experiments were recorded using a Bruker AVANCE 300, 400 or 500 MHz 
spectrometer. All 13C NMR experiments were recorded using a Bruker AVANCE 75, 100 or 
125 MHz spectrometer. Chemical shifts (δ) are given in ppm, and coupling constants (J) are 
given in Hz. The 7.26 resonance of residual CHCl3 for proton spectra and the 77.23 ppm 
resonance of CDCl3 for carbon spectra were used as internal references. High-resolution 
mass spectra (HRMS) were obtained using DART AccuTOF or JEOL JMS-AX505HA mass 
spectrometers. Reaction progress was monitored by 1H NMR analysis and/or by thin layer 
chromatography (TLC) performed on glass plates coated with silica gel UV254. Visualization 
was achieved by ultraviolet light (254 nm), 0.5% KMnO4 in 0.1 M aqueous NaOH solution 
and/or 5% phosphomolybdic acid in ethanol. Column chromatography was performed using 
silica gel, 40 microns flash silica. 
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2.5.2 Preparation of α-methylene-β-hydroxyacids 
General procedure for the preparation of α-methylene-β-hydroxyacids 
 
Methylacrylate (2 equiv) was added to a solution of aldehyde (1 equiv), MeOH (0.75 
equiv), and quinuclidinol (0.25 equiv), and the mixture was stirred at rt. The reaction progress 
was monitored by 1H NMR over a period of 2-3 days until >95% conversion. The reaction 
mixture was concentrated in vacuo to remove MeOH and excess methylacrylate. Aqueous 
2.0 M NaOH (2 equiv) was added dropwise to the resulting crude mixture dissolved in MeOH 
(half the volume of NaOH solution). This was stirred for 2 days or until complete saponification. 
The progress of the reaction was monitored by 1H NMR analysis or TLC. The reaction mixture 
was concentrated in vacuo to remove MeOH. The resulting aqueous solution was acidified 
using 10% aqueous HCl until pH 1 to 2. This was extracted with Et2O (same volume as 
aqueous solution) three times. The combined organic extracts were dried (Na2SO4), filtered, 
and concentrated in vacuo. The crude product was purified by flash chromatography on silica 
gel. 
 
3-Hydroxy-2-methylene-5-phenylpentanoic acid (37a). The general procedure was 
followed using hydrocinnamaldehyde (4.00 g, 30.0 mmol), and the reaction mixture was 
stirred for 2 days. 1H NMR analysis of the crude reaction mixture showed 95% conversion. 
Hydrolysis was done in 2 days. Purification by flash chromatography on silica gel (petroleum 
ether/EtOAc, 70:30) gave 37a as a white solid (3.65 g, 59% over 2-steps):34 1H NMR (300 
R
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OH
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OH
MeOH
2 equiv KOH
H2O/MeOH
(0.25 equiv)
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O
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+
H
OH
OH
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MHz, CDCl3) δ	7.33–7.18 (m, 5H), 6.43 (s, 1H), 5.95 (s, 1H), 4.47 (dd, J = 7.4, 5.5 Hz, 1H), 
2.89-2.67 (m, 2H), 2.09–1.98 (m, 2H).  
 
3-Hydroxy-2-methylene-4,4-diphenylbutyric acid (37b). The general procedure was 
followed using diphenylacetaldehyde (2.94 g, 15.0 mmol), and the reaction mixture was stirred 
for 2 days. 1H NMR analysis of the crude reaction mixture showed >95% conversion. 
Hydrolysis was done in 2 days. Purification by flash chromatography on silica gel (petroleum 
ether/EtOAc, 75:25) gave 37b as a white foam (3.30 g, 83% over 2-steps):6 1H NMR (400 
MHz, CDCl3) δ 7.31 (m, 10H), 6.29 (s, 1H), 5.71 (s, 1H), 5.23 (d, J = 8.0 Hz, 1H), 4.38 (d, J = 
8.0 Hz, 1H). 
 
3-Cyclohexyl-3-hydroxy-2-methylenepropanoic acid (37c). The general procedure was 
followed using cyclohexanecarboxaldehyde (1.30 g, 11.6 mmol), and the reaction mixture was 
stirred for 2 days. 1H NMR analysis of the crude reaction mixture showed >95% conversion. 
Hydrolysis was done in 2 days. Compound 37c was obtained as a crude oil and carried to the 
next step with no further purification:59 1H NMR (400 MHz, CDCl3) δ 6.41 (s, 1H) 5.83 (s, 1H) 
4.11 (d J = 7.1 Hz, 1H) 1.97–1.93 (m, 1H) 1.75–1.56 (m, 6H) 1.24–0.96 (m, 4H). 
 
3-Hydroxy-2-methylenehexadecanoic acid (37d). The general procedure was followed 
using tetradecanal (2.98 g, 15.0 mmol), and the reaction mixture was stirred for 2 days. 1H 
OH
OH
O
37b
OH
OH
O
37c
OH
OH
O
37d
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NMR analysis of the crude reaction mixture showed about 100% conversion. Hydrolysis was 
done in 2 days. Purification by flash chromatography on silica gel (petroleum ether/EtOAc 
85:15) gave 37d as a white solid (3.20 g, 75% over 2-steps):17 1H NMR (400 MHz, CDCl3) δ 
6.38 (s, 1H), 5.91 (s, 1H), 4.43 (dd, J = 6.5, 6.5 Hz, 1H), 1.68−1.66 (m, 2H), 1.43−1.41 (m, 
1H), 1.30−1.26 (m, 22H), 0.90 (t, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 171.4, 142.1, 
127.6, 71.8, 36.4, 32.1, 29.9, 29.9, 29.9, 29.8, 29.8, 29.6, 29.6, 26.0, 22.9, 14.3.  
 
3-Hydroxy-2-methylenenonanoic acid (37e). The general procedure was followed using 
heptaldehyde (3.40 g, 30.0 mmol), and the reaction mixture was stirred for 2 days. 1H NMR 
analysis of the crude reaction mixture showed about 100% conversion. Hydrolysis was done 
in 2 days. Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 80:20) 
gave compound 37e as a white solid (2.50 g, 50% over 2-steps):59 1H NMR (400 MHz, CDCl3) 
δ 6.37 (s, 1H), 5.91 (s, 1H), 4.42 (t, J = 7.2 Hz, 1H), 1.75–1.60 (m, 2H) ,1.51–1.20 (m, 8H), 
0.95–0.81 (m, 3H). 
 
3-Hydroxy-2-methylene-4-phenylbutanoic acid (37f).  The general procedure was followed 
using phenyl acetaldehyde (2.28 g, 19.0 mmol), and the reaction mixture was stirred for 3 h. 
1H NMR analysis of the crude reaction mixture showed about 100% conversion with other 
byproducts. Hydrolysis was completed in 1 day. Purification by flash chromatography on silica 
gel (petroleum ether/EtOAc, 80:20) gave 37f as a thick yellowish oil (0.90 g, 23%):60 1H NMR 
(400 MHz, CDCl3) δ 7.32–7.19 (m, 5H), 6.41 (s, 1H), 5.94 (s, 1H), 4.45 (s, 1H) ,2.69 (m, 3H).  
2.5.3 Preparation of α-methylene-β-lactones 
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General procedure for the preparation of α-methylene-β-lactones 
 
 Na2CO3 (10 equiv) was added to α-methylene-β-hydroxyacid (1 equiv) in DCM (5 
volumes; 5 mL DCM/mmol of limiting reagent), and the reaction mixture was stirred at rt. After 
30 min, o-nosyl chloride (2 equiv) was added, and the resulting suspension was stirred at rt 
for 2 days or until complete conversion. The progress of the reaction was monitored by TLC 
or 1H NMR analysis. The reaction mixture was with diluted with DCM (10 volumes) and H2O 
(5 volumes) and stirred for 15 min. The organic layer was separated, and the aqueous layer 
was extracted with DCM (3 x 5 volumes). The combined organic extracts were dried (Na2SO4), 
filtered, and concentrated in vacuo. Purification was done by flash chromatography on silica 
gel.  
 
4-(2-Phenylethyl)-3-methyleneoxetan-2-one (29a). The general procedure was followed 
using 3-hydroxy-2-methylene-5-phenylpentanoic acid (37a) (2.90 g, 14.1 mmol). Purification 
by flash chromatography on silica gel (petroleum ether/EtOAc 95:5) provided 29a as a 
colorless oil (1.70 g, 65%):34 1H NMR (400 MHz, CDCl3) δ 7.36–7.31 (m, 2H), 7.27–7.22 (m, 
3H), 5.86 (dd, J = 2.0, 2.0 Hz, 1H), 5.33 (dd, J = 1.7, 1.7 Hz, 1H), 4.97 (dddd, J = 6.4, 6.4, 1.7, 
1.7 Hz, 1H), 2.87–2.71 (m, 2H), 2.19–2.12 (m, 2H). 
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4-Benzhydryl-3-methyleneoxetan-2-one (29b). The general procedure was followed using 
3-hydroxy-2-methylene-4,4-diphenylbutyric acid (37b) (1.4 g, 5.2 mmol). Purification by flash 
chromatography on silica gel (petroleum ether/EtOAc 95:5) provided 29b as a white solid 
(0.95 g, 73%):6 1H NMR (400 MHz, CDCl3) δ 7.30–7.23 (m, 10H), 5.74 (dd, J = 2.0, 1.4 Hz, 
1H), 5.53 (ddd, J = 9.6, 2.0, 1.4 Hz, 1H), 4.72 (dd, J = 2.0, 1.4 Hz, 1H), 4.20 (d, J = 9.6, 1H). 
 
4-Cyclohexyl-3-methyleneoxetan-2-one (29c). The general procedure was followed using 
3-cyclohexyl-3-hydroxy-2-methylenepropanoic acid (37c) (1.40 g, 5.20 mmol). Purification by 
flash chromatography on silica gel (petroleum ether/EtOAc 95:5) provided 29c as a colorless 
oil (0.67 g, 77%):59 1H NMR (400 MHz, CDCl3) δ 5.91 (dd, J = 1.7, 1.7 Hz, 1H), 5.42 (dd, J = 
1.7, 1.7 Hz, 1H), 4.69 (ddd, J = 7.1, 1.7, 1.7 Hz, 1H), 1.87–1.10 (m, 11H). 
 
 
3-Methylene-4-tridecyloxetan-2-one (29d). The general procedure was followed using 3-
hydroxy-2-methylenehexadecanoic acid (37d) (2.50 g, 9.25 mmol). Purification by flash 
chromatography on silica gel (petroleum ether/EtOAc 98:2) provided 29d as a colorless oil 
(1.60 g, 65%):17 1H NMR (400 MHz, CDCl3) δ 5.85 (dd, J = 1.9, 1.9 Hz, 1H), 5.39 (dd, J = 1.7, 
O
O
29b
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29c
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O
C11H23
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1.7 Hz, 1H), 4.92 (dddd, J = 6.5, 6.5, 1.6, 1.6 Hz, 1H), 1.81 (dddd, J = 7.1, 7.1, 7.1, 0.0 Hz, 
1H), 1.81 (dddd, J = 7.8, 7.8, 7.8, 0.0 Hz, 1H), 1.46–1.40 (m, 2H), 1.33–1.22 (m, 20H), 0.84 
(t, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 163.7, 146.6, 114.8, 79.7, 33.4, 32.0, 29.8, 
29.7, 29.7, 29.6, 29.5, 29.5, 29.3. 
 
4-Hexyl-3-methyleneoxetan-2-one (29e). The general procedure was followed using 3-
hydroxy-2-methylenenonanoic acid (37e) (2.90 g, 14.1 mmol). Purification by flash 
chromatography on silica gel (petroleum ether/EtOAc 94:4) provided 29e as a colorless oil 
(1.85 g, 78%): IR (neat): 2955, 2929, 2859, 1813, 1206, 1077 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 5.85 (dd, J = 1.8, 1.8 Hz, 1H), 5.39 (dd, J = 1.6, 1.6 Hz, 1H), 4.92 (dddd, J = 6.6, 6.6, 1.8, 
1.8 Hz, 1H), 1.80 (ddd, J = 7.4, 7.4, 7.4 Hz, 2H), 1.46–1.37 (m, 2H), 1.33–1.24 (m, 6H), 0.84 
(t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 163.7, 146.5, 114.9, 79.7, 33.4, 31.6, 29.0, 
24.6, 22.5, 14.1; HRMS (ESI) calcd for C10H17O2 (M + H)+ m/z 169.1229, found 169.1217. 
 
4-Benzyl-3-methyleneoxetan-2-one (29f). The general procedure was followed using 3-
hydroxy-2-methylene-4-phenylbutanoic acid (37f) (900 mg, 4.68 mmol). Purification by flash 
chromatography on silica gel (petroleum ether/EtOAc 94:4) provided 29f as a pale yellow oil 
(244 mg, 30%): 1H NMR (400 MHz, CDCl3) δ 7.36–7.23 (m, 5H), 5.89 (dd, J = 1.8, 1.8 Hz, 
1H), 5.23 (dd, J = 1.6, 1.6 Hz, 1H), 5.14 (dddd, J = 6.8, 6.8, 1.6, 1.6 Hz, 1H), 3.29 (dd, J = 
14.1, 6.8 Hz, 1H), 3.05 (dd, J = 14.1, 6.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 163.4, 145.8, 
134.8, 129.5, 128.9, 127.5, 116.2, 79.0, 39.7; HRMS (ESI) calcd for C11H10O2 (M + H)+ m/z 
175.0759, found 175.0742. 
O
O
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2.4.4 Rh-catalyzed conjugate addition of aryl boronic acids to α-methylene-β-lactones 
General procedure for the Rh-catalyzed conjugate addition of α-methylene-β-lactones 
with aryl boronic acids 
 
 Aryl boronic acid (1.5 equiv, 0.75 mmol) and 1 mol% [Rh(cod)Cl]2 (0.05 mmol, 3.0 mg) 
were placed in a reaction tube equipped with a stir bar. The reaction tube was capped with a 
rubber septum then filled and back-filled with N2 three times. Aqueous 2 M KOH solution (1 
equiv, 0.25 mL) was added, followed by the α-methylene-β-lactone 29 dissolved in dioxane 
(2.5 mL). The resulting yellow solution was stirred in an oil bath at 60 oC for 1 h. An aliquout 
of the reaction mixture was analyzed by 1H NMR to determine the diastereoselectivity. The 
reaction was quenched with saturated aqueous NH4Cl (5 mL) and extracted with Et2O (3 x 10 
mL). The combined organic extracts were dried (Na2SO4), filtered, and concentrated in vacuo. 
The crude mixture was purified by flash column chromatography. In all cases, the trans 
isomers were obtained as the major products.  
For inseparable mixture of isomeric products, the major product (trans isomer) is 
drawn. Diastereomeric ratios (dr) were obtained from 1H NMR analyses of the crude mixture. 
 
trans/cis-3-Benzyl-4-(2-phenylethyl)oxetan-2-one (32a). The general procedure was 
followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one 29a (94 mg, 0.50 mmol) and 
phenyl boronic acid (92 mg, 0.75 mmol). Purification by column chromatography on silica gel 
(hexanes/EtOAc 99:1) provided 32a as a colorless oil (122 mg, 92%; trans:cis 2:1):14a 1H NMR 
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for trans-32a (400 MHz, CDCl3) δ 7.37-7.11 (m, 10H), 4.32 (ddd, J = 10.0, 6.0, 4.1 Hz, 1H), 
3.52 (ddd, J = 9.9, 5.9, 4.0 Hz, 1H), 3.14 (dd, J = 14.0, 5.9 Hz, 1H), 2.99 ( dd, J = 14.3, 9.0 
Hz, 1H), 2.27–2.62 (m, 1H), 2.55–2.48 (m, 1H), 2.21–2.12 (m, 1H), 2.01–1.94 (m, 1H); 1H 
NMR for cis-32a (400 MHz, CDCl3) δ 7.37–7.11 (m, 10H), 4.64 (ddd, J = 10.0, 6.4, 3.2 Hz, 
1H), 4.04 (ddd, J = 8.9, 6.9, 6.9 Hz, 1H), 3.22 (dd, J = 14.9, 7.1 Hz, 1H), 2.99 (dd, J = 14.3, 
9.0 Hz, 1H), 2.94–2.89 (m, 1H), 2.72–2.62 (m, 1H), 2.21–2.12 (m, 1H), 2.01–1.94 (m, 1H). 
 
trans-3-Benzyl-4-cyclohexyloxetan-2-one (trans-32c). The general procedure was 
followed using 4-cyclohexyl-3-methyleneoxetan-2-one (29c) (83 mg, 0.50 mmol) and phenyl 
boronic acid (92 mg, 0.75 mmol). Purification by column chromatography on silica gel 
(hexanes/EtOAc 94:6) provided trans-32c as a colorless oil (73 mg, 60%): IR (neat) 2925, 
2853, 1814, 1389, 1113 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.34–7.30 (m, 2H), 7.27–7.23 (m, 
1H), 7.20–7.19 (m, 2H), 3.97 (dd, J = 8.6, 4.1 Hz, 1H), 3.49 (ddd, J = 9.8, 5.9, 4.1 Hz, 1H), 
3.15 (dd, J = 14.1, 5.9 Hz, 1H), 2.97 (dd, J = 14.1, 8.9 Hz, 1H), 1.86–1.79 (m, 1H), 1.73–1.55 
(m, 4H) 1.34–0.64 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 171.2, 137.4, 129.1, 129.0, 127.3, 
81.3, 56.0, 41.8, 34.4, 28.6, 27.0, 26.1, 25.5, 25.3; HRMS (ESI) calcd for C16H21O2 (M + H)+ 
m/z 245.1542, found 245.1540. 
 
cis-3-Benzyl-4-cyclohexyloxetan-2-one (cis-32c). cis-3-Benzyl-4-cyclohexyloxetan-2-one 
(cis-32c) was obtained as the minor isomer from the above reaction. Compound cis-32c was 
obtained as a colorless oil (37 mg, 30%): IR (neat): 2926, 2852, 1814, 1452, 1132 cm-1; 1H 
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O
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NMR (400 MHz, CDCl3) δ 7.34–7.30 (m, 2H), 7.27–7.24 (m, 3H), 4.25 (dd, J = 10.2, 6.2 Hz, 
1H), 3.98 (ddd, J = 8.6, 6.9, 6.9 Hz, 1H), 3.19 (dd, J = 14.8, 8.7 Hz, 1H), 3.05 (dd, J = 14.8, 
7.0 Hz, 1H), 2.00–1.96 (m, 1H), 1.83–1.68 (m, 4H) 1.49–0.88 (m, 6H); HRMS (ESI) calcd for 
C16H21O2 (M + H)+ m/z 245.1542, found 245.1539. 
 
trans-3-Benzyl-4-tridecyloxetan-2-one (trans-32e). The general procedure was followed 
using 3-methylene-4-tridecyloxetan-2-one (29d) (130 mg, 0.50 mmol) and phenyl boronic acid 
(92 mg, 0.75 mmol). Purification by column chromatography on silica gel (hexanes/EtOAc 
99:1) provided trans-32a as a white solid (103 mg, 60%):17 1H NMR (400 MHz, CDCl3) δ 
7.34−7.30 (m, 2H), 7.27−7.25 (m, 2H), 7.20 (m, 1H), 4.27 (ddd, J = 6.7, 6.7, 4.1 Hz, 1H), 3.45 
(m, 1H), 3.18 (dd, J = 14.3, 5.7 Hz, 1H), 3.00 (dd, J = 14.3, 9.4 Hz, 1H), 1.83−1.74 (m, 1H), 
1.62−1.57 (m, 1H), 1.35−1.18 (m, 22H), 0.88 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 171.0, 137.4, 129.1, 128.9, 127.3, 77.8, 57.6, 34.4, 34.0, 32.1, 29.9, 29.9, 29.8, 29.6, 29.6, 
29.6, 29.3, 24.8, 22.9, 14.3. 
 
 
cis-3-Benzyl-4-tridecyloxetan-2-one (cis-32e). cis-3-Benzyl-4-tridecyloxetan-2-one (cis-
32e) was isolated as the minor isomer from the above reaction. Compound cis-32e was 
obtained as a colorless oil (43 mg, 25%):17 1H NMR (400 MHz, CDCl3) δ 7.34−7.30 (m, 2H), 
7.24−7.21 (m, 3H), 4.60 (ddd, J = 10.0, 6.4, 3.6 Hz, 1H), 4.01 (ddd, J = 9.0, 6.9, 6.9 Hz, 1H), 
3.19 (dd, J = 15.1, 7.1 Hz, 1H), 2.98 (dd, J = 15.1, 9.0 Hz, 1H), 1.86−1.76 (m, 1H), 1.71−1.63 
(m, 1H), 1.57−1.46 (m, 1H), 1.37−1.26 (m, 21H), 0.88 (t, J = 6.6 Hz, 3H); 13C NMR (100 MHz, 
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CDCl3) δ 171.7, 137.9, 129.0, 128.6, 127.0, 76.3, 53.5, 32.1, 30.6, 29.9, 29.9, 29.8, 29.7, 29.6, 
29.6, 29.5, 25.8, 22.9, 14.3. 
 
trans/cis-3-(4-Methyl)benzyl-4-(2-phenylethyl)oxetan-2-one (32g). The general procedure 
was followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) (94.mg, 0.50 mmol) and 
tolyl boronic acid (100 mg, 0.75 mmol). Purification by column chromatography on silica gel 
(hexanes/EtOAc 96:4) provided 32g (trans:cis = 2:1) as a colorless oil (122 mg, 87%; dr 2:1): 
IR (neat) 3026, 2923, 1815, 1118 cm-1; 1H NMR (400 MHz, CDCl3) for the major isomer trans-
32g δ 7.35–7.05 (m, 9H), 4.30 (ddd, J = 7.4, 5.9, 4.1 Hz, 1H), 3.49 (ddd, J = 9.0, 6.0, 4.1 Hz, 
1H), 3.07 (dd, J = 14.4, 6.0 Hz, 1H), 2.94 (dd, J = 14.3, 8.8 Hz, 1H), 2.73–2.62 (m, 1H), 2.56–
2.49 (m, 1H), 2.35 (s, 3H), 2.21–2.10 (m, 1H), 2.04–1.92 (m, 1H); for the minor isomer cis-
32g δ 7.35–7.05 (m, 9H), 4.61 (ddd, J = 10.0, 6.4, 3.2 Hz, 1H), 4.00 (ddd, J = 9.0, 7.0, 7.0 Hz, 
1H), 3.16 (dd, J = 15.0, 7.2 Hz, 1H), 2.94 (m, 1H), 2.91–2.87 (m, 1H), 2.73–2.63 (m, 1H), 2.35 
(s, 3H), 2.21–2.10 (m, 1H), 2.04–1.92 (m, 1H); 13C NMR (100 MHz, CDCl3) for the major 
isomer trans-32g δ 170.8, 140.3, 136.8, 134.0, 129.7, 128.7, 128.7, 128.4, 126.5, 76.7, 57.6, 
35.8, 33.3, 31.1; for the minor isomer cis-32g δ 171.4, 140.5, 136.6, 134.5, 129.6, 128.8, 
128.7, 128.3, 126.5, 75.0, 53.5, 32.3, 31.7, 29.4; HRMS (ESI) calcd for C19H21O2 (M + H)+ m/z 
281.1542, found 281.1546. 
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trans/cis-3-[3-(N,N-Dimethylbenzamide)]methyl-4-(2-phenylethyl)oxetan-2-one (32h). 
The general procedure was followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) 
(94 mg, 0.50 mmol) and benzamide-3-boronic acid (145 mg, 0.75 mmol). Purification by 
column chromatography on silica gel (hexanes/EtOAc 85:15) provided 32h as a white solid 
(118 mg, 70%; dr 2.2:1; isolated product contains ~2% Heck coupling product: mp 40–41 oC; 
IR (neat) 3010, 2931, 1818, 1625, 746 cm-1; 1H NMR (400 MHz, CDCl3) for the major isomer 
trans-32h δ 7.35–7.10 (m, 9H), 4.27 (m 1H), 3.48 (m, 1H), 3.19–2.84 (m, 2H), 3.09 (s, 3H), 
2.92 (s, 3H), 2.71–2.64 (m, 1H), 2.57–2.50 (m, 1H), 2.18–2.08 (m, 1H), 2.01–1.91 (m, 1H); for 
the minor isomer cis-32h δ 7.35–7.10 (m, 9H), 4.60 (ddd, J = 9.9, 6.3, 3.1 Hz, 1H), 3.98 (m, 
1H), 3.19–2.84 (m, 3H), 3.09 (s, 3H), 2.92 (s, 3H), 2.71–2.64 (m, 1H), 2.18–2.08 (m, 1H), 
2.01–1.91 (m, 1H); 13C NMR (100 MHz, CDCl3) as a mixture of trans/cis-32g δ 171.3, 171.2, 
171.1, 170.4, 140.3, 140.1, 137.8, 137.3, 137.1, 137.0, 130.0, 129.6, 129.0, 128.9, 128.8, 
128.6, 128.4, 127.6, 127.1, 126.5, 125.9, 125.7, 76.4, 74.8 (minor) , 57.1, 53.1 (minor), 39.6 
(br), 35.8, 35.4, 33.4 (br), 32.4, 31.7, 31.2, 29.7, 29.7 (selected, underlined peaks are major 
peaks relative to those labeled minor peaks); HRMS (ESI) calcd for C21H24NO3 (M + H)+ m/z 
338.1756, found 338.1772. 
 
trans/cis-3-(4-Fluoro)benzyl-4-tridecyloxetan-2-one (32i). The general procedure was 
followed using 3-methylene-4-tridecyloxetan-2-one (29d) (130 mg, 0.50 mmol) and 4-
fluorophenyl boronic acid (150 mg, 0.75 mmol). Purification by column chromatography on 
silica gel (hexanes/EtOAc 98:2) provided trans/cis-32i as a white solid (170 mg, 92%; trans:cis 
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= 4:1): IR (neat) 2923, 2853, 1820, 1510, 1224 cm-1; 1H NMR (400 MHz, CDCl3) for the major 
isomer trans-32i: δ 7.21–7.15 (m, 2H), 7.03-7.0 (m, 2H), 4.25 (ddd, J = 6.7, 6.7, 4.1 Hz, 1H), 
3.42 (ddd, J = 8.9, 6.0, 4.1 Hz, 1H), 3.13 (dd, J = 14.4, 6.1 Hz, 1H), 2.99 ( dd, J = 14.3, 8.9, 
1H), 1.84-1.77 (m, 1H), 1.64–1.57 (m, 1H), 1.32–1.20 (m, 22H), 0.88 (t, J = 6.6 Hz, 3H); for 
the minor isomer cis-32i: δ 7.21–7.15 (m, 2H), 7.03–7.0 (m, 2H), 4.60 (ddd, J = 10.0, 6.4, 3.6 
Hz, 1H), 3.94 (ddd, J = 8.0, 8.0, 6.4 Hz, 1H), 3.17–3.10 (m, 1H), 3.97–2.91 (m,1 H), 1.84–1.77 
(m, 1H), 1.64–1.57 (m, 1H), 1.32–1.20 (m, 22H), 0.88 (t, J = 6.6 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) for the major isomer trans-32i δ 170.8, 162.1 (d, JC-F = 245.9 Hz), 133.0 (d, JC-F = 3.1 
Hz), 130.4 (d, JC-F = 8.0 Hz), 116.0 (d, JC-F = 21.5 Hz), 77.5, 34.4, 33.2, 32.1, 29.9, 29.8, 29.8, 
29.6, 29.6, 29.3, 24.9, 22.9, 14.3; for the minor isomer cis-32i δ 171.4, 162.0 (d, JC-F = 245.2 
Hz), 133.5 (d, JC-F = 2.9 Hz), 130.1 (d, JC-F = 8.1 Hz), 115.8 (d, JC-F = 21.5 Hz), 76.0, 34.4, 
32.1, 30.6, 29.9, 29.8, 29.7, 29.6, 29.5, 29.2, 27.8, 22.9, 14.3; HRMS (ESI) calcd for 
C23H36FO2 (M + H)+ m/z 363.2699, found 363.2684. 
 
trans/cis-3-(2-Naphthyl)methyl-4-(2-phenylethyl)oxetan-2-one (32j). The general 
procedure was followed using 3-methylene-4-phenethyloxetan-2-one (29a) (130 mg, 0.50 
mmol) and naphthyl-2-boronic acid (130 mg, 0.75 mmol). Purification by column 
chromatography on silica gel (hexanes/EtOAc 95:5) provided trans/cis-32j as a colorless thick 
oil (170 mg, 84%; trans:cis = 2:1): IR (neat) 3058, 3026, 2927, 2859, 1813, 1119, 746 cm-1; 
1H NMR (400 MHz, CDCl3) for the major isomer trans-32j δ 7.84–7.78 (m, 3H), 7.58 (s, 1H), 
7.52–7.02 (m, 8H), 4.34 (ddd, J = 7.6, 5.8, 4.1 Hz, 1H), 3.58 (ddd, J = 9.1, 5.9, 4.1 Hz, 1H), 
3.27 (dd, J = 14.3, 5.9 Hz, 1H), 3.13 (dd, J = 14.3, 9.0 Hz, 1H), 2.65–2.58 (m, 1H), 2.54–2.47 
(m, 1H), 2.21–2.09 (m, 1H), 2.06–1.90 (m, 1H); for the minor isomer cis-32j δ 7.84–7.78 (m, 
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3H), 7.62 (s, 1H), 7.52–7.02 (m, 8H), 4.65 (ddd, J = 9.8, 6.3, 3.1 Hz, 1H), 4.13 (ddd, J = 9.0, 
6.8, 6.8 Hz, 1H), 3.35 (dd, J = 15.2, 7.1 Hz, 1H), 3.13 (dd, J = 15.1, 9.0, 1H), 2.90 (ddd, J = 
14.0, 9.3, 4.7 Hz, 1H), 2.72–2.65 (m, 1H), 2.21–2.09 (m, 1H), 2.06–1.90 (m, 1H); 13C NMR 
(100 MHz, CDCl3) for the major isomer trans-32j δ 170.7, 140.2, 134.6, 133.7, 132.6, 128.9–
126.0 (multiple overlapping arene carbon peaks), 76.8, 57.5, 35.8, 34.0, 31.2; for the minor 
isomer cis-32j δ 171.4, 140.4, 135.1, 133.7, 132.5, 128.9–126.0 (multiple overlapping arene 
carbon peaks), 75.1, 53.4, 32.3, 31.7, 30.1; HRMS (ESI) calcd for C22H21O2 (M + H)+ m/z 
317.1542, found 317.1555. 
 
trans-3-[6-(1,4-Benzodioxanyl)]methyl-4-(2-phenylethyl)oxetan-2-one (trans-32k). The 
general procedure was followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) (94 
mg, 0.50 mmol) 1,4-benzodioxan-6-boronic acid (140 mg, 0.75 mmol). Purification by column 
chromatography on silica gel (hexanes/EtOAc 85:15) provided trans-32k as a colorless oil (97 
mg, 60%; combined yield 92%): IR (neat) 2924, 2872, 1816, 1508, 1260 cm-1;  1H NMR (400 
MHz, CDCl3): δ 7.30–7.27 (m, 2H), 7.23–7.19 (m, 1H), 7.11 (d, J = 7.1 Hz, 2H), 6.79 (d, J = 
8.2 Hz, 1H), 6.66 (d, J = 2.1 Hz, 1H), 6.60 (dd, J = 8.2, 2.1 Hz, 1H), 4.28 (ddd, J = 7.4, 5.9, 
4.1 Hz, 1H), 4.24 (s, 4H), 3.43 (ddd, J = 9.1, 5.9, 4.1 Hz, 1H), 2.98 (dd, J = 14.3, 5.9 Hz, 1H), 
2.85 (dd, J = 14.4, 9.0 Hz, 1H), 2.66 (ddd, J = 14.5, 9.6, 5.3 Hz, 1H), 2.52 (ddd, 14.2, 9.2, 7.0 
Hz, 1H), 2.13 (dddd, J = 16.7, 9.0, 7.3, 5.5 Hz, 1H), 1.96 (dddd, J = 15.5, 9.5, 6.7, 6.7 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ 170.7, 143.9, 142.8, 140.3, 130.3, 128.8, 128.5, 126.6, 121.7, 
117.8, 117.6, 76.8, 64.6, 64.5, 57.7, 36.0, 33.1, 31.2; HRMS (ESI) calcd for C20H21O4 (M + H)+ 
m/z 325.1440, found 325.1422. 
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trans-3-(5-N-Methylindolyl)methyl-4-(2-phenylethyl)oxetan-2-one (trans-32l). The 
general procedure was followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) (94 
mg, 0.50 mmol) and N-methyl-5-indolylboronic acid (131 mg, 0.75 mmol). Purification by 
column chromatography on silica gel (hexanes/EtOAc 90:10) provided trans-32l as a light pink 
solid (104 mg, 65%; combined yield 90%): mp 96–98 oC; IR (neat) 2924, 1816, 1508, 1260 
cm-1; 1H NMR (400 MHz, CDCl3): δ 7.37 (d, J = 0.9 Hz, 1H), 7.28–7.24 (m, 3H), 7.21-7.18 (m, 
1H), 7.06–6.99 (m, 3H), 7.00 (dd, J = 3.0, 0.5 Hz, 1H), 6.43 (dd, J = 3.1, 0.6 Hz, 1H), 4.34 
(ddd, J = 7.5, 5.8, 4.1 Hz, 1H), 3.79 (s, 3H), 3.54 (ddd, J = 9.3, 5.6, 4.0 Hz, 1H), 3.21 (dd, J = 
14.3, 5.7 Hz, 1H), 3.07 (dd, J = 14.4, 9.2 Hz, 1H), 2.59 (ddd, J = 14.3, 9.6, 5.7 Hz, 1H), 2.47 
(ddd, J = 14.1, 9.2, 6.9 Hz, 1H), 2.10 (dddd, J = 16.8, 9.1, 7.4, 5.7 Hz, 1H), 1.92 (dddd, J = 
15.6, 9.6, 6.6, 6.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 171.2, 140.4, 136.1, 129.6, 129.0, 
128.7, 128.5, 127.9, 126.4, 122.4, 120.9, 109.8, 100.9, 76.9, 58.3, 36.0, 33.9, 33.1, 31.2; 
HRMS (ESI) calcd for C21H22NO2 (M + H)+ m/z 320.1651, found 320.1652. 
 
trans-3-(5-N-Methylindolyl)methyl-4-tridecyloxetan-2-one (trans-32m). The general 
procedure was followed using 3-methylene-4-tridecyloxetan-2-one (29d) (130 mg, 0.50 mmol) 
and N-methyl-5-indolylboronic acid (131 mg, 0.75 mmol). Purification by column 
chromatography on silica gel (hexanes/EtOAc 90:10) provided trans-32m as a light pink oil 
(130 mg, 67%; combined yield 75%): IR (neat) 3021, 2924, 2853, 1816, 751 cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.41 (d, J = 0.9 Hz, 1H), 7.287 (d, J = 8.1 Hz, 1H), 7.05–7.03 (m, 2H), 
6.43 (dd, J = 3.0, 0.5 Hz, 1H), 4.32 (ddd, J = 6.6, 6.6, 4.1 Hz, 1H), 3.78 (s, 3H), 3.50 (ddd, J 
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= 9.3, 5.5, 4.1 Hz, 1H), 3.25 (dd, J = 14.3, 5.5 Hz, 1H), 3.10 (dd, J = 14.3, 9.3 Hz, 1H), 1.78–
1.13 (m, 24H) 0.89 (t, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 171.6, 136.1, 129.6, 
129.4, 128.1, 122.5, 77.8, 58.2, 34.4, 34.1, 33.1, 32.1, 29.9, 29.9, 29.8, 29.8, 29.6, 29.6, 29.3, 
24.9, 22.9, 14.3; HRMS (ESI) calcd for C26H40NO2 (M + H)+ m/z 398.3059, found 398.3048. 
 
3-Benzyltetrahydrofuran-2-one (39a). The general procedure was followed using 3-
methylenebutyrolactone (38) (49 mg, 0.50 mmol) and phenyl boronic acid (92 mg, 0.75 mmol). 
Purification by column chromatography on silica gel (hexanes/EtOAc 92:8) provided 39a as a 
colorless oil (160 mg, 93%):61 1H NMR (400 MHz, CDCl3) δ 1H NMR (400 MHz, CDCl3) δ 
7.20−7.16 (m, 2H), 7.12–7.07 (m, 3H), 4.05 (ddd, J = 8.8, 8.8, 3.0 Hz, 1H), 3.97 (ddd, J = 9.4, 
9.4, 6.7 Hz, 1H), 3.09 (dd, J = 13.5, 3.9 Hz, 1H), 2.70 (ddd, J = 13.5, 9.2, 4.2 Hz, 1H), 2.61 
(dd, J = 13.5, 9.3 Hz, 1H), 2.12−2.04 (m, 1H), 1.88−1.78 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 178.6, 138.4, 128.8, 128.5, 126.6, 66.4, 40.9, 35.9, 27.8. 
 
3-(6-N-Methylindolyl)methyltetrahydrofuran-2-one (39b). The general procedure was 
followed using 3-methylenebutyrolactone (38) (49 mg, 0.50 mmol) and N-methyl-5-
indolylboronic acid (130 mg, 0.75 mmol). Purification by column chromatography on silica gel 
(hexanes/EtOAc 85:15) provided 39b as a light pink solid (102 mg, 89%): mp 52–53 oC; IR 
(neat) 3013, 2912, 1759, 1150, 1020, 749 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.46 (d, J = 1.1 
Hz, 1H), 7.29 (d, J = 8.4 Hz, 1H), 7.09 (dd, J = 8.4, 1.6 Hz, 1H), 7.07 (d, J = 3.1 Hz, 1H), 6.46 
(dd, J = 3.1, 0.7 Hz, 1H), 4.16 (ddd, J = 9.0, 9.0, 3.4 Hz, 1H), 4.09 (ddd, J = 9.0, 9.0, 7.0 Hz, 
1H), 3.78 (s, 3H), 3.38–3.32 (m, 1H), 2,91–2.83 (m, 2H), 2.23–2.15 (m, 1H), 2.07–1.96 (m, 
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1H); %): 13C NMR (100 MHz, CDCl3) δ 179.2, 135.8, 129.4, 129.1, 128.8, 122.6, 120.8, 109.5, 
100.6, 66.7, 41.7, 36.2, 32.9, 27.9; HRMS (ESI) calcd for C14H16NO2 (M + H)+ m/z 230.1191, 
found 230.1191. 
 
2.5.4 Pd-catalyzed amidation of α-methylene-β-lactones 
General procedure for the Pd-catalyzed amidation of α-methylene-β-lactones with 
amines 
 
 Anhydrous DCM (0.25 mL) was added to a reaction tube containing 5 mol% Pd(OAc)2 
(0.005 mmol, 1.1 mg) and 15 mol% PPh3 (0.015 mmol, 4.0 mg) and stirred for 20 min at rt. 
The α-methylene-β-lactone (1.0 equiv, 0.1 mmol) in DCM (0.25 mL) was added via syringe, 
followed by the amine (1.1 equiv, 0.11 mmol; for aryl amines, 2-4 equiv. were used). The 
reaction mixture was stirred for 24 h at rt or 45 oC. The reaction mixture was filtered through 
a short pad of silica which was rinsed with DCM (2 x 2 mL). The crude mixture was 
concentrated in vacuo and purified by column chromatography on silica gel. 
 
N-Benzyl-3-hydroxy-2-methylene-5-phenylpentanamide (40a). The general procedure 
was followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) (19 mg, 0.10 mmol) and 
benzylamine (12 mg, 0.11 mmol), and the reaction was performed at 45 oC. Purification by 
column chromatography on silica gel (hexanes/EtOAc 70:30) provided 40a as a pale yellow 
solid (29 mg, 98%): mp 96–97 oC; IR (neat) 3307 (br), 3027, 2925, 2855, 1715, 1654, 1605, 
1535, 696 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.28–7.18 (m, 7H), 7.13–7.09 (m, 3H), 6.64 (br 
O
O
R
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s, 1H), 5.71 (s, 1H), 5.38 (s, 1H), 4.45 (dd, J = 14.8, 5.8 Hz, 1H), 4.41 (dd, J = 14.8, 5.7 Hz, 
1H), 4.31 (dd, J = 7.9, 5.7 Hz, 1H), 3.08 (br s, 1H), 2.71 (ddd, J = 14.2, 9.6, 6.0 Hz, 1H), 2.59 
(ddd, J = 15.9, 9.2, 6.7 Hz, 1H), 2.03–1.94 (m, 1H), 1.93–1.84 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 168.0, 145.7, 141.7, 138.2, 129.0, 128.7, 128.6, 128.0, 127.8, 126.2, 120.1, 73.4, 
43.7, 37.5, 32.3; HRMS (ESI) calcd for C19H22NO2 (M + H)+ m/z 296.1651, found 296.1664.  
 
N-Benzyl-3-hydroxy-2-methylene-3-phenylpropanamide (40c). The general procedure 
was followed using 4-cyclohexyl-3-methyleneoxetan-2-one (29c) (19 mg, 0.10 mmol) and 
benzylamine (12 mg, 0.11 mmol), and the reaction was performed at rt. Purification by column 
chromatography on silica gel (hexanes/EtOAc 70:30) provided 40c as a yellowish solid (24 
mg, 89%): mp 82–83 oC; IR (neat) 3306 (br), 2923, 2851, 1654, 1609, 1537, 698 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.35–7.31 (m, 2H), 7.28–7.26 (m, 3H), 7.00 (br s, 1H), 5.82 (s, 1H), 
5.37 (s, 1H), 4.52 (dd, J = 14.9, 5.8 Hz, 1H), 4.48 (dd, J = 14.9, 5.8 Hz, 1H), 3.97 (dd, J = 8.1, 
6.1 Hz, 1H), 3.28 (d, J = 6.1 Hz, 1H), 2.04–2.01 (m, 1H), 1.76–1.50 (m, 5H), 1.23–1.13 (m, 
3H), 0.99–0.81 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 168.2, 144.5, 138.3, 128.9, 127.8, 
127.7, 121.5, 80.0, 43.5, 42.2, 30.0, 29.5, 26.5, 26.1, 26.0; HRMS (ESI) calcd for C17H24NO2 
(M + H)+ m/z 274.1807, found 274.1813. 
 
N-Benzyl-3-hydroxy-2-methylenenonanamide (40e). The general procedure was followed 
using 4-hexyl-3-methyleneoxetan-2-one (29e) (17 mg, 0.10 mmol) and benzylamine (12 mg, 
0.11 mmol), and the reaction was performed at rt. Purification by column chromatography on 
silica gel (hexanes/EtOAc 70:30) provided 40e as a white solid (27 mg, 98%): mp 77–78 oC; 
OH O
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IR (neat) 3389 (br), 2954, 2926, 2856, 1654, 1609, 1536, 697 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.36–7.33 (m, 2H), 7.30–7.28 (m, 3H), 6.83 (br s, 1H), 5.80 (s, 1H), 5.45 (s, 1H), 4.52 (dd, 
J = 14.9, 5.7 Hz, 1H), 4.48 (dd, J = 14.9, 5.7 Hz, 1H), 4.36 (dd, J = 12.5, 6.2 Hz, 1H), 2.94 (d, 
J = 5.5 Hz, 1H), 1.71–1.60 (m, 2H), 1.40–1.27 (m, 8H), 0.88 (t, J = 6.6 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 168.0, 145.8, 138.3, 129.0, 127.9, 127.8, 120.1, 74.3, 43.7, 36.0, 31.9, 29.3, 
26.1, 22.8, 14.3; HRMS (ESI) calcd for C17H26NO2 (M + H)+ m/z 276.1964, found 276.1961. 
 
N-Benzyl-3-hydroxy-2-methylene-4-phenylbutanamide (40f). The general procedure was 
followed using 4-benzyl-3-methyleneoxetan-2-one (29f) (18 mg, 0.10 mmol) and benzylamine 
(12 mg, 0.11 mmol), and the reaction was performed at rt. Purification by column 
chromatography on silica gel (hexanes/EtOAc 70:30) provided 40f as a pale yellow solid (21 
mg, 76%): mp 102–104 oC; 1H NMR (300 MHz, CDCl3) δ 7.39–7.16 (m, 10H), 6.72 (br s, 1H), 
5.77 (s, 1H), 5.42 (s, 1H), 4.62 (dd, J = 5.7, 5.7 Hz, 1H), 4.53 (d, J = 5.7 Hz, 2H), 3.06–2.94 
(m, 3H), 3.02 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 167.8, 144.6, 138.2, 137.9, 129.6, 128.9, 
128.6, 127.8, 127.6, 126.7, 120.8, 74.7, 43.5, 42.9; HRMS (ESI) calcd for C18H20NO2 (M + H)+ 
m/z 282.1494, found 282.1482. 
 
N-(3-Hydroxy-2-methylene-5-phenyl)pentanoylmorpholine (40g). The general procedure 
was followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) (19 mg, 0.10 mmol) and 
morpholine (10 mg, 0.11 mmol), and the reaction was performed at rt. Purification by column 
chromatography on silica gel (hexanes/EtOAc 60:40) provided 40g as a pale yellow oil (25 
mg, 92%): IR (neat) 3386 (br), 2922, 2855, 1643, 1604, 1436, 1069, 700 cm-1; 1H NMR (400 
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MHz, CDCl3) δ 7.31–7.26 (m, 3H), 7.21–7.19 (m, 2H), 5.50 (s, 1H), 5.18 (s, 1H), 4.32 (ddd, J 
= 12.9, 6.4, 6.4 Hz, 1H), 3.65 (br s, 8H), 3.05 (d, J = 6.3 Hz, 1H), 2.85 (ddd, J = 14.2, 7.6, 7.6 
Hz, 1H), 2.71 (ddd, J = 14.4, 7.9, 7.9 Hz, 1H), 1.94–1.88 (m, 2H); 13C NMR (100 MHz, CDCl3) 
δ 170.0, 145.1, 141.7, 128.7, 128.7, 126.2, 116.4, 77.43, 73.2, 67.1, 37.8, 32.3; HRMS (ESI) 
calcd for C16H22NO3 (M + H)+ m/z 276.1600, found 276.1617. 
 
N-Allyl-3-hydroxy-2-methylene-5-phenylpentanamide (40h). The general procedure was 
followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) (19 mg, 0.10 mmol) 
allylamine (6 mg, 0.11 mmol), and the reaction was performed at rt. Purification by column 
chromatography on silica gel (hexanes/EtOAc 70:30) provided 40h as a pale yellow solid (24 
mg, 97%): mp 74–75 oC; IR (neat) 3306 (br), 2922, 2860, 1655, 1605, 1531, 921, 698 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.30–7.26 (m, 3H), 7.20–7.17 (m, 2H), 6.53 (br s, 1H), 5.90–5.81 
(m, 1H), 5.78 (s, 1H), 5.45 (s, 1H), 5.20 (dddd, J = 17.2, 1.6, 1.6, 1.6 Hz, 1H), 5.16 (dddd, J = 
10.3, 1.4, 1.4, 1.4 Hz, 1H), 4.37 (ddd, J = 7.8, 5.8, 5.8 Hz, 1H), 3.95–3.92 (m, 2H), 3.23 (d, J 
= 6.0 Hz, 1H), 2.79 (ddd, J = 14.0, 5.9, 5.9 Hz, 1H), 2.68 (ddd, J = 14.1, 6.7, 6.7 Hz, 1H), 
2.10–2.01 (m, 1H), 1.99–1.91 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 168.0, 145.7, 141.7, 
134.0,  128.7, 128.6, 126.2, 120.0, 116.8, 73.4, 42.0, 37.5, 32.3; HRMS (ESI) calcd for 
C15H20NO2 (M + H)+ m/z 246.1494, found 246.1521. 
 
3-Hydroxy-2-methylene-N-phenyl-5-phenylpentanamide (40i). The general procedure 
was followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) (19 mg, 0.10 mmol) 
aniline (41 mg, 0.44 mmol), and the reaction was performed at 45 oC. Purification by column 
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chromatography on silica gel (hexanes/EtOAc 70:30) provided 40i as a pale yellow solid (26 
mg, 92%): mp 126–128 oC; IR (neat) 3306 (br), 3305, 2924, 2860, 1650, 1618, 1522, 747, 
694 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.60 (br s, 1H), 7.57–7.55 (m, 2H), 7.36–7.26 (m, 4H), 
7.21–7.11 (m, 4H), 6.01 (s, 1H), 5.54 (s, 1H), 4.48 (dd, J = 7.8, 7.8 Hz, 1H), 2.94 (br s, 1H), 
2.84–2.76 (m, 1H), 2.75–2.68 (m, 1H), 2.18–2.08 (m, 1H), 2.07–1.98 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 165.6, 145.6, 141.4, 137.8, 129.3, 128.7, 126.3, 124.8, 122.1, 120.4, 73.6, 
37.3, 32.3; HRMS (ESI) calcd for C18H20NO2 (M + H)+ m/z 282.1494, found 282.1498.  
 
3-Hydroxy-N-(4-methylphenyl)-2-methylene-5-phenylpentanamide (40j). The general 
procedure was followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) (19 mg, 0.10 
mmol) toluidine (24 mg, 0.22 mmol), and the reaction was performed at 45 oC. Purification by 
column chromatography on silica gel (hexanes/EtOAc 70:30) provided 40j as a pale yellow 
solid (28 mg, 96%): mp 113–115 oC; IR (neat) 3286 (br), 3026, 2921, 2861, 1658, 1597, 1513, 
813, 697 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.58 (br s, 1H), 7.44–7.42 (m, 2H), 7.30–7.26 (m, 
2H), 7.21–7.17 (m, 3H), 7.14–7.12 (m, 2H), 5.98 (s, 1H), 5.50 (s, 1H), 4.45 (dd, J = 7.9, 5.8 
Hz, 1H), 3.19 (br s, 1H), 2.83–2.67 (m, 2H), 2.32 (s, 3H), 2.16–2.07 (m, 1H), 2.05–1.96 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 165.6, 145.6, 141.4, 135.2, 134.5, 129.7, 128.7, 128.7, 
126.2, 121.9, 120.5, 73.5, 37.4, 32.3, 21.1; HRMS (ESI) calcd for C19H22NO2 (M + H)+ m/z 
296.1651, found 296.1681. 
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3-Hydroxy-N-(4-fluorophenyl)-2-methylene-5-phenylpentanamide (40k). The general 
procedure was followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a)  (19 mg, 0.10 
mmol) and 4-fluoroaniline (50 mg, 0.44 mmol), and the reaction was performed at 45 oC. 
Purification by column chromatography on silica gel (hexanes/EtOAc 70:30) provided 40k as 
a pale yellow solid (24 mg, 80%): mp 78–79 oC; IR (neat) 3293 (br), 2926, 2859, 1660, 1611, 
1540, 1508, 832, 700 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.73 (br s, 1H), 7.54–7.49 (m, 2H), 
7.31–7.26 (m, 2H), 7.21–7.18 (m, 3H), 7.04–6.99 (m, 2H), 6.03 (s, 1H), 5.52 (s, 1H), 4.47 (dd, 
J = 7.8, 7.8 Hz, 1H), 3.05 (br s, 1H), 2.84–2.66 (m, 2H), 2.18–1.95 (m, 2H); 13C NMR (75 MHz, 
CDCl3) δ 165.5, 141.3, 139.7 (d, JC-F = 653 Hz), 128.7, 128.7, 126.3, 122.2 (d, JC-F = 8.3 Hz), 
115.9 2 (d, JC-F = 22.5 Hz), 73.5, 37.4, 32.3; HRMS (ESI) calcd for C19H19FNO2 (M + H)+ m/z 
300.1400, found 300.1417. 
 
N-(3-hydroxy-2-methylene-5-phenyl)-pentanoylindoline (40l). The general procedure was 
followed using 4-(2-phenylethyl)-3-methyleneoxetan-2-one (29a) (19 mg, 0.10 mmol) and 
indoline (52 mg, 0.44 mmol), and the reaction was performed at 45 oC. Purification by column 
chromatography on silica gel (hexanes/EtOAc 60:40) provided 40l as a brownish thick oil (28 
mg, 90%): IR (neat) 3404 (br), 2922, 1641, 1618, 1481, 1408, 698 cm-1; 1H NMR (400 MHz, 
CDCl3): δ 8.10 (br s, 1H), 7.29–7.26 (m, 3H), 7.22–7.15 (m, 5H), 7.06 (dd, J = 7.4, 7.4 Hz, 
1H), 5.62 (s, 1H), 5.42 (s, 1H), 4.44 (dd, J = 6.6, 6.6 Hz, 1H), 4.17–4.04 (m, 2H), 3.14 (dd, J 
= 14.9, 8.2 Hz, 1H), 3.07 (dd, J = 14.9, 8.2 Hz, 1H), 2.94–2.87 (m, 1H), 2.77–2.70 (m, 1H), 
2.01 (dd, J = 7.7, 7.7 Hz, 1H), 1.99 (dd, J = 7.7, 7.7 Hz, 1H),; 13C NMR (100 MHz, CDCl3) δ 
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168.9, 147.2, 142.4, 141.9, 132.6, 128.7, 128.6, 127.6, 126.1, 125.1, 124.6, 117.8, 116.9, 
73.1, 50.8 (br), 38.0, 32.4, 28.3 (br); HRMS (ESI) calcd for C20H22NO2 (M + H)+ m/z 308.1651, 
found 308.1662. 
 
N-Benzyl-3-hydroxy-2-phenylpropanamide (43). The general procedure was followed 
using 2-phenyloxetan-2-one (8a) (15 mg, 0.10 mmol) and benzyl amine (12 mg, 0.11 mmol), 
and the reaction was performed at rt. Purification by column chromatography on silica gel 
(hexanes/EtOAc 60:40) provided 43 as a white solid (25 mg, 96%): mp 116–118 oC; IR (neat) 
3276 (br), 3030, 2924, 1638, 1548, 697 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.36–7.25 (m, 8H), 
7.18–7.16 (m, 2H), 5.82 (br s, 1H), 4.43 (dd, J = 14.9, 5.8 Hz, 1H), 4.43 (dd, J = 14.9, 5.8 Hz, 
1H), 4.18 (dd, J = 11.0, 8.8 Hz, 1H), 3.80 (dd, J = 11.0, 4.3 Hz, 1H), 3.70 (dd, J = 8.7, 4.5 Hz, 
1H), 3.44 (br s, 1H); 13C NMR (100 MHz, CDCl3) δ 173.7, 138.0, 136.8, 129.4, 128.9, 128.7, 
128.2, 127.7, 127.7, 65.3, 54.6, 43.7; HRMS (ESI) calcd for C16H18NO2 (M + H)+ m/z 256.1338, 
found 256.1349. 
 
(2R*,3R*)-N-Benzyl-3-hydroxy-2-methyl-5-phenylpentanamide (44). The general 
procedure was followed using  trans-3-methyl-4-(2-phenylethyl)-oxetan-2-one (8i) (19 mg, 
0.10 mmol) and benzyl amine (12 mg, 0.11 mmol), and the reaction was performed at rt for 
48 h. Purification by column chromatography on silica gel (hexanes/EtOAc 60:40) provided 
44 as a white solid (24 mg, 82%): mp 133–135 oC; IR (neat) 3293 (br), 2914, 1643, 1549, 697 
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.34–7.24 (m, 7H), 7.20–7.16 (m, 3H), 6.17 (br s, 1H), 4.43 
(d, J = 2.5 Hz, 1H), 4.41 (d, J = 2.5 Hz, 1H), 3.63 (dddd, J = 5.4, 5.4, 5.4, 0.0 Hz, 1H), 3.40 
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(br s, 1H), 2.86 (ddd, J = 14.2, 7.4, 7.4 Hz, 1H), 2.67 (ddd, J = 13.9, 8.0, 8.0 Hz, 1H), 2.26 
(dq, J = 7.1, 5.2 Hz, 1H), 1.82–1.76 (m, 2H), 1.26 (d, J = 7.1 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 176.1, 142.2, 138.2, 128.9, 128.7, 128.6, 127.9, 127.8, 126.1, 73.5, 46.2, 43.5, 37.6, 
32.4, 15.9; HRMS (ESI) calcd for C19H24NO2 (M + H)+ m/z 298.1807, found 298.1813. 
 
 
4-Benzhydryl-3-heptylideneoxetan-2-one (29g). 1-Octene (84 mg, 0.75 mmol) was added 
to a solution of 4-benzhydryl-3-methyleneoxetan-2-one 29b  (130 mg, 0.50 mmol equiv) under 
N2 in DCM (2 mL). Catalyst 34 (5 mol%) was added, and the resultant solution was heated at 
reflux. The reaction was monitored by 1H NMR. Upon consumption (~20 h) of 29b, the solution 
was cooled and concentrated, and the brown residue was purified by column chromatography 
on silica gel (petroleum ether/EtOAc 99:1). Lactone 29g was obtained as a clear oil (114 mg, 
68%, Z/E >19:1): 1H NMR (400 MHz, CDCl3) for the major isomer: δ 7.37–7.28 (m, 7H), 7.26–
7.22 (m, 3H), 5.48 (d, J = 9.2 Hz, 1H), 5.18 (ddd, J = 8.1, 8.1, 1.0 Hz, 1H), 4.20 (d, J = 9.2 Hz, 
1H), 2.45–2.30 (m, 2H), 1.33–1.21 (m, 8H), 0.89 (t, J = 6.7 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 163.9, 140.0, 139.6, 139.0, 136.1, 129.0, 128.8, 128.5, 127.8, 127.3, 79.1, 55.1, 
31.6, 29.2, 28.8, 28.7, 22.7, 14.2. 
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N-Benzyl-4,4-diphenyl-2-heptylidene-3-hydroxybutanamide (40m). The general proce-
dure for the Pd-catalyzed amidation was followed using 4-benzhydryl-3-heptylideneoxetan-2-
one (29g) (34 mg, 0.10 mmol) and benzyl amine (12 mg, 0.11 mmol), and the reaction was 
performed at 45 oC. Purification by column chromatography on silica gel (hexanes/EtOAc 
80:20) provided 40m as a pale yellow oil (40 mg, 90%, Z/E 19:1): IR (neat) 3323 (br), 2954, 
2926, 2856, 1660, 1601, 746, 697 cm-1; 1H NMR (400 MHz, CDCl3) for the major isomer: 
δ 7.37–7.28 (m, 9H), 7.22–7.08 (m, 6H), 5.93 (dd, J = 5.3, 5.3 Hz, 1H), 5.30 (dd, J = 10.4, 7.6 
Hz, 1H), 4.89 (dd, J = 10.0, 5.4 Hz, 1H), 4.49 (dd, J = 14.6, 5.9 Hz, 1H), 4.45 (dd, J = 14.6, 
5.9 Hz, 1H), 4.16 (d, J = 10.0 Hz, 1H), 3.09 (d, J = 5.4 Hz, 1H), 2.09–2.04 (m, 2H), 1.26–1.00 
(m, 8H), 0.85 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 168.6, 142.0, 141.5, 138.3, 
138.1, 135.8, 129.0, 128.9, 128.8, 128.8, 128.6, 128.3, 127.9, 127.0, 126.8, 78.9, 57.4, 43.6, 
31.8, 29.3, 29.3, 28.9, 22.7, 14.3; HRMS (ESI) calcd for C30H36NO2 (M + H)+ m/z 442.2746, 
found 442.2770. 
 
 
(4R)-4-(2-Phenylethyl)-3-methyleneoxetan-2-one [(R)-29a]. Lipase CAL-B (lipase acrylic 
resin from Candida Antarctica; 19 mg) was added to a solution of 4-(2-phenylethyl)-3-
methyleneoxetan-2-one (rac-29a) (190 mg, 1.0 mmol) and benzyl alcohol (4 mmol) in MTBE 
(5 mL). The resulting suspension was stirred at rt, and conversion was monitored by 1H NMR. 
After 24 h, ~50% conversion was obtained. Percent conversion was estimated based from the 
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ratio of unreacted 29a and 42. The reaction mixture was passed through a pad of Celite and 
washed with MTBE (3 x 5 mL). The filtrate was dried (Na2SO4) and concentrated in vacuo. 
The crude mixture was purified by column chromatography on silica gel (hexanes/EtOAc 95:5) 
and gave (R)-29a as a colorless oil (79 mg, 42%):34 [α]20D = (+)-60.3 (c = 1.00, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 7.36–7.31 (m, 2H), 7.27–7.22 (m, 3H), 5.86 (dd, J = 2.0, 2.0 Hz, 
1H), 5.33 (dd, J = 1.7, 1.7 Hz, 1H), 4.97 (dddd, J = 6.4, 6.4, 1.7, 1.7 Hz, 1H), 2.87–2.71 (m, 
2H), 2.19–2.12 (m, 2H); 99% ee, retention time 7.7 min (major) and 8.7 min (minor) on 
Chiralpak AY3 (5% IPA/hexane, 1.0 mL/min). 
 
 
(3R)-N-Benzyl-3-hydroxy-2-methylene-5-phenylpentanamide [(R)-40a]. Anhydrous DCM 
(0.25 mL) was added to a reaction tube containing 5 mol% Pd(OAc)2 (0.005 mmol, 1.1 mg) 
and 15 mol% PPh3 (0.015 mmol, 4.0 mg), and the solution was stirred for 20 min at rt. (R)-4-
(2-Phenylethyl)-3-methyleneoxetan-2-one [(R)-29a] (19 mg, 0.1 mmol) in DCM (0.25 mL) was 
added via syringe, followed by the benzyl amine (12 mg, 0.11 mmol). The reaction mixture 
was stirred for 24 h 45 oC. The reaction mixture was filtered through a short pad of silica which 
was rinsed with DCM (2 x 2 mL). The crude mixture was concentrated in vacuo and purified 
by column chromatography on silica gel (hexanes/EtOAc 70:30) and gave (R)-40a as a pale 
yellow solid (27 mg, 92%): [α]20D = (+)-24.8 (c = 1.00, CHCl3); mp 96–97 oC; 1H NMR (400 
MHz, CDCl3): δ 7.28–7.18 (m, 7H), 7.13–7.09 (m, 3H), 6.64 (br s, 1H), 5.71 (s, 1H), 5.38 (s, 
1H), 4.45 (dd, J = 14.8, 5.8 Hz, 1H), 4.41 (dd, J = 14.8, 5.7 Hz, 1H), 4.31 (dd, J = 7.9, 5.7 Hz, 
1H), 3.08 (br s, 1H), 2.71 (ddd, J = 14.2, 9.6, 6.0 Hz, 1H), 2.59 (ddd, J = 15.9, 9.2, 6.7 Hz, 
O
Ph
O
+
OH
NHBn
O
Ph
(+)-(R)-40a (92% yield)
99% ee; [α]D +24.8
5 mol% Pd(OAc)2
15 mol% PPh3
(+)-(R)-29a
99% ee
BnNH2
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1H), 2.03–1.94 (m, 1H), 1.93–1.84 (m, 1H); 99% ee, retention time 12.2 min (major) and 13.2 
min (minor) on Chiralcel OJ (2% IPA/hexane, 1.5 mL/min). 
 
General procedure for the Pd-catalyzed kinetic resolution of α-methylene-β-lactones 
with benzylamine.  
 
Deuterated chloroform (0.50 mL) was added to a reaction tube containing 2 mol% Pd(OAc)2 
(0.004 mmol, 1.0 mg) and 5 mol% L5 (0.010 mmol, 6.6 mg), and the solution was stirred for 
20 min at rt. The α-methylene-β-lactone (1.0 equiv, 0.2 mmol) in CDCl3 (0.50 mL) was added 
via syringe, followed by the amine (1.0 equiv, 0.2 mmol). The reaction mixture was stirred at 
rt for 16 to 20 h until 50–55% conversion was reached. The reaction was monitored by 1H 
NMR analysis. The reaction mixture was filtered through a short pad of silica which was rinsed 
with DCM (2 x 2 mL). The crude mixture was concentrated in vacuo and purified by column 
chromatography on silica gel. 
 
(4R)-4-(2-Phenylethyl)-3-methyleneoxetan-2-one ([R]-[+]-29a). The general procedure 
was followed using racemic 29a (38 mg, 0.20 mmol). Purification by column chromatography 
on silica gel (petroleum ether/EtOAc 95:5) provided (R)-(+)-29a as a colorless oil (16 mg, 
43%):34 [α]20D = (+)-40.3 (c = 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.36–7.31 (m, 2H), 
7.27–7.22 (m, 3H), 5.86 (dd, J = 2.0, 2.0 Hz, 1H), 5.33 (dd, J = 1.7, 1.7 Hz, 1H), 4.97 (dddd, 
J = 6.4, 6.4, 1.7, 1.7 Hz, 1H), 2.87–2.71 (m, 2H), 2.19–2.12 (m, 2H); 68% ee, retention time 
7.7 min (major) and 8.7 min (minor) on Chiralpak AY3 (5% IPA/hexane, 1.0 mL/min). 
O
O
R
rac-29
BnNH2+
2 mol% Pd(OAc)2
5 mol% L5
CDCl3, rt, 16 to 20 h
~50-55% conversion
O
O
R
O O
PPh2 Ph2P
L5 (R,R,R)-SKP ligand
*
O
O
(R)-(+)-29a
Ph
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4-Benzhydryl-3-methyleneoxetan-2-one ([+]-29b). The general procedure was followed 
using racemic 29b (0.2 mmol, 50 mg). Purification by column chromatography on silica gel 
(petroleum ether/EtOAc 95:5) provided (+)-29b as a white solid (19 mg, 37%):6 [α]20D = (+)-
51.4 (c = 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.30–7.23 (m, 10H), 5.74 (dd, J = 2.0, 
1.4 Hz, 1H), 5.53 (ddd, J = 9.6, 2.0, 1.4 Hz, 1H), 4.72 (dd, J = 2.0, 1.4 Hz, 1H), 4.20 (d, J = 
9.6, 1H); 74% ee, retention time 6.5 min (major) and 7.1 min (minor) on Chiralpak AY3 (5% 
IPA/hexane, 1.0 mL/min). 
 
3-Methylene-4-tridecyloxetan-2-one ([+]-29d). The general procedure was followed using 
racemic 29d (53 mg, 0.20 mmol). Purification by column chromatography on silica gel 
(petroleum ether/EtOAc 98:2) provided (+)-29d as a colorless oil (21 mg, 40%):17 [α]20D = (+)-
37.0 (c = 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 5.85 (dd, J = 1.9, 1.9 Hz, 1H), 5.39 (dd, 
J = 1.7, 1.7 Hz, 1H), 4.92 (dddd, J = 6.5, 6.5, 1.6, 1.6 Hz, 1H), 1.81 (dddd, J = 7.1, 7.1, 7.1, 
0.0 Hz, 1H), 1.81 (dddd, J = 7.8, 7.8, 7.8, 0.0 Hz, 1H), 1.46–1.40 (m, 2H), 1.33–1.22 (m, 20H), 
0.84 (t, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 163.7, 146.6, 114.8, 79.7, 33.4, 32.0, 
29.8, 29.7, 29.7, 29.6, 29.5, 29.5, 29.3; 56% ee, retention time 10.1 min (major) and 10.8 min 
(minor) on Chiralpak AY3 (5% IPA/hexane, 0.5 mL/min). 
O
O
(+)-29b
*
O
O
C10H21
(+)-29d
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4-Hexyl-3-methyleneoxetan-2-one ([+]29e). The general procedure was followed using 
racemic 29e (34 mg, 0.20 mmol). Purification by column chromatography on silica gel 
(petroleum ether/EtOAc 94:4) provided (+)-29e as a colorless oil (13 mg, 38%): [α]20D = (+)-
40.1 (c = 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 5.85 (dd, J = 1.8, 1.8 Hz, 1H), 5.39 (dd, 
J = 1.6, 1.6 Hz, 1H), 4.92 (dddd, J = 6.6, 6.6, 1.8, 1.8 Hz, 1H), 1.80 (ddd, J = 7.4, 7.4, 7.4 Hz, 
2H), 1.46–1.37 (m, 2H), 1.33–1.24 (m, 6H), 0.84 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 163.7, 146.5, 114.9, 79.7, 33.4, 31.6, 29.0, 24.6, 22.5, 14.1; 72% ee, retention time 
5.5 min (minor) and 6.8 min (major) on Chiralpak AY3 (5% IPA/hexane, 0.5 mL/min). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(+)-29e
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A. HPLC traces 
 
 
 
 
 
 
 
 
 
Method: Chiralpak AY3 (Particle size: 3 um; column size: 4.6 x 250 mm) 
5.0% IPA/hexane; 1.0 mL/min 
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Method: Chiralpak AY3 (Particle size: 3 um; column size: 4.6 x 250 mm) 
5.0% IPA/hexane; 1.0 mL/min 
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Method: Chiralcel OJ (Particle size: 3 um; column size: 4.6 x 250 mm) 
2.0% IPA/hexane; 1.5 mL/min 
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Method: Chiralcel OJ (Particle size: 3 um; column size: 4.6 x 250 mm) 
2.0% IPA/hexane; 1.5 mL/min 
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Retention	time																										Area														Height											%	Area	
	
RT6.514	 6.514	 	 283650	 38926	 						50.1704	 	
RT7.067	 7.067	 	 281724	 33203	 						49.8296	 	
	
	
	
Method: Chiralpak AY3 (Particle size: 3 um; column size: 4.6 x 250 mm) 
5.0% IPA/hexane; 1.0 mL/min 
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Retention	time																					Area																					Height																		%	Area	
	
RT6.462		 	 1431262	 193060											 87.0550		
RT7.013		 	 212827	 	 24595	 										 12.9450		
	
 
 
Method: Chiralpak AY3 (Particle size: 3 um; column size: 4.6 x 250 mm) 
5.0% IPA/hexane; 1.0 mL/min 
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Retention	time																													Area																		Height																		%	Area	
	
RT10.120	 10.120	 	 4153842	 383727		 50.3263	
RT10.882	 10.882	 	 4100737	 345173		 49.6829	
	
	
	
Method: Chiralpak AY3 (Particle size: 3 um; column size: 4.6 x 250 mm) 
5.0% IPA/hexane; 0.5 mL/min 
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Retention	time																																				Area																				Height														%	Area	
	
RT10.068	 10.068	 	 2613948	 243431		 78.3454	 	
RT10.788	 10.788	 	 722495		 61480	 	 21.6546	 	
	
	
	
	
Method: Chiralpak AY3 (Particle size: 3 um; column size: 4.6 x 250 mm) 
5.0% IPA/hexane; 0.5 mL/min 
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Method: Chiralpak AY3 (Particle size: 3 um; column size: 4.6 x 250 mm) 
5.0% IPA/hexane; 1.0 mL/min 
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Method: Chiralpak AY3 (Particle size: 3 um; column size: 4.6 x 250 mm) 
5.0% IPA/hexane; 1.0 mL/min 
 
 
 
 
 
 
 
 
 
 
 
(+)-29e (38% yield)
72% ee, [α]D +40.1
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